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While XMAP215 (CKAP5 / ch-TOG) has been best characterized for its microtubule 
polymerase function, recent studies have highlighted a novel role for XMAP215 in facilitating an 
interaction between microtubules and F-actin in the embryonic neuronal growth cone, a critical 
structure involved in neuronal outgrowth and guidance mechanisms. Microtubule and F-actin 
cytoskeletal cross talk and reorganization are important aspects of axonal guidance mechanisms, 
but how associated proteins facilitate this function largely remains a mystery. In addition, it has 
long been established that neuronal growth cone navigation depends on changes in microtubule 
(MT) and F-actin architecture downstream of guidance cues. However, the mechanisms by 
which MTs and F-actin are dually coordinated remain a fundamentally unresolved question.  
Here, I report that the well-characterized MT polymerase, XMAP215 (also known as ch-
TOG / CKAP5), plays an important role in mediating MT–F-actin interactions within the growth 
cone. I demonstrate that XMAP215 regulates MT–F-actin alignment through its N-terminal TOG 
1–5 domains. Additionally, I show that XMAP215 directly binds to F-actin in vitro and co-
localizes with F-actin in the growth cone periphery. By working with lab colleagues, we also 
find that XMAP215 is required for regulation of growth cone morphology and response to the 
guidance cue, Ephrin A5. Our findings provide the first strong evidence that XMAP215 
coordinates MT and F-actin interaction in vivo. It is here that I suggest a model in which 
XMAP215 regulates MT extension along F-actin bundles into the growth cone periphery and 





Furthermore, I then go on to study this dual microtubule and F-actin role, diving deeper 
into the mechanism behind this novel ability of XMAP215. Here, I report that XMAP215 is 
capable of spatially localizing populations of microtubules into distinct domains in the growth 
cone through its less well-characterized microtubule-lattice binding activity. In addition, through 
the use of purified proteins and biochemical assays, I show that XMAP215 is capable of binding 
directly to F-actin, facilitated by its unique TOG5 domain. Finally, through biochemical means 
and super resolution imaging, I show that this novel function of XMAP215 is mediated by 
polymerase-incompetent mutants of XMAP215. Taken together, my findings show strong 
evidence of a non-microtubule-polymerase function of XMAP215, providing mechanistic 
insights into how microtubule populations can be guided by interaction with the F-actin 
cytoskeleton.  
In conclusion, I explore a novel and functionally important role for XMAP215 in 
facilitating interactions between microtubule and actin cytoskeletons, bridging the two structural 
components of the cell together. In this way, XMAP215 is now known as a distinct 
microtubule/F-actin regulator that governs microtubule exploration through the help of actin in 
neurons, in addition to its previously characterized function as a microtubule polymerase. While 
this thesis explores the very groundwork of XMAP215’s new novel function, there is still a great 
deal more to learn about the overall mechanism occurring, as well as an understanding of its role 
in various cell types. 
 
Portions of abstract were adapted:  
(Adapted from Slater and Cammarata et al., 2019 – Journal of Cell Science) 








iii. List of Figures 
iv. List of Symbols and Abbreviations 
 
Chapter 1. Introduction 
I. The Growth Cone 
II. Actin Networks in the Growth Cone 
III. Microtubule Dynamics in the Growth Cone 
IV. The Coupling of Microtubules to Actin Dynamics in the Growth Cone 
V. +TIPs act as signaling transduction elements to alter cytoskeletal dynamics 
VI. Proteins Linking Microtubules to F-actin and Retrograde Flow 
VII. Current Models for how Microtubules Interact with F-actin to Control Cytoskeletal 
Coupling 
VIII. Outline of Research Presented on XMAP215 Functioning 
 
Chapter 2. XMAP215 promotes microtubule–F-actin interactions to regulate 
growth cone microtubules during axon guidance 
I. Introduction 
II. Results 
i. XMAP215 knockdown leads to global morphological changes in the 
growth cone and defects in axon guidance 
ii. XMAP215 knockdown disrupts MT organization in the growth cone 
iii. XMAP215 promotes penetration of MTs into growth cone filopodia 




v. The N-terminus of XMAP215 is necessary and sufficient to promote MT–
F-actin alignment 
vi. XMAP215 can interact with F-actin directly, but does not affect F-actin 
distribution 
III. Discussion 
IV. Materials and Methods 
V. Supplementary Information 
 
Chapter 3. XMAP215 displays a unique lattice based function that links MTs to 
F-actin in the Growth Cone 
I. Introduction 
II. Results 
i. The TOG5 domain is uniquely important in allowing direct interaction 
with F-actin in vitro 
ii. Localization of XMAP215 to the microtubule lattice or plus end in growth 
cones is facilitated by distinct domains 
iii. TOG3-Cterm construct is capable of affecting microtubule looping and 
extension phenotypes in the growth cone 
iv. Microtubule lattice-bound XMAP215 is capable of rescuing knockdown-
induced microtubule/F-actin misalignments in growth cones 
III. Discussion 
IV. Materials and Methods 
V. Supplementary Information 
 
Chapter 4. Discussion / Conclusion 
I. Contributions to the Literature 
II. Future Directions 





Chapter 5. Appendix 
I. The microtubule plus-end-tracking protein TACC3 promotes persistent axon 
outgrowth and mediates responses to axon guidance signals during development 
II. Abelson-induced phosphorylation of TACC3 modulates its interaction with 
microtubules and affects its impact on axon outgrowth and guidance 
III. Characterization of Xenopus laevis Guanine Deaminase reveals new insights for its 







I would like to thank everyone who has helped me along this journey, through all of the 
hardships, mistakes, and successes of graduate school. I think most importantly, and the only 
reason that I have made it this far, is from all of the kind support of everyone around me during 
my time at Boston College.  
The first person that I have to thank is my girlfriend, Mary Alice. You have been the 
most wonderful source of support for me. Even though you have heard my research a million 
times, and could probably recite much of it better than me, you were always so attentive and an 
amazing source of motivation for me. Similarly, I have to thank my wonderful family members 
and friends. Each of you have kept me motivated (and sane) until the very end of my graduate 
career. 
I also have to acknowledge my PI, Laura Anne, my Thesis Committee members, 
Sangmook Lee, my collaborators, as well as my friends and graduate student colleagues, 
Micaela, Beth, and Burcu. Each one of you has provided me the environment to become a great 
scientist, and enjoy every day that I come to work. My favorite part about graduate school has 
always been the friends that I have made along the way, and I will always be thankful for that. 
Finally, I wanted to thank the BC Biology Dept., Animal Care Facility, and the entire 
faculty. There are too many people to list, but so many people have left their mark on this 
transformative process for me. Specifically, I wanted to thank Eric Folker for being like a 
secondary PI to me this last year. I am forever grateful for the help you have extended to me. 
Finally, I wanted to thank Welkin, Dina, Colette, Diane, and Walter, for always having the time 




List of Figures 
Figure 1.I.1. Overview of the different compartments of the neuronal growth cone. 
Figure 1.I.2. Microtubule and F-actin functioning in the periphery of the growth cone. 
Figure 1.II.1. F-actin polymerization and retrograde flow provide a constant treadmilling of actin. 
Figure 1.III.1. Microtubule stabilizers and destabilizers are able to control growth cone steering. 
Figure I.IV.1. Microtubules interact with several distinct F-actin structures throughout the growth cone. 
Figure 1.V.1. Microtubule protrusion and advancement into the periphery can be altered through 
coupling with F-actin retrograde flow. 
Figure 1.VI.1. Example +TIP proteins affect MT attachment to F-actin bundles. 
Figure 2.II.1. XMAP215 KD leads to global growth cone phenotypic changes and guidance defects. 
Figure 2.II.2. XMAP215 KD disrupts MT organization in the growth cone. 
Figure 2.II.3. XMAP215 promotes penetration of MTs into growth cone filopodia. 
Figure 2.II.4. XMAP215 partial KD does not affect MT polymerization rates in the growth cone. 
Figure 2.II.5. XMAP215 is required for normal MT–F-actin alignment in growth cones. 
Figure 2.II.6. The N-terminal TOG1–5 domains of XMAP215 are necessary and sufficient to localize to 
F-actin in the growth cone periphery. 
Figure 2.II.7. The N-terminal of XMAP215 is necessary and sufficient to promote MT–F-actin 
alignment. 
Figure 2.II.8. XMAP215 can directly bind to F-actin but does not affect local F-actin density.  
Figure 2.II.9. XMAP215 KD correlates with increased total F-actin levels, although F-actin distribution 
is not affected. 
Figure 3.I.1. Depiction of Growth Cone regions and parameters of analysis for MT exploration 
Figure 3.II.1. The TOG5 domain is uniquely important in allowing direct interaction with F-actin in 
vitro. 
Figure 3.II.2. Localization of XMAP215 to the MT lattice or plus end in growth cones is facilitated by 
distinct domains. 
Figure 3.II.3. Removal of TOG1-2 domains of XMAP215 diminish microtubule velocity effects. 
Figure 3.II.4. TOG3-C-term construct is capable of affecting MT looping and extension phenotypes in 
the growth cone. 
Figure 3.II.5. XMAP215 utilizes its lattice-binding region to facilitate MT and F-actin interaction in the 
growth cone. 
Figure 3.III.1. Table summarizing F-actin binding, MT localization, and rescuing of MT/F-actin filament 




List of Symbols and Abbreviations 
MT = microtubule 
F-actin = filamentous actin 
XMAP215 = Xenopus microtubule associated protein 215  
chTOG = colorectal and hepatic Tumor Overexpressed Gene 
CKAP5 = Cytoskeletal Associated Protein 5 
KD = knockdown 
OE = overexpression 
+TIP = plus end tracking protein 
MAP = microtubule associated protein 
EB1 = End binding protein 1 
TACC3 = Transforming acidic coiled-coil 3 protein 
CLASP = Cytoplasmic linker associated protein 








Chapter 1. Introduction 
(Adapted from Cammarata et al., 2016 – Cytoskeleton Reviews) 
 
I. The Growth Cone 
The growth cone is a dynamic structure found on the ends of growing axons, which allows 
axons to navigate through their environment by intercepting a myriad of extracellular cues and 
translating them into mechanical behaviors 1. The structure of the growth cone is thus suitably 
complex, containing several compartments each with unique cytoskeletal arrangements (Figure 
1.I.1.). The structure of the growth cone is chiefly divided into three domains (central, 
transitional and peripheral), which contain distinct cytoskeletal arrangements of actin filaments 
(F-actin) and microtubules 2. Both of these polymers form complex arrays to create traction, 
transduce force, and facilitate trafficking, in order to permit proper elongation and navigation of 
the axon. Along the axon shaft, microtubules are tightly bundled 3–6. Upon arrival at the growth 
cone central domain, their dynamic plus-ends splay more freely, growing and shrinking as they 
come into contact with F-actin arcs 7. Many microtubule plus-ends are sequestered here and 
undergo both looping and catastrophe. Some microtubules, commonly referred to as “pioneer 
microtubules”, break through to the peripheral domain, where they traverse through the 
crisscrossing F-actin lamella 6–9. Once they have reached the periphery, these pioneer 
microtubules intersect and then crosslink with F-actin bundles, which are thought to guide the 




of the growth cone together, these interacting microtubule and F-actin networks are exposed to 
signaling events downstream of extracellular guidance cues. 
These guidance-signaling pathways directly and indirectly modify filopodial actin and 
microtubule networks, catalyzing mechanical movements of the growth cone. Initially, precise 
mechanistic interactions between signaling molecules and the growth cone cytoskeleton were not 
clear, and early studies focused mainly on how these cascades may specifically impact the 
remodeling of F-actin 11,12. However, it had long been established that microtubules are also 
important for successful axon guidance 6,13–16. Approximately a decade ago, an important set of 
Figure 1.I.1. Overview of the different compartments of the neuronal growth cone. The growth cone is made up of several 
distinct compartments, each containing unique microtubule (blue) and F-actin (red) structural elements. The central domain 
(gray) is comprised of stable microtubules that have entered through the axon shaft and are then consolidated. These stable 
microtubules are hindered by F-actin arcs; structures located in the transitional domain (tan) that act as barriers for microtubule 
growth. Microtubules that do emerge from the transitional domain into the peripheral domain (peach) are called “pioneer 
microtubules”. It is in this domain that pioneer microtubules are guided along F- actin bundles and traverse through a 
lamellipodial-like F-actin network. F-actin is orientated so that their barbed plus-ends are directed towards the leading edge of the 
growth cone while their pointed minus-ends are directed towards the central domain. These pioneer microtubules follow the F-




studies revealed that guidance signaling pathways could evoke changes in growth cone guidance 
by direct modification of a specific set of proteins found on the distal tips of dynamic 
microtubules, the plus-end tracking proteins (+TIPs) (Figure 1.I.2.) 17,18. Since then, increasing 
evidence has accumulated that +TIPs may be important for axon guidance and turning 19. 
However, their participation in these behaviors may stem from more than a single ability to 
interact with and regulate microtubules; many +TIPs interact with actin as well 20–23. This 
affinity for both cytoskeletal networks makes +TIPs intriguing candidates as ‘bilingual’ 
networking facilitators, positioned to interact at the intersection of signaling pathway 
transduction and cytoskeletal remodeling. Understanding this precise junction is a dominant 
focus in the cell biological study of the growth cone; thus, more information is needed about how 
microtubules and actin work downstream of these signals and about how +TIPs may be 
regulating these behaviors. 
 
II. Actin Networks in the Growth Cone 
 Actin dynamics have classically been credited with generating the major driving force behind 
growth cone steering and motility. Early on, the “clutch” hypothesis was put forth 8, later 
described as the substrate-cytoskeletal coupling model 12,24,25, which links actin dynamics to 
Figure 1.I.2. Microtubule and F-actin functioning in the periphery of the growth cone. A +TIP complexes allow pioneer 




growth cone protrusion. F-actin bundles 
found in the peripheral domain are 
oriented such that their barbed plus-ends 
point towards the cell membrane, while 
their pointed minus ends are directed 
towards the central domain of the 
growth cone (Figure 1.II.1.). F-actin 
lamellar networks are comprised of 
crisscrossed actin filaments, which are 
located in the peripheral domain (Figure 1.I.1.). Under the effects of F-actin retrograde flow 
2,26,27, the actin filaments are simultaneously in a constant state of polymerization (at the plus-
ends) and severing/depolymerization (at the minus ends). This affects protrusion and retraction 
of the actin filaments and corresponding protrusion and retraction of the growth cone 26,28 (Figure 
1.II.1.). While polymerization occurs in the peripheral domain of the growth cone, F-actin 
buckling and severing occurs in the transition zone, likely due to mechanical strain applied by 
either myosin II contraction or by the pushing of F-actin assembly. F-actin severing is followed 
by depolymerization of F-actin fragments 27, thus allowing free actin subunits to be recycled 
back to the plus-end (Figure 1.II.1.). The interaction of actin with an adhesive substrate causes 
the filaments to be stabilized, reducing the rate of retrograde flow and allowing polymerization at 
the plus-end to dominate, resulting in net growth toward the edge of the cell 24. However, this 
stability is counterbalanced by a need for dynamicity within the growth cone; developing and 
specified axons demonstrate an intrinsically less-stable actin network compared to developing 
Figure 1.II.1. F-actin polymerization and retrograde flow provide 
a constant treadmilling of actin towards the central domain. In the 
transitional domain, F-actin bundles are contracted and bent by 
myosin motor proteins while ADF/ cofilin severs actin filaments into 
a pool of actin monomers. This pool provides G-actin that is then 




dendrites, and this instability is critical for rapid axonal outgrowth. This unstable actin 
cytoskeleton facilitates extension of microtubules into the periphery of the growth cone 29. 
 
III. Microtubule Dynamics in the Growth Cone 
Although it is widely accepted that the actin cytoskeleton provides a majority of the motile 
function in the growth cone, microtubules certainly do play an extensive role in axon guidance 
and outgrowth. This was initially shown by studies that demonstrated that microtubules were 
required for growth cone forward progression 6,13. Microtubules are dynamic structures by 
nature, constantly undergoing periods of polymerization followed by periods of shrinking 30, 
which seem to assist exploratory microtubules in “feeling” around the peripheral domain and 
making functional connections 31. Tubulin subunits (α/β tubulin heterodimers) are either added or 
removed at the microtubule plus-end by certain classes of +TIPs uniquely suited to this task 
(Figure 1.II.1.) 32,33. (However, note that interaction of different types of +TIPs with microtubule 
plus-ends is quite complex and involves various 
processes and regulatory mechanisms. For review, 
see 32,34–38). Importantly, it was demonstrated that 
guidance cues could affect microtubule turning 
behavior of the growth cone and predict overall 
direction of outgrowth 6,9,39–41. Following careful 
local application of a microtubule stabilizing drug, 
Taxol, or a depolymerizing drug, Nocodazole, a 
growth cone could be encouraged to turn towards or 
away from a specific axis 16 (Figure 1.III.1). This led 
Figure 1.III.1. Microtubule stabilizers and 
destabilizers are able to control growth cone 
steering. Microtubules that bind stabilizers on a 
specific side of the growth cone will cause growth cone 
turning towards that axis (left). Conversely, 
destabilizing compounds, or regulated removal of 
stabilizing molecules, can cause repulsion or retraction 




to the hypothesis that individual peripheral domain microtubules act as guidance sensors of the 
growth cone, helping to govern growth cone advancement and directionality 42.  
  
IV. The Coupling of Microtubules to Actin Dynamics 
Several studies have shown a clear connection 
between the role of microtubules in interaction 
with the actin cytoskeleton and overall growth cone 
steering 10,43–45. Microtubules usually follow the 
same path as F-actin bundles in the peripheral zone 
of the growth cone, leading to the idea that F-actin 
provides tracks for the microtubules to follow into 
the periphery 46 (Figure I.IV.1.). When actin 
networks were manipulated with ML-7, a myosin 
kinase inhibitor that produces selective loss of actin 
bundles and resultant growth cone collapse without 
significantly disrupting actin lamellipodial veils 10,41, microtubules seemed to be completely 
removed from the peripheral domain. In addition, growth cone turning in response to guidance 
cues was impaired when the F- actin structure was altered under treatment of ML-7 and 
cytochalasin D, an actin depolymerizer 41. By acting as predetermined tracks for microtubule 
growth, actin networks may regulate or even limit microtubule advancement into the periphery 
45,47 (Figure I.IV.1.). 
Microtubules are transiently coupled to these F-actin tracks, leaving them susceptible to F- 
actin retrograde flow 7,48,49. Coupling of exploratory microtubules to F-actin retrograde flow 
Figure I.IV.1. Microtubules interact with several 
distinct F-actin structures throughout the growth cone. 
F-actin arcs surround the central domain and restrict 
microtubules from exploring the periphery. F-actin bundles 
provide tracks for growing microtubules to follow into 




caused a reduction in the number of microtubules to advance into the periphery 10,26,41, and 
furthermore, caused looping of microtubules back towards the central domain 49. In a separate 
study, uncoupling of F-actin- microtubule interactions caused microtubules to progress further 
into the periphery 47. The absence of F-actin bundles was not found to influence central domain 
microtubules; however, when F-actin arcs located in the transitional domain were disrupted, 
central domain microtubules were abnormally broad and irregular in appearance 47. This suggests 
that the F-actin arcs create a selective barrier in the transitional zone to limit microtubule escape 
into the periphery (Figure I.IV.1.). These data indicate that F- actin-microtubule interactions can 
profoundly affect growth cone morphology and extension, which, in turn, suggest that regulation 
of these interactions may take place downstream of guidance cue interception. We postulate that 
+TIPs act as signaling pathway intermediates that can affect these cytoskeletal-coupling events. 
 
V. +TIPs act as signaling transduction elements to alter cytoskeletal dynamics 
 Within the context of closely coupled actin and microtubule networks at the ‘sensory’ ends of 
growth cone filopodia, +TIPs are in the perfect location to act as cytoskeletal “social 
networking” agents. +TIPs can interact with a multitude of molecules and structures including 
microtubules, actin filaments, and regulatory kinases, which can induce microtubule-actin 
crosslinking 18,20–22,32,50. In addition, +TIPs are very dynamic molecules and share a large 
interaction network with each other 32. Furthermore, +TIPs have been demonstrated to mediate 
some of the F-actin-microtubule interactions that were shown to affect growth cone guidance in 
seminal works 21,22,50–53. +TIPs can orchestrate transient coupling events to F-actin during 
microtubule polymerization, thought to guide microtubules progressing into the periphery 22 




microtubules to undergo retrograde flow, and thus effectively oppose microtubule outgrowth 51–
53 (Figure 1.V.1.). Asymmetric or spatially regulated accumulations of these +TIPs could 
therefore be imagined to couple microtubules to F-actin in a way that leads to axial steering of 
the growth cone. In this next section, we discuss some of the current evidence showing that 
+TIPs may work to influence growth cone guidance, in part, through the regulation of 
microtubule-F-actin interactions.  
 
VI. Proteins Linking Microtubules to F-actin and Retrograde Flow 
 The first axon guidance-relevant +TIPs: CLASP/APC—The first +TIPs that were identified 
in directing axon guidance mechanisms were CLASP and APC 17,18. Lee et al. showed that the 
CLASP1 homolog in Drosophila is downstream of Abl tyrosine kinase pathways 17, a signaling 
effector known to function downstream of repellent guidance cues. This initial study highlighted 
the localization of CLASP on “pioneer microtubules” in the growth cone peripheral domain, 
Figure 1.V.1. Microtubule protrusion and 
advancement into the periphery can be altered 
through coupling with F-actin retrograde flow. 
When uncoupled from retrograde F-actin flow, 
microtubules may progress further into the periphery 
through polymerization and translocation/sliding. 
When microtubules are transiently coupled to F-actin 
retrograde flow, through +TIP complexes, they follow 
F-actin bundles towards the ends of the filopodia. 
However, if microtubules are coupled strongly 
enough, or undergo enduring coupling, then 
microtubules can be translocated by F-actin 




which were previously exhibited to follow actin filaments 7–9,54 (Figure 1.VI.1.). Furthermore, 
when CLASP was overexpressed in Xenopus laevis growth cones, microtubules remained 
sequestered in the central domain and exhibited a peculiar looping phenotype 17 (Figure 1.VI.1.). 
This finding suggested that Abl signaling, in addition to its known role in actin remodeling 55–57, 
could affect microtubule dynamics in the growth cone periphery via its interaction with CLASP. 
However, whether there was any direct communication between the actin and microtubule 
cytoskeletons by way of CLASP regulation was not completely clear. 
 Later studies alluded to a more direct link between CLASP, F-actin, and microtubule 
behaviors. Marx et al. first demonstrated that depletion of CLASP in Xenopus leads to slower 
velocities of microtubules growth as they exit the axonal shaft into the growth cone 52. This 
phenotype was intriguing when coupled to evidence from earlier studies that had shown 
CLASP’s ability to bind actin and microtubules through a shared domain, and CLASP’s ability 
to undergo retrograde flow 21. This led them to question whether it was CLASP that might be 
affecting microtubule coupling to F- actin retrograde flow, in turn affecting microtubule forward 
velocities. While speckle microscopy did not illustrate any marked change in actin retrograde 
flow following CLASP depletion, both the microtubule advance in filopodial and overall actin 
network morphology in the lamellae were disrupted. This resulted in weakened F-actin structure 
as well as impaired axon outgrowth 52. These experiments supported a functional role for 
CLASP-mediated microtubule-F-actin crosslinking in the growth cone. 
 Additional studies showed that CLASP-mediated cytoskeletal coupling could be regulated 
downstream of both Abl and GSK3 signaling mechanisms. Engel et al. indicated that Abl 
possesses the ability to phosphorylate CLASP within its microtubule and F-actin binding domain 




end of the microtubule was decreased, and its interaction with actin rich structures in the central 
domain increased. Thus, it was postulated that Abl activity could trigger a ‘switch’ between the 
microtubule and actin binding properties of CLASP; when CLASP is heavily phosphorylated, 
microtubule plus-end affinity could be reduced, and CLASP may then be targeted to the 
microtubule lattice where it could facilitate microtubule-F-actin crosslinking. Similarly, GSK3, a 
serine/threonine kinase and Wnt downstream effector, was also demonstrated to regulate CLASP 
localization and actin-microtubule binding in both a positive and negative manner. It was found 
that highly active GSK3 caused phosphorylation of multiple sites along CLASP, prompting 
CLASP to dissociate from the plus-ends and reduce overall axon outgrowth 53. The same study 
indicated that a moderate GSK3 kinase activity allowed CLASP plus-end binding to promote 
axon elongation, while low GSK3 kinase activity promoted CLASP accumulation to the lattice, 
thereby promoting association with F-actin retrograde flow and causing characteristic 
microtubule looping. CLASP lattice localization could be effectively mitigated by treatment with 
blebbistatin, a myosin II inhibitor that affects F-actin retrograde flow, thus permitting 
microtubules to extend into the periphery once again 53. Together, these studies illustrate a 
critical role for dynamic, +TIP-mediated cytoskeletal crosslinking during axon outgrowth. 
Further evidence reveals that this role is not unique to CLASP, but is also shared by other +TIPs. 
 APC is another +TIP that emerged early on as an important mediator of microtubule-F-actin 
coupling during growth cone steering. APC promotes axon outgrowth by acting at the plus- end 
to stabilize microtubules 18. Also, APC undergoes phosphorylation by GSK3 in a CLASP-like 
manner, and its different phosphorylation states can change its interactions with the cytoskeleton. 
In one study, when GSK3 was inactive, APC bound to the plus-ends of microtubules, where it 




microtubules are located primarily in the actin-rich 
growth cone periphery, where GSK3 activity is 
repressed (Figure 1.VI.1.). Later observations 
indicated that this colocalization with actin 
structures might be a product of APC-mediated 
interaction, as APC was shown to interact with 
actin filaments in vitro and colocalize to actin 
structures in fibroblasts 58. Interestingly, APC’s 
ability to interact with the microtubule plus-end or 
potentially facilitate microtubule-F-actin coupling 
may not only affect axon outgrowth, but also 
guidance and growth cone turning. APC’s 
localization to a particular side of the growth cone 
caused axonal direction to change towards that 
side of the axis 59. It could be speculated that 
spatially restricted phosphorylation downstream of a localized signaling cascade may 
preferentially cause APC plus-end binding and microtubule stabilization, whereas separate 
signaling events on the opposite side of the growth cone may prompt microtubule-F-actin 
coupling and slowed microtubule velocities. Furthering this notion, loss of APC localization to 
the MT through GSK3 signaling presented large increases in microtubule looping and loss of 
growth cone progression 60. While this data supports a role for APC in microtubule-F-actin 
coupling, the more intricate details of its regulation within the growth cone remain to be 
elucidated, as studies that have examined F-actin interactions with APC focused primarily on 
Figure 1.VI.1. Example +TIP proteins affect MT 
attachment to F-actin bundles. The +TIPs, CLASP and 
APC, are found on the plus-ends of microtubules located 
in the periphery of the growth cone. Asymmetric 
localization of both CLASP (dark blue) and APC (purple) 
can alter microtubule protrusion and interaction with F-
actin. Together, APC and CLASP bind to the plus-end, 





non-neuronal cells 58,61. Looking beyond CLASP and APC, a number of +TIPs have also been 
affiliated with cytoskeletal coupling functions apart from their classical roles as microtubule 
regulators.  
 EB1/3 can connect actin-binding proteins to the plus-end and are some of the best 
characterized +TIPs that regulate microtubule dynamics. The binding of EB proteins in an 
autonomous manner at the microtubule plus-end is sufficient to affect microtubule growth speeds 
and catastrophe rates 62,63. However, perhaps their most powerful regulatory role centers on their 
ability to act as scaffolding proteins for other +TIPs, as well as some known actin binding 
proteins. This ability stems from EB1’s well-known SXIP motif, which acts as a microtubule tip 
localization signal for a variety of proteins 64. Indeed, EB1 is necessary to recruit two of the 
aforementioned +TIPs, APC and CLASP, to the plus-end, in addition to recruiting other known 
actin modulators, such as Formins and Spectraplakins 32,64. In addition to +TIPs, EB1/3 have 
been recently shown in the growth cone to interact with the classic microtubule associated 
protein, MAP1B 65, which, in conjunction with Tau, have been shown to interact with actin 
filaments and alter actin dynamics 66–68. Interaction with MAP1B caused sequestering of EB1 
and EB3 into the cytosol of the growth cone. When overexpressed, MAP1B caused reduced EB 
binding to plus-ends, which in turn affected microtubule dynamics 65. Therefore, it is important 
to note that EB proteins may play a central role in connecting classical MAPs and +TIPs to the 
regulation of actin dynamics in the growth cone. 
 There is also strong evidence that EB3 is involved in coupling microtubules to F-actin in the 
growth cone through an affiliation with the actin binding protein Drebrin 22,69,70. EB3-bound 
microtubules were demonstrated to follow the tracts of F-actin bundles into peripheral filopodia, 




bind microtubules but lacked a Drebrin-interacting domain, growth cones showed arrested 
forward extension 22. One recent study disputed this, indicating that a loss of Drebrin-binding 
caused only minimal effects 71; but others have illustrated that a loss of this interaction could 
affect axon extension and actin-microtubule coupling in the growth cone 22,69,70,72. These studies 
indicated that Drebrin is regulated downstream of Cdk5 and potentially PTEN phosphorylation 
69,70,72,73. Cdk5 was shown to phosphorylate Drebrin on Ser142, causing an open conformation 
that allowed both binding to actin filaments and EB3-microtubule interactions. Phosphorylated 
Drebrin was associated to a larger extent with actin filaments in the filopodia of growth cones 
69,70. Not surprisingly, phospho-mimetic mutants of Drebrin increased microtubule association 
with filopodial actin, while phospho-dead mutants reduced this association 69. These data point 
towards an EB3-Drebrin interaction that may allow exploratory microtubules to be guided into 
the filopodia through their dynamic interface with F-actin bundles. 
 Recent data in non-neuronal cells points to another possible role for coupling of EB3 and 
Drebrin to F-actin. Namely, Drebrin has recently been found to compete with the actin severing 
protein, cofilin. Although not demonstrated in vivo or in neuronal growth cones presently, 
Drebrin was able to compete with cofilin for binding to actin filaments in several studies 74–76. 
Mikati et al. indicated that using the neuron specific isoform, Drebrin A, could alter actin 
polymerization dynamics in vitro. One likely role of cofilin in the growth cone is to contribute to 
F-actin recycling following the severing of F-actin bundles, a process that is promoted through 
myosin II contractility in the transition zone and through mechanical forces created during F-
actin assembly 27. Therefore, coupling of EB3 and Drebrin to F-actin in the growth cone may 
potentially inhibit cofilin-severing activity. This might indirectly affect how coupled 




still needs rigorous growth cone-specific substantiation, as growth cone cytoskeletal dynamics 
may undergo unique regulation compared to other types of directed cell migration. 
 Spectraplakins are a class of proteins long shown to interact with both microtubules and actin 
cytoskeletons 77–82. However, such interactions have only recently been documented to occur at 
microtubule plus-ends 50,80,83 and shown to do so within the growth cone 50. Several studies have 
demonstrated that Spectraplakins are required for microtubule protrusion and axon outgrowth 
50,84,85, as well as filopodial formation 86. Structure-function studies of one such Spectraplakin, 
actin crosslinking factor 7 (ACF7), showed that it can impact microtubule organization in the 
growth cone, an effect that requires both microtubule and actin interaction domains 86. 
Spectraplakins are guided to the plus-ends of microtubules by EB1 50, and furthermore, actin-
microtubule interactions are controlled by Spectraplakin binding through this EB1 interaction 
50,87. EB1 interactions at the plus-end conformationally change Spectraplakin shape, thus opening 
domains for microtubule attachment, and once in its conformationally active form, 
Spectraplakins preferentially bind to the microtubule lattice, where it may interact with actin 
filaments 50,87. While there is much known about how Spectraplakins regulate F-actin-
microtubule interactions, several aspects of this specific mechanism have not been explicitly 
examined in growth cones. 
 While interactions of Spectraplakins with other classes of +TIPs have not been rigorously 
examined in neurons, non-neural data indicate that such interactions may take place to modulate 
F-actin-microtubule coupling. There is evidence that ACF7 may act in a manner upstream of the 
+TIP, CLASP 88. Furthermore, a deficiency in ACF7 resulted in disorganization of peripheral 
microtubule bundles 89,90, an effect that was comparable to a CLASP deficiency 91. Similarly, 




together with the F-actin-microtubule coupling role of these proteins individually, these data may 
support a more elaborate or collaborative mechanism for Spectraplakins in regulating 
cytoskeletal coordination. 
 Finally, the microtubule polymerase, XMAP215, is a +TIP protein that has only been 
speculated to be a potential MT/F-actin interacting protein, but no clear evidence has been put 
forward before now. Early on, XMAP215 was classically characterized as a microtubule growth 
enhancement protein 93 and, more recently, as a processive microtubule polymerase 94. First 
showing some initial hints that XMAP215 could possibly interact in some way with F-actin, 
msps (minispindles), a Drosophila orthologue to XMAP215, was shown to genetically interact 
with and antagonize the activity of the actin binding +TIP, CLASP, during axon outgrowth 
events 95. Subsequent studies led to the discovery that ch-TOG, the XMAP215 mammalian 
orthologue, interacted with the +TIPs, SLAIN1/2, CLASP and CLIPs, to increase microtubule 
growth rates and reduce catastrophe rates 96,97 and that the +TIP, TACC3, promoted the 
microtubule polymerization function of XMAP215 98. It has been shown more recently that 
TACC3, the well-known XMAP215 interactor, may interact with the branched actin modulator 
ENA/Vasp 99, which could potentially alter actin in the growth cone to affect axon outgrowth and 
guidance behaviors 100, although how this could function in combination with XMAP215 is 
entirely unknown.  
 While much of XMAP215’s role as a MT polymerase has been mapped out to its various 
pentameric TOG (Tumor Overexpressed Gene) domains 34,94,101,102, nothing is known about how 
a suspected F-actin related function would be facilitated by these regions, or its less well 
characterized C-terminal domain 97,103,104. In addition, it is entirely unknown if any suspected F-




noticed that the suspected F-actin interacting TOGL domain of CLASP shares a high sequence 
similarity to that of one of the TOG domains of XMAP215 21,105. Given that microtubule 
exploration of the growth cone periphery is suggested to result from frequent transient coupling 
with F-actin retrograde flow 106,107, it is possible that XMAP215 directly or indirectly mediates 
the coupling and uncoupling of microtubules to actin flow, although whether this could be 
independent of EB1/other +TIPs is entirely unknown. The evidence presented in this thesis work 
will focus on outlining the distinctive discoveries involving XMAP215’s role in growth cones, 
and highlights a novel interaction with F-actin, governing the organization of microtubules to 
affect overall outgrowth and guidance mechanisms as a whole.  
 
VII. Models for how Microtubules Interact with F-actin to Control Coupling 
 Although evidence for how +TIPs control axon guidance through microtubule/F-actin 
interaction remains in its early stages, a basic model may be put forward. While microtubules 
actively extend into the periphery of the growth cone, they are in regular contact with F-actin. 
Depending on the specific configuration of +TIPs localizing to the plus-end 18,21,22,32,50, as well as 
the accumulation of localized signaling molecules 6,9,41, microtubules may couple with F-actin 
retrograde flow through both F-actin bundles in the periphery and F-actin arcs in the transitional 
domain 7,41,45,47,49. While prevention of microtubule extension through the coupling to retrograde 
flow would cause an inhibition of forward growth cone progression 10,26,41, it may be that an 
asymmetrical coupling of microtubules to F-actin throughout the growth cone causes some 
microtubules to progress forward while others retract, which can result in altered steering of the 




Some +TIPs that do couple microtubules to actin, like EB1 and the actin binding protein 
Drebrin, or XMAP215, may not cause microtubule looping back to the central domain, but 
instead allow transient coupling of microtubules along F-actin bundles 22. This may effectively 
guide microtubules out alongside F-actin, thereby allowing polymerization to dominate and 
extend microtubules further into the periphery. This may well be the case with the MT 
polymerase, XMAP215, and it’s specific F-actin related function in growth cones109. There is 
some evidence that the appropriate balance of these persistent or transient coupling behaviors (or 
alternatively, complete dissociation from the plus-end) is influenced by +TIP modifications 
downstream of signaling kinases 17,18,51,110, thus linking microtubule and actin behaviors to the 
guidance molecules encountered by the remodeling growth cone. However, as future studies 
investigate additional details of microtubule and F-actin interactions, more advanced models will 
undoubtedly be put forward. 
 
VIII. Outline of Research Presented on XMAP215 Functioning  
In this thesis work presented here, I show specifically how XMAP215, a microtubule 
polymerase, is capable of correctly localizing populations of microtubules in the embryonic 
neuronal growth cone through a previously unknown MT/F-actin interaction. Chapter 1 has 
focused on the background of the growth cone, the roles that MTs and F-actin play individually 
in growth cones, as well as how MTs and F-actin dually coordinate each other to facilitate proper 
cytoskeletal functioning internally. Bringing together work that was started by my collaborator, 
Paula Slater, in Chapter 2, I combine super resolution microscopy imaging and growth cone 
analysis, with biochemical assays and structure/function analysis. In this way, I determined a 




through F-actin interaction, leading to insights into the role XMAP215 plays during axon 
outgrowth and guidance mechanisms. In Chapter 3, I explored more deeply this novel 
mechanism, highlighting the domains responsible for XMAP215/F-actin interaction, as well as 
how XMAP215 is utilizing this function through an uncharacterized MT lattice based 
localization. Finally, I show that XMAP215’s function in coordinating MT populations through 
F-actin interactions is separate from its characteristic MT polymerase capabilities, establishing 
an entirely new role for XMAP215, and providing a new light in which XMAP215 can be 






Chapter 2. XMAP215 promotes microtubule–F-actin interactions to regulate 
growth cone microtubules during axon guidance 
(Adapted from Slater and Cammarata et al., 2019 – Journal of Cell Science) 
 
I. Introduction 
The growth cone is a structure at the tip of the growing axon that is responsible for directing 
neuronal extension and guidance. Growth cone motility depends upon actin filament (F-actin) 
dynamics in the periphery, while growth cone steering occurs as microtubules (MTs) from the 
axon shaft advance in the direction of new outgrowth 111–113. There are also dynamic MTs that 
explore the F-actin-rich periphery, and these MTs appear to probe along filopodial F-actin 
bundles as if they were tracks to follow 7,46. There is a complicated interplay between these two 
cytoskeletal systems during axonal extension and guidance, and coordination between MTs and 
F-actin is essential for the axon to mechanically respond to extracellular guidance cues. Thus, 
crosstalk between these two systems is a critical component of axonal pathfinding. 
Recent work has increasingly shown the importance of canonically described MT-associated 
proteins in facilitating regulation of interactions between MTs and F-actin within the growth 
cone. These studies have ascribed these roles in cytoskeletal coordination to well-characterized 
MT regulators TAU (also known as MAPT) and CLASP family proteins, among others, and 




19,22,52,110,114–117. Nevertheless, many of the molecular mechanisms underlying this cytoskeletal 
crosstalk during axonal growth are still largely unresolved. Elucidating these mechanisms is 
essential for understanding how neuronal development occurs in both normal and pathological 
conditions.  
It was shown that Xenopus microtubule associated protein 215 (XMAP215, also known as 
CKAP5) is important for promoting axon outgrowth as well as regulating MT trajectories within 
the growth cone 112. However, it was unclear how changes in XMAP215 activity affected MT 
behaviors within the growth cone, although it was apparent that XMAP215 must have additional 
functions beyond catalyzing MT polymerization. Given that MT advancement into the growth 
cone periphery depends upon MT extension along F-actin bundles, I wondered whether 
XMAP215 might be specifically involved in the regulation of MT–F-actin interactions within the 
growth cone. XMAP215 family members have received significant attention as critical regulators 
of MT polymerization and nucleation 94,101,118–121, but there were no previous studies that 
examine whether XMAP215 can bind directly to F-actin or mediate MT–F-actin interactions in 
any system. 
In this study, I used a combination of approaches, ranging from super-resolution microscopy 
of cultured neurons to in vitro assays with purified proteins. Here, I uncovered a critical role for 
XMAP215, and specifically the N-terminal TOG 1–5 domains, in regulating MT–F-actin 
interactions within the growth cone in Xenopus laevis embryos. In addition, with the help of 
imaging taken by a lab colleague, we show that XMAP215 is required for maintaining normal 
growth cone morphology and its accurate response to guidance cues. Finally, I demonstrate that 








XMAP215 knockdown leads to global morphological changes in the growth cone and 
defects in axon guidance 
 Previous studies demonstrated that XMAP215 is important for promoting axon outgrowth 
but did not provide thorough characterization of the growth cone phenotype after XMAP215 
knockdown 112. It was at this point that Paula Slater, a collaborator on this work, utilized 
neuronal explant culturing and microscopy to determine morphological changes in the growth 
cone. When XMAP215 levels were knocked down by 70% in X. laevis embryos (XMAP215 KD 
hereafter) (Fig. 2.S.1A), it was observed that distinct and unexpected phenotypic changes in the 
growth cone occurred (Fig. 2.S.1B). The most noticeable effect of XMAP215 KD was increased 
area of the growth cone by 52% (Fig. 2.II.1A; Fig. 2.S.1B, C). Additionally, while the number 
of growth cone filopodia was not significantly altered (Fig. 2.II.1B), XMAP215 KD resulted in 
increased filopodia mean length by 43% (Fig. 2.II.1C). These phenotypes were rescued by 
concomitant expression of XMAP215–GFP mRNA in the KD condition (Fig. 2.II.1A, C), 
suggesting that the XMAP215 is necessary and sufficient to maintain normal growth cone 
morphology. 
 Axon pathfinding is a dynamic process consisting of growth cone exploratory movements, in 
which the growth cone pauses before advance, retraction or turning. Growth cone pauses are 




advancing growth cones 6,122. As XMAP215 KD also results in larger growth cones and longer 
filopodia, it was next investigated whether XMAP215 KD leads to changes in parameters of 
Figure 2.II.1. XMAP215 KD leads to global growth cone phenotypic changes and guidance defects. (A–C). XMAP215 
KD induces growth cone pausing-like morphology. XMAP215 KD increases growth cone area (A), has no effect on 
number of filopodia (B), and increases the mean length of filopodia (C). See Fig. S1C for more information regarding how 
the quantifications were performed. (D–F). XMAP215 KD increases number and duration of growth cone pauses. (D) 
Time- lapse montage of representative axons from control, XMAP215 KD and XMAP215 KD rescued by expression of 
TOG1–5. Scale bar: 25 µm. XMAP215 KD increases the number of pauses per hour (E) and the mean pause duration (F). 
(G,H) TOG1–5 rescues the axon outgrowth parameters affected by XMAP215 KD.(G) XMAP215   XMAP215 KD 
increases the percentage of growth cones on Ephrin A5 stripes per explant. See Fig. S2C for representative images. 
*P<0.05; **P<0.01; ****P<0.0001; ns, not significant, from a one-way ANOVA analysis comparing multiple conditions, 




growth cone pausing (Fig. 2.II.1D-F). It was determined that XMAP215 KD led to a 20% 
increase in the number of growth cone pauses per hour (Fig. 2.II.1E) and a 22% increase in the 
duration of the pauses (Fig. 2.II.1F) compared to a control condition. In addition, we were able 
to rescue these phenotypes by concomitant expression of the XMAP215 N-terminal TOG1–5 
domains (TOG1–5 hereafter) to the KD condition (Fig. 2.II.1E, F). Furthermore, it was 
determined that expression of the XMAP215 N-terminus could rescue the decrease in overall 
axon length and axon outgrowth that is observed with XMAP215 KD (Fig. 2.II.1G).  
 Next, I wanted to determine whether XMAP215 KD might affect axon guidance in addition 
to outgrowth. Stripe assays have been widely used to study the responsiveness of growing axons 
to external cues 123–125. My collaborator investigated the effect of XMAP215 KD on axon 
guidance by determining whether cultured axons avoided stripes containing the repellent 
guidance cue Ephrin A5. There was a twofold increase in the number of growth cones per 
explant that were trespassing on Ephrin A5 stripes when comparing XMAP215 KD cells to 
controls (Fig. 2.II.1H). Importantly, this guidance defect was rescued by concomitant expression 
of exogenous TOG1–5 along with XMAP215 KD (Fig. 2.II.1H). These results suggest that 
normal levels of XMAP215 expression are necessary for axons to be responsive to Ephrin A5 
and, thus, for correct axon guidance. 
 
XMAP215 KD disrupts MT organization in the growth cone  
 It was previously demonstrated that partial XMAP215 KD led to abnormal MT trajectories 
within the neuronal growth cone 112. The mechanism by which this occurred was unclear, but it 
seemed likely that XMAP215 might display another function in growth cones other than simply 




several MT parameters in axonal growth cones after XMAP215 KD. Because X. laevis neurons 
express very high levels of XMAP215 compared to other cell types, knocking down XMAP215 
by 70% still allows for sufficient XMAP215 to facilitate MT polymerization, while also resulting 
in abnormal MT behaviors specifically in growth cones 112. MT dynamics vary depending on 
axonal behaviors 126; during pausing periods, growth cones present looped or bundled MTs, 
Figure 2.II.2. XMAP215 KD disrupts MT organization in the growth cone. (A) Representative SIM images of growth cone 
MTs considered as ‘splayed’ and ‘looped’. XMAP215 KD increases the MT looped morphology compared to controls. Scale bar: 
3 µm. (B) Representative SIM image of growth cones stained for actin and tubulin. The labeled lines letter indicate how the MT 
measurements were performed for the corresponding plots in C-E. Scale bar: 8 µm. (C-E) Quantification of the different MT 
parameters. XMAP215 KD increases the MT–MT distance in growth cone neck (C), the MT–MT distance in the growth cone’s 
widest region (D), as well as the growth cone length (E). **P<0.01; ***P<0.001; ****P<0.0001; ns, not significant, from a 




which then reorganize into splayed MTs during growth cone advance 127,128. MT morphology 
was then quantified by Paula Slater, and the percentage of growth cones presenting ‘splayed’ 
versus ‘looped’ MTs after tubulin staining was counted, as previously described 14. XMAP215 
KD axons displayed a significant increase in the number of growth cones presenting a looped 
morphology (almost twice as many as in controls) (Fig. 2.II.2A). Finally, the distribution of MTs 
within the growth cone was assayed using structured illumination microscopy (SIM) imaging. 
There was an observed 48% increase in MT spreading within the growth cone neck after 
XMAP215 KD and an 85% increase in the widest part of the central domain (Fig. 2.II.2B-E). 
Moreover, XMAP215 KD resulted in a 44% increase in the overall length of the growth cone, 
from axon shaft to end of the central domain (Fig. 2.II.2E). These results demonstrate that 
XMAP215 regulates MT organization in terms of morphology, dynamicity and distribution 
throughout the growth cone. 
 
XMAP215 promotes penetration of MTs into growth cone filopodia 
 We next wanted to investigate whether XMAP215 regulates MT penetration into the 
peripheral domain of the growth cone. We overexpressed (OE), and knocked down XMAP215 in 
X. laevis embryos and analyzed axonal growth cone MTs and F-actin. We collected SIM images 
after immunostaining for F-actin and tubulin and counted the number of ‘exploring’ MTs, which 
are defined as MTs that extend beyond the central domain of the growth cone, into the actin-rich 
peripheral domain (Fig. 2.II.3A; Fig. 2.S.2A, B). To determine whether these exploring MTs 




F), as well as measured the extent of penetration of these MTs into the peripheral domain (Fig. 
2.S.2A-C). With XMAP215 KD, there was a 23% decrease in the number of MTs that were 
present specifically within filopodia (Fig. 2.II.3E). By contrast, the data showed a 26% increase 
in the number of MTs within filopodia upon XMAP215 OE (Fig. 2.II.3F). MT penetration into 
the peripheral domain was 28% less with XMAP215 KD (Fig. 2.II.3B) and 35% greater with 
XMAP215 OE (Fig. 2.II.3C). 
Figure 2.II.3. XMAP215 promotes penetration of MTs into growth cone filopodia. (A,B) Growth cone mask images 
outlining the growth cone peripheral domain colored in orange (A), and the filopodia colored in blue (B). C) Quantification 
of MT penetration into the actin-rich peripheral domain of the growth cone after XMAP215 knockdown (KD) or 
overexpression (OE). D) Quantification of the percentage of exploring microtubules present in filopodia after KD or OE. 
XMAP215 KD effects were rescued by co-expression of KD-resistant XMAP215–GFP mRNA. **P<0.01; ****P<0.0001; 
ns, not significant, from a one-way ANOVA analysis comparing XMAP215 KD, XMAP215 rescue and control, and from a 





As XMAP215 is a well-characterized MT polymerase, we wondered whether there might 
be a change in the number of total growing MTs within the growth cone that may be accounting 
for the change in the percentage of microtubules reaching filopodia. For this purpose, along with 
XMAP215 KD or OE, we concomitantly expressed GFP–MACF43, which binds growing MT 
plus-ends 64, and used automated imaging analysis to quantify the number of GFP–MACF43 
comets in high-resolution live images. Despite observing more broadly distributed GFP–
MACF43 trajectories within the XMAP215 KD growth cones compared to controls (Fig. 
2.II.4A), there were no significant differences in the number of growing MTs in XMAP215 KD 
growth cones (Fig. 2.II.4B). Thus, with the levels of XMAP215 protein that are present in our 
partial KD condition, the number of MTs undergoing polymerization is not negatively affected, 
although MTs are unable to properly penetrate into filopodia. It is also important to note that this 
lack of MT penetration is not due to reduction in MT polymerization rate, as it was previously 
shown that MT polymerization rate was not significantly reduced with partial XMAP215 KD in 
these growth cones 112. 
Figure 2.II.4. XMAP215 partial KD does not affect MT polymerization rates in the growth cone. No difference was 
observed between XMAP215 KD and control when comparing the number of growing MTs. ns, not significant from a Student’s 






XMAP215 is required for normal MT–F-actin alignment in growth cones 
 MT trajectories and penetration into the peripheral domain depend upon MT extension along 
F-actin bundles. Thus, we wondered whether XMAP215 might play a role in MT alignment to F-
Figure 2.II.5. XMAP215 is required for normal MT–F-actin alignment in growth cones. (A) Top: representative SIM 
images of growth cones from control, XMAP215 KD and XMAP215 OE neural explants stained for actin and tubulin. Scale 
bar: 8 µm. Middle insets: magnification of the boxed region of interest in the upper panels. Scale bar: 3 µm. Arrows point to 
MTs that are aligned with F-actin, while arrowheads point to exploring MTs that are not aligned with F-actin. Bottom insets: 
‘camera lucida’-type depictions with subtracted background and highlighted MTs and F-actin. (B,C) XMAP215 KD decreases 
(B) while XMAP215 OE increases (C) the percentage of exploring MTs aligned to F-actin, compared to controls. (D,E). 
XMAP215 KD increases (D) while XMAP215 OE does not affect (E) the number of orientations followed by exploring MTs in 
the growth cone peripheral (P) domain. **P<0.01; ****P<0.0001; ns, not significant, from a one-way ANOVA analysis 




actin bundles in the growth cone periphery. Upon XMAP215 KD, there was a 28% decrease in 
the percentage of F-actin-aligned MTs, compared to controls (Fig. 2.II.5A, B), while there was a 
16% increase in F-actin-aligned MTs in the case of XMAP215 OE (Fig. 2.II.5C). It was noted 
that there were some MT plus-ends that were nowhere close to bundled F-actin in the XMAP215 
KD condition (Fig. 2.II.5A, arrowheads). These results suggest that XMAP215 promotes MT–F-
actin alignment in the growth cone. As trajectories of MTs within the growth cone are normally 
restricted to following F-actin bundles 7,46, we quantified the number of different MT orientations 
within the growth cone after XMAP215 KD. We defined the orientations as being different if the 
direction followed by the tip of a MT forms an angle greater than 30° with other neighboring 
MTs, and angles were measured with respect to a central line that follows the growth direction of 
the axon. We observed that XMAP215 KD led to a 34% increase in the number of unique 
orientations followed by exploring MTs in the peripheral domain in comparison to controls (Fig. 
2.II.5D), while XMAP215 OE did not generate any changes (Fig. 2.II.5E). Taken together, these 
results suggest that XMAP215 is important for MT spatiotemporal guidance along F-actin tracks 
within growth cones. Additionally, the MT–F-actin alignment defects were rescued by co-
expression of KD-resistant XMAP215–GFP mRNA (Fig. 2.II.5B, D), attributing these effects 
specifically to XMAP215. Furthermore, all of the aforementioned experiments were completed 
using another antisense oligonucleotide to knock down XMAP215 and obtained similar results 
(data not shown), suggesting that the observed effects of XMAP215 KD on MT–F-actin 
alignment was not because of off-target effects of the antisense oligonucleotide. 
 




Several previous studies have determined that the XMAP215 N-terminal domain [TOG1–
5, amino acids (aa) 1–1460] is composed of five TOG domains that bind tubulin dimers 34,94,101 
and a MT lattice-binding domain that comprises the region between TOG4 and TOG5 as well as 
Figure 2.II.6. The N-terminal TOG1–5 domains of XMAP215 are necessary and sufficient to localize to F-actin in the 
growth cone periphery. (A) Schematic representation of the GFP-tagged XMAP215 domain constructs used, showing full-
length XMAP215, XMAP215 domains TOG1–2, TOG1–4, TOG1–5 and C-terminal region (C-term). (B) Western blot showing 
the expression of the different XMAP215 domain constructs in Xenopus embryo lysates. (C) Representative confocal images 
showing localization of GFP-tagged XMAP215 mutants (green) and F-actin (red) in the growth cone. White arrowhead in full-





part of TOG5 101. Additionally, the TOG1–2 region is known for being responsible for the MT 
polymerase activity 101. The C-terminal domain (aa 1461–2070) is conserved and known to bind 
the protein TACC3 103,129, and is important for XMAP215 localization at centrosomes 104,130,131. 
It was also recently shown to be required for MT nucleation and direct binding to gamma-tubulin 
120. To investigate which domain(s) of XMAP215 are responsible for promoting MT–F-actin 
alignment, I generated a series of XMAP215 deletion constructs (similar to those previously 
described in Widlund et al., 2011) (Fig. 2.II.6A) and expressed them in X. laevis embryos (Fig. 
2.II.6B). I first compared their localizations in the growth cone in conjunction with F-actin 
(mScarlet–Lifeact) using time-lapse imaging, and I observed that each XMAP215 deletion 
mutant displayed unique localizations (Fig. 2.II.6C; Movies 1– 4). Both XMAP215 full-length 
(FL) and the TOG1–5 construct displayed characteristic MT lattice binding, which has 
previously been observed in these growth cones 112. However, there was little to no MT plus-end 
tracking seen with the TOG1–5 construct (Movie 3). While the XMAP215 C-terminal domain 
did display distinct MT plus-end tracking localization (likely due to C-terminal domain 
interaction with endogenous TACC3), the localization did not overlap with F-actin in the 
periphery (Movie 4). Most strikingly, there was a clear co-localization pattern of XMAP215-FL 
and TOG1–5 with F-actin in the growth cone periphery (Fig. 2.II.6C, white arrowheads), while 
the TOG1–2 and TOG1–4 constructs did not show this co-localization with F-actin (they 
displayed only diffuse localization throughout the growth cone). This localization data suggests 
that a region within TOG1–5 is required for XMAP215 co-localization with F-actin in growth 
cones. 
 Then (with the help of my lab colleagues’ growth cone imaging data), we determined 




XMAP215 KD condition (Fig. 2.II.7A). Of all the deletions, only the TOG1–5 rescue had a 
similar growth cone MT phenotype to that of the control and the rescue with XMAP215 full 
length (Fig. 2.II.7A). In addition, expression of TOG1–5 was able to rescue the percentage of 
Figure 2.II.7. The N-terminal of XMAP215 is necessary and sufficient to promote MT–F-actin alignment. (A)  
Representative SIM images of growth cones from control, XMAP215 KD and XMAP215 KD rescue with the XMAP215 domain 
constructs as indicated. Scale bar: 5 µm. (B–E) Determination of the XMAP215 domain responsible for MT–F-actin alignment. 
Expression of TOG1–5, but not TOG1–2, TOG1–4 or C-term, rescues the increase in the number of exploring MTs (B), the 
decrease in the percentage of MTs aligned to F-actin (C), the increase in the number of orientations followed by exploring MTs in 
the peripheral (P) domain (D), and the decrease in the percentage of exploring MTs present in filopodia (E), induced by 
XMAP215 KD. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns, not significant, from a one-way ANOVA analysis. Data 





MTs aligned to F-actin (Fig. 2.II.7C), and the percentage of MTs present in filopodia (Fig. 
2.II.7B), to a similar extent to that of XMAP215 full length (Fig. 2.II.7A-C). These results are 
consistent with the localization data and suggest that the region comprising all five TOG 
domains is both necessary and sufficient for XMAP215 to promote MT–F-actin alignment in the 
growth cone. 
  
XMAP215 can interact with F-actin directly, but does not affect F-actin bundles 
Given previous findings that XMAP215 promotes the ability of MTs to enter filopodia (Fig. 
2.II.3) and promote MT alignment to F-actin bundles (Fig. 2.II.5), I wondered whether 
XMAP215 might directly bind to F-actin. Thus, I first tested for XMAP215–F-actin binding 
using an F-actin co-sedimentation assay, and, intriguingly, I observed that XMAP215 is able to 
Figure 2.II.8. XMAP215 can directly bind to F-actin but does not affect local F-actin density. (A, B). XMAP215–F-actin co-
sedimentation assays. Coomassie Blue- stained gels from binding assays containing a constant F-actin concentration (A) or increasing 
F-actin concentrations (B), show direct binding of XMAP215 to F-actin. BSA was used as a negative control. S, supernatant; P, pellet. 
(C) XMAP215–F-actin binding curve obtained by plotting the percentage of XMAP215 present in the pelleted fraction over the total, 
against the F-actin concentration. Data points from multiple experiments plotted for each concentration. Non- linearly fit binding curve 




co-sediment with F-actin in vitro (Fig. 2.II.8A). While using BSA as a negative control showed 
little to no sedimentation with F-actin, I saw XMAP215 presence switched from supernatant to 
pelleted fractions upon addition of F-actin. Next, by adding increasing concentrations of F-actin 
(Fig. 2.II.8B), I was able to obtain a binding curve for XMAP215 against F-actin. XMAP215 
was shown to bind F-actin at a low (F-actin) concentration and with a high affinity. Fitting the 
data to the binding curve gave an XMAP215 Kd value of 0.032 ± 0.0051 μM (mean ± s.e.m.), 
and XMAP215 maximum binding corresponded to a Bmax of 0.682 ± 0.0283 when the data was 
non-linearly fit to a curve (Fig. 2.II.8C). These results indicate the novel finding that XMAP215 
is able to directly bind F-actin in addition to MTs.  
Figure 2.II.9. XMAP215 KD correlates with increased total F-actin levels, although F-actin distribution is not affected. (A) 
Representative phalloidin-stained images of growth cones from control and XMAP215 KD neural explants. Scale bars: 10 µm. (E–G) 
Quantification of F-actin amount and distribution. XMAP215 KD increases total phalloidin fluorescence (E), while it does not affect 
phalloidin fluorescence normalized by growth cone area (F) or the number of pixel values for phalloidin fluorescence (G). a.u., 
arbitrary units; Phall, phalloidin. **P<0.01; ns, not significant, from Student’s t-test comparing XMAP215 KD to control. Data 






I next wanted to determine if XMAP215 KD led to specific changes in the amount and 
distribution of F-actin within the growth cone (Fig. 2.II.9A). With the help of lab colleagues’ 
imaging data, we measured phalloidin fluorescence intensity within the growth cone as a read-
out for F-actin and observed a 27% increase in overall fluorescence intensity within the growth 
cone in XMAP215 KD compared to controls (Fig. 2.II.9B). However, when F-actin levels were 
examined after normalizing the total fluorescence intensity by the growth cone area (since 
XMAP215 KD growth cones are larger than controls), there was no difference observed in the 
XMAP215 KD compared to controls (Fig. 2.II.9C). To investigate this further, the number of 
pixel values for phalloidin fluorescence was examined (as a means to determine if Phalloidin was 
accumulating more or less in the different regions of the growth cone). There were no observable 
differences when comparing XMAP215 KD to controls (Fig. 2.II.9D), suggesting that the F-
actin distribution within the growth cone was not specifically affected. These results demonstrate 
that XMAP215 is capable of a direct interaction with F-actin, although the increase in overall F-
actin levels is not due to denser F-actin bundles but correlates with the increased size of the 
growth cone. It remains to be determined how XMAP215 KD leads to this increase. 
 
III. DISCUSSION 
In this chapter, I reveal new functions for the MT polymerase XMAP215 in promoting MT–
F-actin interaction in both spinal cord explants from X. laevis embryos and in vitro biochemical 
assays. With the help of my lab colleague and collaborator, we utilized knockdown and 
overexpression studies to determine that XMAP215 is required for the axon to respond to the 
repellent guidance cue Ephrin A5 and affects axonal extension by influencing growth cone 




in the growth cone, and XMAP215 is important for determination of growth cone size, filopodia 
length, and MT morphology and distribution throughout the growth cone. Additionally, I found 
that XMAP215 is able to bind F-actin in vitro and co-localize with F-actin in the growth cone 
peripheral domain. XMAP215 and its family members have been some of the most intensively 
studied and well-characterized MT polymerases over the last decade 94,101,102,118,121,132. Moreover, 
they have received recent attention for having additional MT-related functions, including MT 
nucleation 119,120, mitotic spindle scaling 133,134 and MT destabilization 135,136. This chapter, 
focusing on using F-actin co-sedimentation assays and growth cone imaging, adds a new element 
to the arsenal of XMAP215 functions, as it is demonstrated that XMAP215 also exhibits the 
potential to directly interact with F-actin. This provides the first strong evidence that XMAP215 
may function as a MT–F-actin crosslinker in growth cones, although it is still unclear whether 
XMAP215 is sufficient to bind both cytoskeletal structures simultaneously, or whether additional 
protein complexes are required for mediating MT–F-actin interaction in growth cones. 
Interestingly, my lab colleague observed that XMAP215 KD leads to changes in growth cone 
area and filopodial length (Fig. 2.II.1A). While it is unclear exactly how XMAP215 KD could 
lead to such increases, it is likely through an indirect mechanism. As there are complicated 
feedback mechanisms between MTs and F-actin within growth cones, it is possible that when 
alignment of MTs with F-actin is reduced, the overall cytoskeletal architecture and mechanical 
response of the growth cone is disrupted, thus leading to growth cone pausing and a 
corresponding increase in growth cone area. Early studies showed that the local loss of F-actin 
bundles on one side of the growth cone drives subsequent remodeling of MT organization, where 
MTs are no longer present in the F-actin bundle depleted zone, and instead reorient towards the 




guidance cue sensing 137, while separately, the absence of F-actin bundles can act as a repulsive 
signal, inducing growth cone turning 41. The findings from XMAP215-depleted growth cones 
replicate a similar scenario in that a decrease in MT–F-actin alignment randomizes the 
directionality of exploring MTs, indicative of a loss in MT guidance by the F-actin bundles in the 
growth cone peripheral domain. This loss in MT guidance and resultant MT–F-actin cytoskeletal 
discoordination could facilitate a loss in growth cone directionality, and prompt the growth cone 
to pause and await cues that would recalibrate it to its environment. Mechanically, growth cone 
extension may also demonstrate decreased efficiency if MT–F-actin interactions are reduced 
around the area of transient focal point contacts, as dynamic MTs are required at sites of 
adhesion remodeling 138. 
Importantly, the results here demonstrate that XMAP215 affects several MT phenotypes such 
as MT organization, extension into growth cone periphery and filopodia, and MT–F-actin 
alignments (Fig. 2.II.2-2.II.5). When XMAP215 levels were reduced, MT behaviors were 
severely impacted throughout the growth cone. MT trajectories into the peripheral domain 
showed increased randomization, while central domain MTs demonstrated an increase in 
looping. Additionally, there was also increased widening of the MT array throughout the growth 
cone neck and central domain that occurs with XMAP215 KD. This phenotype is strikingly 
reminiscent of the growth cone MT bundling defect previously observed upon myosin II 
inhibition 139. These studies suggested that MT arrays must be spatially consolidated to form the 
core of the axon as the growth cone progresses forward, and that actin- and myosin II- dependent 
compressive forces are required for MT bundling 139,140. Interestingly, it was previously observed 
that the reduction of axon outgrowth that occurs with XMAP215 KD could be partially rescued 




interact with myosin II, in addition to F-actin, during the regulation of MT dynamics within 
growth cones. However, while MT bundling defects caused by partial XMAP215 KD may 
account for some of the MT phenotypes that we observe, such as growth cone neck widening and 
changes in growth cone size, it does not explain the changes in peripheral MTs aligning to F-
actin in filopodia. In addition, the N-terminal portion of XMAP215, capable of rescuing the MT–
F-actin alignment defect, is also the region that is necessary to co-localize with F-actin in the 
growth cone. 
It has been well-established that MTs follow along F-actin bundles in growth cones 10,46, and 
that when MTs lose the ability to interact with F-actin (for example, by filopodial F-actin bundle 
removal), this induces lateral excursions by MTs that penetrate the peripheral domain at various 
angles 47 and promote formation of random MT loops 41. A similar phenotype is observed when 
the MT–F-actin linker Spectraplakin is knocked out 50. Consistently, increasing MT–F-actin 
interaction can lead to areas that are devoid of MTs in S2 Drosophila cells 141. Thus, the MT 
phenotypes that are observed with XMAP215 KD are consistent with previous studies in which 
MT–F-actin interaction is disrupted. The deletion construct analysis and rescue experiments 
demonstrate that the XMAP215 N-terminus, comprising the TOG1–5 domains, is both necessary 
and sufficient for promoting MT–F-actin alignment (Fig. 2.II.5-2.II.6). Many previous studies 
have dissected the specific functions of the various domains of XMAP215 (for example, 
101,118,120), and the N-terminal TOG1–5 domains are known to bind to α/β-tubulin heterodimers 
and promote MT polymerization 101. In my experiments, the deletion comprising only the 
TOG1–4 domains, which lacks the MT lattice-binding domain, was not able to rescue any of the 
MT–F-actin phenotypes within XMAP215 KD growth cones. In addition, the cytoplasmic 




localization with actin in the periphery of the growth cone, unlike TOG1–5 or full-length 
XMAP215 (Fig. 2.II.6C, Movies 1–4). The C-terminal portion, while not showing distinct co-
localization to actin in the growth cone, did show MT plus-end tracking (most likely through 
coiled-coil homodimerization or C-terminal interactors TACC3 and SLAIN1/2) 96,103. Thus, it 
seems likely that the N-terminal portion of XMAP215, specifically the area between its TOG4 
and TOG5 domains, is important in determining a close MT–F-actin interaction in the growth 
cone periphery. 
In order to determine if XMAP215 can bind directly to F-actin, I performed an F-actin co-
sedimentation assay with purified XMAP215 protein. I determined that XMAP215 and F-actin 
can indeed bind directly, the binding saturates at low F-actin concentrations, and the binding 
affinity is in the sub-micromolar range in vitro (Fig. 2.II.8). Given that it was previously shown 
that MT plus-end-tracking protein CLASP can likely bind F-actin through its N-terminal Dis1 
(TOG) domain 21, it is possible that one or more of the TOG domains of XMAP215 can also bind 
to F-actin. Thus, with TOG domains of XMAP215 binding to F-actin while the MT lattice-
binding domain interacts with MTs, MTs would be able to extend along F-actin into the growth 
cone periphery. While augmenting XMAP215 levels affected growth cone morphology, MT 
distributions and MT–F-actin alignment in the growth cone, these effects were not the result of 
altered F-actin densities or levels in the growth cone (Fig. 2.II.9). Additionally, it was previously 
reported that F-actin retrograde flow rates were not affected after partial XMAP215 KD 112. 
Given that the N-terminus of XMAP215 was also sufficient to rescue axonal responsiveness to 
Ephrin A5, we speculate that there may be phosphorylation sites within the N-terminus that are 
phosphorylated  downstream of guidance signals and modulate the ability of XMAP215 to 




While this study is the first to demonstrate that XMAP215 can directly bind F-actin, promote 
MT–F-actin alignment in growth cones, and mediate axon guidance, it is notable that two well-
known XMAP215 interactors have also been implicated in processes that are consistent with this 
function. The most frequently characterized binding partner of XMAP215, TACC3, was 
previously described to be necessary for stabilizing XMAP215 on the MT plus-end 98,103,104,129 
and for the growth cone response to the guidance cue Slit2 142. Furthermore, the Drosophila 
orthologue of XMAP215, Mini spindles (MSPS), genetically and biochemically interacts with 
the plus-end-tracking protein CLASP (also known as Orbit, MAST and CHB) 95, which was one 
of the first MT-associated proteins identified to participate downstream of axon guidance cue 
signals 17. In that seminal study, CLASP was shown to specifically bind to MT plus-ends that 
entered the growth cone periphery and could regulate MT entry into this domain 17. Additional 
studies on CLASP function have since demonstrated that changing levels of this MT-associated 
protein can result in striking changes in actin architecture throughout the growth cone 51,52.  
 Taken together, the results shown in this chapter demonstrate how XMAP215 can regulate 
MT polymerization and extension along F-actin bundles into the growth cone periphery, and that 
these interactions can be modulated downstream of a repulsive guidance cue. Partial KD of 
XMAP215 leads to decreased MT–F-actin alignment, resulting in an inability to exert proper 
coordination between MTs and F-actin during growth cone extension, increased pausing and 
desensitization to guidance cues. This chapter explores and defines a novel function of 
XMAP215 in MT–F-actin behavioral coordination and axonal guidance, in addition to its 
classical and recently emerged roles in MT polymerization and nucleation. Future work should 
seek to address whether there are other participants in this functional coupling and how MT–F-




associated proteins can dynamically tune their behaviors to regulate MT dynamicity and 
stability, and separately or additionally facilitate MT–F-actin cytoskeletal coordination 
downstream of environmental cues, is necessary to fully describe the mechanistic underpinnings 
of proper neuronal pathfinding. 
 
IV. Materials and Methods 
Xenopus embryonic neural tube explants 
 Eggs collected from female X. laevis frogs were fertilized in vitro, dejellied and cultured 
following standard methods 143. Embryos were grown to stage 22–24 144, and neural tubes were 
dissected as described 112. All experiments were approved by the Boston College Institutional 
Animal Care and Use Committee and performed according to national regulatory standards. 
 
Constructs, RNA and antisense oligonucleotides 
 Capped mRNAs were transcribed in vitro using SP6 or T7 mMessage mMachine Kit 
(Ambion). RNA was purified with LiCl precipitation. Constructs used were: XMAP215–GFP (a 
gift from the Hyman lab; Widlund et al., 2011) sub-cloned into pT7TS; GFP–MACF43 (a gift 
from the Hoogenraad Lab) and GFP in pCS2+. XMAP215 domain constructs TOG1–2–GFP, 
TOG1–4–GFP, TOG1–5–GFP, and the C-terminus were obtained by PCR from the XMAP215–
GFP plasmid, and sub-cloned into pT7TS for generation of mRNA or into pFB HTA for protein 
purification. Previously validated morpholino antisense oligonucleotides targeted to the 
translation start site of X. laevis XMAP215 (5′-TCATCCACTCGCTGTCATCCCCCAT-3′), and 




validated herein (Fig. 2.S.1A), in addition to standard control antisense oligo (5′-
cctcttacctcagttacaatttata-3′) (Gene Tools, LLC) were used. The embryos were injected four times 
in dorsal blastomeres at two-to-four cell stage in 0.1× Marc's Modified Ringer's (MMR) solution 
containing 5% Ficoll. Total mRNA amounts injected per embryo were: 400 pg of GFP; 700 pg 
of XMAP215–GFP for rescue experiments and 4000 pg of XMAP215–GFP for overexpression 
experiments; 300 pg of GFP–MACF43; 2000 pg of TOG1–2, 1000 pg of TOG1–4, 2000 pg of 
TOG1–5 and 2000 pg of C-terminus (these concentrations are molar equivalents to 4000 pg of 
XMAP215 and 400 pg of GFP). Antisense oligonucleotides were injected in a concentration of 8 
ng/embryo (5′-tcatccactcgctgtcatcccccat-3′) and 20 ng/embryo (5′-ggctttccaaacctaccatgaaaca-3′), 
in both cases equivalent to a 70% knockdown 112. 
 
Immunocytochemistry 
 Embryonic explant cultures were fixed with 0.2% glutaraldehyde and labeled as described 40. 
Immunostaining was done using rat anti-tyrosinated tubulin [YL1/2] (1:1000, ab6160, Abcam), 
rabbit anti-de-tyrosinated tubulin (1:1000, AB3201, Millipore), mouse anti-DM1a (1:100, 
T6199, Sigma-Adrich), mouse anti-GFP (1:200, 3E6, Invitrogen) or rabbit anti-GFP (1:500, 
AB290, Abcam) antibodies, Alexa Fluor 488–phalloidin, Alexa Fluor 568–phalloidin and Alexa 
Fluor 633–phalloidin (1:500, Molecular Probes). The secondary antibodies used were goat anti-
rat Alexa Fluor 568 (1:500, ab175476, Abcam), goat anti-rabbit Alexa Fluor 488 (1:500, A-
11008, Life Technologies), goat anti-mouse Alexa Fluor 488 (1:500, A32723, Life 
Technologies), and goat anti-rabbit Alexa Fluor 647 F(ab′)2 fragment specific (1:500, 111-605-






 High-resolution images of cultured spinal cord explants were obtained with a CSU-X1M 
5000 spinning-disk confocal (Yokogawa) on a Zeiss Axio Observer inverted motorized 
microscope with a Zeiss Plan-Apochromat 63×/1.40 numerical aperture lens, or with a phase 
contrast 20× objective (Zeiss). Images were acquired with an ORCA R2 charge-coupled device 
camera (Hamamatsu) controlled with Zen software. For analyzing the number of growing MTs, 
time-lapse images were collected every 2 s for 1 min using the 63×/1.40 oil objective. The 
number of growth cone pauses and duration of the pauses were obtained by analyzing time-lapse 
images collected every 5 min for 4 h using a phase contrast 20× objective. This objective was 
also utilized to collect images for quantifying axon length, number of axons per explant and 
guidance cue assays. Structured illumination super-resolution images were collected on a Zeiss 
Axio Observer.Z1 for super-resolution microscope with Elyra S.1 system, utilizing an Objective 
Plan-Apochromat 63×/1.40 oil (DIC). Images were acquired with a PCO-Tech Inc. pco.edge 4.2 
sCMOS camera. The images were obtained in a chamber at approximately 28°C and utilizing the 
immersion oil Immersol 518F 30°. Stacked images were obtained with a z-step of 100 nm per 
growth cone. Channel alignment and structured illumination processing were applied to the 
super-resolution images using the Zeiss Black program. The fluorochromes Alexa Fluor 488–
phalloidin, Alexa Fluor 633–phalloidin, Alexa Fluor 568 and Alexa Fluor 488 were used.  
 
Image analysis 
 For the following quantifications, the growth cone was defined as the region contained 
between the growth cone neck and the tip of filopodia. The number of growth cone growing MTs 




All the rest of the quantifications were done using Fiji software. To determine the growth cone 
area, the region starting on the growth cone neck and extending to the tip of the filopodia was 
manually selected using the drawing/selection tool of Fiji (Fig. 2.S.1C). To determine the 
number of filopodia, all the filopodia extending from the growth cone central domain into the 
periphery, contained within the growth cone area, were manually quantified (Fig. 2.S.1C), and 
the length of each filopodium was measured using the Simple Neurite Tracer ImageJ plugin. The 
quantification of number of exploring MTs and MTs present in the filopodia were performed 
manually. To determine the number of exploring MTs, all of the MTs entering into the peripheral 
domain (trespassing the F-actin mesh, orange line in Fig. Fig. 2.S.2B, C) were quantified; for the 
number of MTs present in filopodia, only the MTs present in the peripheral domain that were 
extending into the filopodia (dotted yellow line in Fig. 2.S.2A, B) were considered. For the 
quantification of MT penetration into the peripheral domain, the region of the MT present in the 
F-actin mesh and extending throughout the peripheral domain was manually selected using the 
segmented line tool, and the length was measured (Fig. 2.S.2A,B).  
 For the quantification of MT spreading, the distance between MTs was measured in the 
growth cone neck at the widest region of the growth cone (spreading through the central 
domain); and for the central domain width, the distance occupied by MTs, starting at the growth 
cone neck, was measured. The quantifications of fluorescence intensity for tubulin were 
performed on the manually selected regions of interest using the drawing/selection tool in 
ImageJ. Intensity outside of the growth cone area was measured with the same area drawn for 
growth cone and was considered as background.  
 The percentage of MTs aligned to F-actin was quantified by measuring the distance and 




if closer than 300 nm and separated by an angle not greater than 15°. For MT orientation 
quantification, a line was drawn following the axon growth (central line) and the central line was 
intersected by arrows showing the direction followed by each MT. The angle between the central 
line and the arrows were measured and every 30° was considered as a different orientation. The 
length of the axons was measured using the Simple Neurite Tracer ImageJ plugin. For the 
quantification of the number of growth cone pauses and duration of the pauses, a pause was 
defined as when the center of the growth cone movement at each time point was less than the 
control mean movement minus the standard deviation, or when the growth cone changed the 
orientation of the movement by more than 180°, as growth cones pause before turning. For the 
duration of the pauses, the total number of frames where the growth cone was paused was 
divided by the number of pauses, and then multiplied by the number of minutes between two 
consecutive frames. For the guidance cue assay, the number of growth cones on and off Ephrin 
A5 stripes was manually quantified. Only growth cones with the soma localized off the stripes 
were quantified. Additionally, a growth cone was considered ‘off stripe’ when it had not been on 
an Ephrin A5 stripe at any time. All the quantifications that were manually performed were 
quantified by two different individuals in double blind experiments. 
 
Protein purification 
 XMAP215 was purified using a bac-to-bac purification system as previously described 94,147. 
The pFB HTA XMAP215 vector was used to create bacmid and amplified baculovirus, which 
was subsequently used to infect cultures of Hi-5 insect cells (Trichoplusia ni) (Thermo Fisher 
Scientific, B85502) at a density of 2.0×106 cells ml−1. Following 48 h incubation, cells were 




Protein elution was done using a 250 mM imidazole elution buffer (50 mM HEPES pH 7.25, 200 
mM NaCl, 250 mM imidazole, 0.1% Triton-X, 1 mM DTT, 0.5 mM EDTA, 5% glycerol, 1 mM 
PMSF, 1× complete protease inhibitor cocktail). Buffer was exchanged using Amicon 
ultracentrifugation 100,000 MWCO column (storage buffer: 10 mM K-HEPES pH 7.25, 100 
mM KCl, 5.0 mM EGTA, 2.0 mM MgCl2, 0.1 mM CaCl2, 10% glycerol), then snap frozen and 
stored at −80°C. Purified monomeric actin (Cytoskeleton Inc., APHL99) was diluted to 0.4 
mg/ml in a general actin buffer (5 mM Tris pH 8.0, 0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM DTT) 
and polymerized by the addition of a 10× actin polymerization buffer (500 mM KCl, 20 mM 
MgCl2, 10 mM ATP) at room temperature. 
 
F-actin co-sedimentation assays 
 F-actin co-sedimentation assays were performed as described previously (Srivastava and 
Barber, 2008). Polymerized F-actin or an equivalent amount of F-actin control buffer were 
incubated with either BSA protein (as a negative control) or purified XMAP215 in injection 
buffer (10 mM Tris pH 7.0, 150 mM NaCl, 1 mM ATP, 0.1 mM CaCl2, 2.0 mM MgCl2, 0.2 
mM DTT and 1.0 mM EGTA) for 30 min at room temperature. Protein was precleared to remove 
any aggregates. Actin was added to XMAP215 purified protein in excess. Following incubation, 
samples were centrifuged at 100,000× g for 20 min at 22°C using a Beckman TLA100.4 
ultracentrifuge. For F-actin binding curves, a constant concentration of 0.1 µM of XMAP215 
was incubated with increasing concentrations of 0, 0.05, 0.1, 0.25, 0.5, 1.0 and 2.0 µM of 
phalloidin-stabilized F-actin. Samples were run on SDS-PAGE gels and stained with Coomassie 
Brilliant Blue G-250 before being imaged. ImageJ was used to calculate densitometry of protein 




times before curves were plotted (curves fit by GraphPad Prism non-linear regression assuming a 
one-site saturation model). 
 
Stripe assay 
 Stripe assays were performed following the modified version of the stripe assay described 
previously 123. The Ephrin A5-Fc solution was prepared by mixing 10 µg ml−1 of the Ephrin A5-
Fc, human (R&D Systems, 374-EA) with 2.5 µg ml−1 of anti-human IgG, Fc-specific Cy3-
conjugated (Sigma-Adrich, C2571), and the Fc control solution was generated by mixing 10 µg 
ml−1 Fc (Calbiochem, 401104) with 2.5 µg ml−1 of anti-human IgG, Fc-specific (Sigma-Adrich, 
I2136). Both solutions were kept for 30 min on a rotator, covered from light. Zig-zag striped 
silicon matrices attached to glass coverslips were used. The Ephrin A5-Fc solution was applied 
to the matrices and incubated for 30 min at 37°C. After three washes in 1× PBS, the Fc control 
solution was applied on the glass coverslips and incubated for 30 min at 37°C. Following that, 
three washes in 1× PBS were done and the glass coverslips were coated with 20 µg ml−1 
laminin. X. laevis spinal cord explants were plated and imaged 24 h later. 
 
Experimental design and statistical analysis 
 All graphs and statistical analyses were performed using the statistical software Prism 5 
(GraphPad Software Inc.). Three to four independent experiments were performed for each 
condition to ensure reproducibility. Images of 8–10 explants acquired from 2–3 different 
embryos were obtained for each condition in every independent experiment. All data sets were 




conditions, the unpaired Student's t-test was performed, and when comparing multiple 
conditions, one-way ANOVA was used, by comparing the mean of each column with the mean 
of the control column under the multiple comparison option. In the cases that the data did not 
pass the normality test, Mann–Whitney test was used for comparing two conditions, and 
Kruskal–Wallis test for multiple comparisons. To analyze MT morphology, as it is a categorical 
variable, a χ2 test was performed. The α-value was set at 0.05 for all statistical tests, and the P-
values are represented as follows: *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001. Values 
are expressed as mean±s.e.m 
 
 
V. Supplemental Data 
 






Figure 2.S.1. A) Western blot showing increasing levels of XMAP215 knockdown with increasing levels of antisense 
oligonucleotide. Actin was used as a loading control. B. DIC images (left) and actin and tubulin merge images (right) 
of growth cones from control and XMAP215 KD neural explants. Scale bar: 5 µm. C. Diagrams illustrating the 
measurements taken to analyze either growth cone area (left), or filopodia length (right) following XMAP215 KD, 
rescue, or OE. Structures analyzed are highlighted in green. Growth cone measurements correspond to data shown in 
Figure 2.II.1A. Average filopodia length corresponds to data shown in Figure 2.II.1C. 
Figure 2.S.2. Example of the measurements taken of MT and actin-stained SIM imaging, corresponding to data displayed 
in Figure 2.II.3. A. Representative images of control, XMAP215 KD and XMAP215 OE growth cone stained for F-actin, MT 
and merge. Orange lines delineate the central domain, the beginning of the actin mesh is considered as the limit of the central 
domain, and the yellow dotted lines denotes the beginning of the filopodia. B. Growth cone cartoon showing that MTs that 
progress out of the central domain (orange line) are considered “exploring MTs”, and the ones progressing beyond the doted 






Chapter 3. XMAP215 displays a unique lattice based function that links MTs 
to F-actin in the Growth Cone 
(Adapted from Cammarata et al., 2020 – Molecular Biology of the Cell (In Submission)) 
 
I. Introduction 
The neuronal growth cone is a structure that is found at the end of growing axons, governing 
proper guidance and pathfinding capabilities for the neuron. In order for neurons to make proper 
connections in the brain, cytoskeletal networks need to be tightly controlled and regulated. These 
cytoskeletal networks are largely made up of microtubules and actin filaments (F-actin), which 
each control unique portions of the growth cone’s ability to drive forward and steer 111, 112, 113. 
While F-actin provides for the protrusion of new membrane growth and reorganization, 
microtubules act as scaffolds for guidance cue signaling pathways in the growth cone 1. In 
addition, there is constant interplay between these two systems, facilitating correct localization of 
each other in the proper compartments of the growth cone 115. 
Importantly, populations of dynamically-growing microtubules are found to extend into the 
periphery of the growth cone and into the ends of filopodia (Figure 3.I.1.) 46. In order for 
microtubules to penetrate out of the compartmentalized central domain of the growth cone and 
explore the periphery, dynamic microtubules follow F-actin bundles, using them as tracks to be 
guided into the periphery 7,46. Here, dynamic microtubules interact with guidance cues and 




cytoskeletons 1. In addition to facilitating microtubule advancement into the periphery, F-actin 
higher order structures are capable of restricting dynamic microtubules from reaching the 
periphery when the microtubules are strongly bound to F-actin retrograde flow 7, 10. This dual 
facultative and restrictive role of F-actin regulates advancing microtubules in the growth cone, 
and together, regulate protrusion and steering of the axon.  
The ability of microtubules to be guided by F-actin tracks is thought to be initiated by groups 
of microtubule associated proteins (MAPs) that decorate the microtubule lattice and plus end 
19,22,52,53,114–117. These proteins, depending on their localization to microtubule and actin 
filaments, as well as their strength of interaction, can alter spatial localization of microtubules in 
the growth cone 115. It has been shown that when microtubules are tightly coupled to F-actin in 
Figure 3.I.1. Depiction of Growth Cone regions and parameters of analysis for MT exploration in Growth Cone. A) 
Growth cones structure is dominated by MTs in the central domain (magenta) and a rich F-actin periphery (green). Exploring 
microtubules can break out of the central domain (orange), and be guided by F-actin bundles into filopodial extensions (yellow 
dotted lines). A, example two colored SIM image of a growth cone is depicted as either merged (top right), or with a 




the growth cone, microtubules are carried with F-actin retrograde flow back towards the central 
domain 17,49. This has been shown to be the case when levels of MAPs, like CLASP, are 
increased in the growth cone, or when certain phosphorylation conditions in the growth cone are 
met 17,51,52. Oppositely, certain MAPs, like EB3/Drebrin, allow microtubules to be transiently 
coupled to F-actin, allowing microtubules to be free to polymerize while simultaneously using 
bundles of F-actin as routes of guidance 22. It is thought that through this unique mechanism, 
proteins linking MTs and F-actin together rapidly bind on and off from either filament, allowing 
a close guidance based association of MTs for bundles of F-actin, while not being subjected to 
the strong treadmilling translocation through F-actin retrograde flow. 
One such protein that is uniquely positioned for this task is the microtubule polymerase, 
XMAP215 (part of the Dis1/TOG family). XMAP215 has been analyzed thoroughly for its 
ability to affect microtubule polymerization 94,101,102,105,118,121,132, while only recently shown to 
affect microtubule nucleation 119,120. These unique functions of XMAP215 are attributed to its 
unusual pentameric TOG (Tumor overexpressed gene) domain array. Individually, these TOG 
domains contribute to both GTP and GDP-tubulin binding, catalyzing tubulin subunits onto the 
ends of microtubules 94,101,148. However, in addition, XMAP215 also contains a highly charged 
microtubule lattice binding region in between its TOG4 and TOG5 domain, and contains a 
largely disordered C-terminal domain involved in protein-protein interactions 34,96,101,103,104. 
While much is known about the earlier TOG domains, there is less known about the structurally 
diverse TOG5 domain 34,105. In addition, up until recently, there was no information regarding 
XMAP215’s ability to interact with the F-actin cytoskeleton in any fashion 149. 
I have shown that this important protein is capable of binding to F-actin directly, and can 




the mechanism of XMAP215’s interaction with both F-actin and microtubule populations to 
carry out this function in the growth cone remained a mystery. In this Chapter, I utilize 
biochemical assays in combination with high and super resolution imaging to determine the role 
of XMAP215 in linking microtubules to the F-actin cytoskeleton in the growth cone. Here, I 
establish the TOG5 domain as a necessary region to influence interactions with F-actin directly. 
In addition, I determined that XMAP215 lattice binding activity and TOG5 mediated F-actin 
binding domains are essential for influencing microtubule guidance into the growth cone 
peripheral domain. Finally, I establish that this dual cytoskeletal role is separate from its classical 
polymerase activity. Thus, my work highlights the important role that XMAP215 plays in 
directing microtubule extension into targeted regions of the growth cone through F-actin 
interaction, facilitating protrusion and steering pathways of the axon during growth. 
 
II. Results 
The TOG5 domain is uniquely important in allowing direct interaction with F-actin in 
vitro 
While XMAP215 has been previously implicated in coordinating microtubule extension 
into the growth cone periphery through an F-actin-related mechanism 109, it was still unclear as to 
what particular region of XMAP215 binds to F-actin however. In order to probe for a distinct F-
actin binding domain, I created numerous XMAP215 deletion constructs and purified protein for 
each (Figure 3.II.1A, and Figure 3.S.1A). I then utilized F-actin sedimentation assays in order 
determine whether these protein fragments could directly bind to F-actin 150. First, I tested larger 
constructs made up of several TOG domains: TOG1-4, TOG1-4+microtubule lattice-binding 




concentrations of F-actin (0 to 2.5 µM F-actin), I saw little increase in sedimenting TOG1-4 
protein at >100,000 x g (Figure 3.II.1B, C). Given that TOG1-4 protein was not sufficient to 
promote binding to F-actin, I wondered next whether the highly charged microtubule lattice-
binding region 34,101 was playing a key role. However, when I analyzed binding of the TOG1-
Figure 3.II.1. The TOG5 domain is uniquely important in allowing direct interaction with F-actin in vitro. A) Diagram of 
XMAP215 deletion proteins purified for use in sedimentation assays. B) F-actin Binding Curves of different TOG and C-term-
containing purified proteins interacting with F-actin in sedimentation assays. C) TOG1-4, TOG1-4++, and TOG1-5 proteins 
incubated with increasing amounts of F-actin protein in F-actin Sedimentation Assays. Approximately 0.250 µM XMAP215 
deletion protein, F-actin concentrations ranging from 0-2.5 µM. D) TOG3-C-term, TOG5-C-term, and C-terminal domain proteins 
(approximately 0.250 µM) incubated with increasing amounts of F-actin protein (0-1.0 µM F-actin). Sedimentation of C-terminal 




4++ region, I observed little sedimentation with F-actin, similar to the results with TOG1-4. 
However, when I purified and examined XMAP215 constructs that included the TOG5 domain, 
we observed a large increase in apparent binding to F-actin (Figure 3.II.1C). Plotting 
densitometry values on a binding curve showed a saturating curve, with an apparent KD of ~1.2 
µM and ~70% maximal binding (Figure 3.II.1B). This showed that specifically adding on the 
TOG5 domain, a largely uncharacterized domain 105, to the N-terminus of the protein was 
important for binding to F-actin with a strong affinity.  
While I had observed that the TOG5 domain was important for XMAP215 binding to F-
actin, I next set out to test whether it was sufficient for binding. I purified a host of proteins 
containing the TOG5 domain along with other domains to see how they affected binding. 
Interestingly, the TOG5 domain alone, TOG5+MT lattice (TOG5++), or TOG3-TOG5 domains 
did not facilitate binding to F-actin (Figure 3.S.1A). However, when adding on the C-terminal 
domain to TOG5, I did observe direct binding to F-actin (Figure 3.II.1D, Figure 3.II.1B). In 
addition, proteins containing TOG3-Cterm and TOG5-Cterm showed saturated binding to F-
actin, with TOG3-Cterm giving an apparent binding affinity of ~ 0.06 µM with ~85% maximal 
binding (Figure 3.II.1B). TOG5-Cterm was able to sediment with F-actin, although a binding 
affinity was not accurately measurable due to saturation at very low F-actin concentrations and 
problems of aggregation at room temperature. I also tested whether the XMAP215 C-terminal 
domain alone could bind to F-actin, but found that no affinity was measurable even at very high 
F-actin concentrations of 16.0 µm. This shows while TOG5 alone is not sufficient to bind F-
actin, other adjacent domains – either the complete pentameric TOG array, or the C-terminal 





Figure 3.II.2. Localization of XMAP215 to the MT lattice or plus end in growth cones is facilitated by distinct domains. A) 
Diagram depicting mNeonGreen-labelled XMAP215 deletion proteins and associated domains, comprised of N-terminal TOG 
domains (1-5), a MT lattice binding region (purple), and a plus-end localizing C-terminal domain (C-term). B) Live cell imaging of 
XMAP215-FL-GFP overexpressed in embryonic neuronal growth cones. Right inset depicts time-lapse montage of XMAP215 along 
both the lattice and the plus end of a MT. C) Live cell imaging of XMAP215 deletion constructs shown in A overexpressed in growth 
cones. Tubulin (magenta), XMAP215 deletion protein (green), and merged image of the two channels are depicted. Inset pictures 





Localization of XMAP215 to the microtubule lattice or plus end in growth cones is 
facilitated by distinct domains 
While XMAP215 has been previously implicated in localization to both the plus end and 
lattice of microtubules in growth cones (Figure 3.II.2B) 112, and facilitating microtubule/F-actin 
interactions 109, no previous study has yet examined whether the plus-end-localized or lattice-
bound fraction of XMAP215 facilitates this novel microtubule/F-actin interaction. First, I sought 
to determine which domains of XMAP215 promote localization to either plus-end or lattice in 
growth cones. I created several deletion mutants of XMAP215 that contain a previously 
characterized microtubule lattice binding region 101, as well as a C-terminal domain that is 
implicated in microtubule plus end binding through protein-protein interactions 96,98,103,104,129 
(Figure 3.II.2A).  
Importantly, while full length XMAP215 contains five TOG domains and the C-terminal 
region, the deletion mutants that I created all lack at least the TOG1-2 domains. Deletion of the 
GTP-tubulin binding TOG1-2 domains hinders these proteins from acting as microtubule 
polymerases 101,105, which was confirmed when looking at changes in microtubule growth speeds 
Figure 3.II.3. Removal of TOG1-2 
domains of XMAP215 diminish 
microtubule velocity effects. A) Plus 
end tracking of MACF43 puncta 
velocities following overexpression of 
XMAP215-FL, TOG5++, TOG3-
Cterm, and TOG5-Cterm constructs in 
growth cones. B) Microtubule growth 
velocity speeds quantified 
automatically through use of 
plusTipTracker software. Average 
comet velocity of growth cones 
displayed as normalization to control 




after OE of deletion proteins in growth cones (Figure 3.II.3A, B). Normally, full length 
XMAP215 localizes to both the lattice of the microtubule and the plus end of the microtubule 112 
(Figure 3.II.2B, insert right). While these proteins were not acting as microtubule polymerases, 
they did still localize correctly to either the microtubule lattice (triple arrows, TOG5++ and 
TOG3-Cterm), or the microtubule plus end (single arrow, TOG3-Cterm and TOG5-Cterm) 
(Figure 3.II.2C insert right). By establishing differentially localized pools of XMAP215 protein 
that do not affect microtubule polymerization levels, I could then test whether populations of 
microtubules were still being affected by XMAP215 in a polymerization-independent manner. 
 
Figure 3.II.4. TOG3-C-term 
construct is capable of affecting MT 
looping and extension phenotypes in 
the growth cone. A) Expression of 
mKate-tubulin in growth cone. Arrows 
= straight MTs extending towards 
periphery. Arrowheads = looping MTs 
coupled to retrograde flow. B) 
Percentage of MTs undergoing looping 
over total MTs. C) Average lengths of 
MTs extending into the periphery 
following XMAP215 knockdown 
(KD), or XMAP215 KD and rescue 
with indicated deletion construct. D) 
Percentage of exploring MT 
populations that extend into filopodia 
measured following XMAP215 KD, or 
XMAP215 KD and rescue with 
indicated deletion construct. * P<0.05, 
*** P<0.001, **** P<0.0001. Scale 




TOG3-Cterm construct is capable of affecting microtubule looping and extension 
phenotypes in the growth cone 
Indeed, I saw that certain truncation mutations did change characteristics of microtubules 
in the growth cone. As my previous chapter highlights a novel F-actin interactions through 
microtubule bound XMAP215 109, I thought that this might also be affecting microtubule 
populations here in a similar manner. I then tested microtubules for looping, a phenotype 
commonly involved in microtubule attachment to F-actin retrograde flow or for inability of 
microtubules to escape the central domain of the growth cone during normal internal signaling 
states 14,109,127. When overexpressed in the growth cone, TOG5++ and TOG5-Cterm did not 
significantly affect microtubule looping in the central domain over control levels (1.01% and 
2.47 % difference, P = 0.951 and 0.877, respectively). However, OE of TOG3-Cterm 
significantly decreased the microtubule looping that was occurring in growth cones over control 
(30.35% reduction, P = 0.035) (Figure 3.II.4A). This potentially indicated that microtubules 
could not escape the central domain of the growth cone without interaction with guide F-actin 
bundles, and so I then looked at how microtubules were penetrating into the peripheral domain. 
Here, I partially knocked down XMAP215 levels to around 70%, which leaves enough wild-type 
XMAP215 protein present in growth cones to allow for normal rates of microtubule 
polymerization (previously validated in 109,112). When XMAP215 levels are partially knocked 
down, there is a significant reduction in microtubule penetration distances (30.72 % reduction, P 
value = 0.002), and microtubules present in filopodia (37.18% reduction, P value = 0.0004) 
(Figure 3.II.4C, D).  
Adding back deletion mutant mRNA showed that only TOG3-Cterm was capable of 




percentage in filopodia P value = 0.634). It is notable that while TOG5++ was not able to bind 
directly to F-actin (Figure 3.S.1A), TOG5-Cterm and TOG3-Cterm were capable (Figure 
3.II.1D, Figure 3.S.1B). Thus, only constructs capable of binding to F-actin, and containing the 
lattice-binding domain, were able to rescue microtubule extension phenotypes. Importantly, I 
also established that XMAP215 is capable of facilitating microtubule extension into the 
periphery of growth cones without its main polymerase function. 
 
Microtubule lattice-bound XMAP215 is capable of rescuing knockdown-induced 
microtubule/F-actin misalignments in growth cones  
Given that F-actin commonly facilitates exploratory microtubule extension into the 
periphery of growth cones 7,46, where they can act as guidance cue sensors 1, I wanted to examine 
how XMAP215 was affecting microtubule and F-actin alignments in the growth cone. Thus, I 
analyzed microtubule and F-actin bundles in the growth cone using super resolution Structured 
Illumination Microscopy, after expression of XMAP215 deletion constructs. I partially knocked 
down XMAP215 as before, and then rescued with either TOG5++, TOG5-Cterm, or TOG3-
Cterm OE. I found that XMAP215 constructs (shown in red), that contain lattice-binding regions, 
localize along microtubules in the growth cone (Figure 3.II.6A, center panel). Plus-end 
localizing constructs like TOG5-Cterm were difficult to establish tracking to the ends of the 
microtubule, which may have been due to fixation artifacts of samples, or background 
interference.  
In order to assess if microtubules were using F-actin as tracks, I analyzed microtubules that 
were exploring along these F-actin bundles. Microtubules that were exploring at an angle >30.0º 




were considered misaligned (arrows), following previously explained criteria 109. Diagrams of 
microtubules and F-actin are given in “camera lucida” type images to more easily depict aligned 
and misaligned filaments (Figure 3.II.6A, right panel).  When I examined how these constructs 
could rescue microtubule alignments to F-actin, I saw similar results to the microtubule 
penetration phenotypes shown earlier. While XMAP215 KD produced a 22.45% reduction in 
microtubules aligned to F-actin bundles (P = <0.0001), neither TOG5++ nor TOG5-Cterm 
Figure 3.II.5. XMAP215 utilizes its lattice-binding region to 
facilitate MT and F-actin interaction in the growth cone. A) 
Structured Illumination Microscopy images showing TOG5++, 
TOG5-C-term, and TOG3-C-term proteins overexpressed in 
embryonic neuronal growth cones. Tubulin (magenta), XMAP215 
deletion protein (red), F-actin (green), and merged channels shown. 
Final panel depicts MT and F-actin filaments in a “camera lucida” 
type image. Arrows highlight MTs that are misaligned to F-actin 
bundles in the growth cone periphery. Scale bar = 5.0 µm. B) 
TOG3-C-term rescues XMAP215 knockdown (KD)-induced MT-F-





constructs could rescue levels of microtubule/F-actin alignment back to control levels. However, 
OE of TOG3-Cterm was capable of rescuing XMAP215-KD induced misalignment completely 
back to control levels (1.16%, P value = 0.850) (Figure 3.II.6B). Thus, together with its ability 
to promote microtubule extension into the periphery, and into filopodia, XMAP215 displays a 
microtubule dependent guidance mechanism for microtubules dependent on F-actin interaction 
and microtubule lattice binding. 
 
III. Discussion 
In this Chapter, I expand upon the recent discovery of XMAP215 functioning as a novel 
microtubule/F-actin co-interactor. Using biochemical assays, super resolution imaging, and 
structure-function analysis, I mechanistically explore XMAP215’s role in facilitating 
microtubule exploration in key regions of the neural growth cone through F-actin related 
mechanism. In order for microtubules to reach the periphery of the growth cone and affect 
axonal outgrowth and steering mechanisms 42, microtubules require the ability to polymerize, as 
well as a way to be guided through dense F-actin mesh 10,41. In this chapter, I explored 
XMAP215’s ability to interact with F-actin in a direct fashion using biochemical assays. In 
addition, I showed that XMAP215 requires a microtubule lattice binding localization to carry out 
Figure 3.III.1. Table 
summarizing F-actin binding, 
MT localization, and rescuing of 
MT/F-actin filament alignments 
abilities of XMAP215 deletion 
constructs. Asterisk (*) denotes 
data concluded from (Slater and 




its extension of microtubules into the peripheral domain of the growth cone. Finally, I show that 
the ability of XMAP215 to link microtubules to F-actin bundles in the growth cone requires both 
an F-actin binding domain, and microtubule lattice localization, all capable of acting 
independently from its classical polymerase function (Figure 3.III.1).  
XMAP215 has been studied quite extensively over the last few decades as a microtubule 
polymerase 94,101,102,105,118,121 and depolymerase 94,135,151. Only recently, however, have new 
functions been attributed to it, such as acting as a microtubule nucleation factor 119,120, as well as 
acting as a potential microtubule and F-actin crosslinking protein 109. In order to establish a more 
precise view of XMAP215 acting as a cross-linking protein, I had to establish the domain 
capable of binding to F-actin. Previous studies hinted at a region of XMAP215 between the 
TOG4 and the TOG5 domain that was important in facilitating microtubule/F-actin interactions 
in growth cones 109. Probing this region for F-actin binding activity, I purified numerous deletion 
constructs (Figure 3.II.1A, Figure 3.S.1C), containing the microtubule lattice binding region, as 
well as the TOG5 domain.  
Both of these proposed regions were good candidates for F-actin binding. The microtubule 
lattice-binding domain is a highly positively charged region consisting of stretches of serine and 
lysine 94,101,152, attributes that make it likely to interact with the outer surfaces of tubulin carboxy-
terminal tails and potentially to actin filaments 153,154. However, If XMAP215 is a cross linking 
protein, domains of tubulin binding and F-actin binding would likely be separate from one 
another to facilitate binding to both filaments. When differentiating between the TOG1-4 
construct, and the TOG1-4++ construct in F-actin binding, there seemed to be little change 
shown by my biochemical assays (Figure 3.II.1). In addition to the previously characterized 




TOG domain to facilitate interaction with F-actin. The TOG5 domain is the most widely varied 
domain in sequence to other TOG domains 34,101,102,105. In addition, the TOG5 domain, over all 
other TOG domains, has higher sequence homology to that of the TOG-like domain of another 
+TIP protein, CLASP 34. The TOGL1 domain of CLASP has been implicated in direct F-actin 
interaction 21 and interaction to F-actin in neurons 51,53, indicating that the TOG5 domain of 
XMAP215 may possess a similar capability here. Interestingly, interactions of either the TOG5 
domain alone, or the TOG5 domain with the microtubule lattice-binding region (TOG5++), 
showed no indication of F-actin binding in our sedimentation assays (Figure 3.S.1A). Only with 
the addition of the complete pentameric TOG array (TOG1-5) or the adjacent C-terminal domain 
(TOG5-Cterm) did I see successful binding to F-actin (Figure 3.II.1). In each case, the presence 
of the TOG5 domain was required for F-actin binding. Thus, my data indicates that TOG5 
domain is acting as an F-actin binding domain, although proper conformation is likely required 
by other adjacent domains to facilitate the interaction. 
Not only did I determine that the TOG5 domain was necessary for F-actin interaction, but the 
XMAP215 C-terminal domain was important as well. The C-terminal domain of XMAP215 has 
been studied for its ability to interact with the coiled-coil domains of other proteins such as 
TACC3 103,104,129, SLAIN1/2 96,97, and for its involvement in microtubule nucleation 120. While I 
saw apparent binding affinity of the TOG1-5 domains to F-actin of around 1.2 µM, addition of 
the C-terminal domain to TOG5 produced an over ten-fold stronger affinity of around 0.06 µM 
for F-actin. Comparing this to the binding affinity of the full length XMAP215 (Kd = ~0.03 µM) 
109, the C-terminal domain rescued levels of F-actin binding to that of WT protein levels (Figure 
3.II.1B). The C-terminal domain on its own, however, had no effect in binding to F-actin 




C-terminal domain 155, highlighting the possibility of C-terminal domain co-involvement with 
this TOG5 oriented function. In addition, little information regarding C-terminal conformational 
changes upon binding to F-actin or microtubules exist. As the C-terminal domain is largely made 
up of alpha helices and unordered regions 103,155, structural flexibility may either hinder or 
facilitate adjacent TOG5 binding to F-actin based on protein-protein interactions or 
phosphorylation states. Thus, the C-terminal domain may play a role in facilitating the correct 
conformation of the TOG5 domain in order to ensure correct F-actin binding, although more 
information regarding this important domain is required. In addition, how other MAP/F-actin 
binding proteins can influences F-actin interaction through this domain needs to be studied 
further. 
In addition to determining the necessary domain for F-actin interaction, through my 
biochemical assays and super-resolution imaging of the growth cone, I establish a potential F-
actin/microtubule crosslinking function as separate from its role as a polymerase. First, I show 
that XMAP215 is capable of distinctly binding to either the microtubule lattice (through its 
microtubule lattice binding domain), or to the plus end of the microtubule (through its C-terminal 
domain) in growth cones (Figure 3.II.2A). Interactions with the lattice and the plus end are still 
possible without these two initial TOG domains 34, as long as their respective interaction 
domains are present. Without the use of its TOG1-2 domains, required for catalyzing the addition 
of GTP-tubulin subunits 94, XMAP215 deletion mutant OE shows no effect on microtubule 
growth speeds in the growth cone (Figure 3.II.3). These TOG1-2 deletion mutants confirmed 
what was seen previously in other cell types 105 and in vitro 101. More importantly, while not 
affecting growth speeds, we show that XMAP215 is capable of influencing microtubule 




leads to a significant reduction in microtubule looping (Figure 3.II.3A, B). While Microtubules 
are inhibited in their ability to transition outside the central domain by F-actin arcs and 
lamellaepodia 7,41, microtubules are thought to interact transiently along F-actin bundles for 
extension into the periphery 10,46. When microtubules cannot effectively use these F-actin 
guidance mechanisms, some populations are stuck inside of the central domain 41, while others 
penetrate into the peripheral domain in a disorganized fashion 47. Utilizing a similar knockdown 
and rescue experimentation system as in previous studies 109, I show that the TOG3-Cterm 
construct is capable of rescuing both KD induced microtubule penetration (Figure 3.II.4C) as 
well as reductions in populations of microtubules capable of reaching filopodia (Figure 3.II.4D). 
Thus, I believe that XMAP215, specifically its combination of microtubule lattice and F-actin 
binding domains, facilitates transient microtubule interactions along bundles of F-actin in the 
growth cone. 
To test that possibility further, I took super-resolution images of F-actin and microtubules 
alignments in the growth cone. Microtubules capable of being guided along F-actin bundles 
would follow similar trajectories and would grow closely together 54. While some microtubule 
associated proteins may cause a strong interaction between microtubule and F-actin 17,50, others 
are thought to allow a transient microtubule/F-actin interaction, not restricted by F-actin 
retrograde flow to the same extent 22,115. When microtubule and F-actin interaction is affected in 
the growth cone, microtubules can display varied trajectories in the periphery 41,47, as well as 
showing areas devoid of microtubules 141. When I analyzed exploratory microtubules in the 
growth cone, I saw that the TOG3-Cterm construct could again affect microtubule populations 
(Figure 3.II.5). Addition of TOG3-Cterm mRNA to partial XMAP215 KD rescued alignments 




Importantly, only deletion constructs that contained a microtubule lattice-binding domain, and 
were capable of directly interacting with F-actin, could rescue all microtubule related 
phenotypes. Thus, XMAP215 is capable of facilitating microtubule extension and guidance most 
likely along F-actin bundles in the periphery. 
Taken together, my data suggests a unique microtubule guidance mechanism directed 
through XMAP215/F-actin interaction. In this Chapter, we have shown that pools of lattice 
bound XMAP215 are capable of rescuing microtubule guidance defects. In addition, I have 
shown that the TOG5 domain is critically important for binding directly to F-actin, while the C-
terminal domain assists in this functional binding. Through transient interactions with F-actin, 
microtubules can escape the central domain of growth cone and explore the periphery 10,22. In 
this way, XMAP215 can spatially regulate populations of exploring microtubules, controlling 
downstream signaling events through these guidance cue “sensors” in the periphery.  
Indeed, in the previous chapter, it was shown that XMAP215 could affect microtubule and F-
actin interactions downstream of Ephrin repellent signaling cascades in the growth cone 109. 
Furthermore, while not affecting F-actin retrograde flow rates 112, this unique F-actin related 
XMAP215 function was shown to affect growth cone pausing, highlighting its role in changing 
the internal signaling state through microtubule spatial alterations 109. Importantly, I show here 
that this function of XMAP215 is separate from its microtubule polymerase function, solidifying 
XMAP215’s diverse and important role in linking microtubule and F-actin cytoskeletons 
together. While capable of binding to microtubule and F-actin directly, the ability of XMAP215 
in cross-linking F-actin and microtubule simultaneously needs to be validated still. In addition, 




to understand the extend of other protein’s involvement in this microtubule/F-actin related 
function of XMAP215. 
 
IV. Materials and Methods 
 
Xenopus embryonic neural tube explants 
Eggs collected from female X. laevis frogs were fertilized in vitro, dejellied, and cultured 
following standard methods 156. Embryos were grown to stage 22-24 144, and neural tubes were 
dissected as described 146. All experiments approved by the Boston College Institutional Animal 
Care and Use Committee and performed according to national regulatory standards. 
 
Constructs, RNA, and Antisense oligonucleotides 
Constructs used in Xenopus embryonic growth cone imaging: pT7TS XMAP215-FL-
GFP (a gift from the Hyman lab 101), pT7TSr TOG3-Cterm-mNG, pT7TSr TOG5-Cterm-mNG, 
pCS2+ TOG5+lattice-mNG (TOG5++). Constructs were subcloned (PCR of full-length 
XMAP215-GFP vector) into either pT7 or pCS2+ vectors for mRNA transcriptions and 
subsequent microinjection into Xenopus embryos. Constructs used in in vitro protein purification 
and biochemistry experiments: pFB XMAP215, pFB TOG1-4, pGEX GST TOG1-4+lattice, pFB 
TOG1-5, pStr TOG3-Cterm (gift from Petry lab), pStr TOG5-Cterm (gift from Petry lab), pGEX 
GST TOG5, pGEX GST TOG3-5, pGEX GST TOG4-5, and pFB XMAP215 C-terminal only. 
Constructs subcloned (PCR of full-length XMAP215-GFP vector) into either pFastbac, pStr, or 
pGEX GST vectors for protein purification and in vitro experiments. For constructs to be in vitro 




(Ambion). Previously validated antisense oligo targeted to a splice site (5' 
ggctttccaaacctaccatgaaaca 3') were used in these experiments for XMAP215 KD experiments 
(Lowery 2013, Slater and Cammarata 2019), in addition to using a standard control antisense 
oligo (5’ cctcttacctcagttacaatttata 3’) (GeneTools, LLC, Philomath OR, USA). All embryos were 
injected 4 times in dorsal blastomeres at two to four cell stage in 0.1X MMR/ 5% Ficoll at 
concentrations listed: 750 pg of XMAP215-FL-GFP and equimolar concentrations of either 
TOG5+lattice, TOG3-Cterm, or TOG5-Cterm. Antisense oligonucleotides injected at 20 
ng/embryo, equivalent to 70% KD 112,149. 
 
Protein purification 
XMAP215-FL and other constructs in pFastBac vectors were purified using a bac-to-bac 
purification system as previously described 94,147,149. Constructs contained in the pFB vector were 
used to create bacmid and amplified Baculovirus using cultures of SF9 insect cells. P2 
Baculovirus containing proteins of interest were transfected into Hi-5 insect cells for protein 
expression (Trichoplusia ni) (ThermoFisher Scientific) at a density of 2.0 x 106 cells/ml. Filtered 
lysate purified using Nickel or Cobalt column chromatography. Protein eluted with a 250 mM 
imidazole elution buffer (50 mM HEPES pH 7.25, 200 mM NaCl, 250 mM imidazole, 0.1% 
Triton-X, 1 mM DTT, 0.5 mM EDTA, 5% glycerol, 1 mM PMSF, 1X complete protease 
inhibitor cocktail). Constructs containing pStr or pGEX GST transformed into pRare containing 
Rosetta2 bacteria, grown in Amp/Chloramp broth, induced using 0.1-0.4 mM IPTG at 16 hours 
(20.0C), and purified using either Nickel/Cobalt, Streptavidin, or Glutathione agarose. 
Constructs with GST tags were cleaved off beads using Prescission Protease (GE Healthcare) 




further clarification. Protein buffers exchanged using Amicon ultracentrifugation 10,000 or 
100,000 MWCO column (Storage Buffer: 10 mM K-HEPES pH 7.25, 100 mM KCl, 5.0 mM 
EGTA, 2.0 mM MgCl2, 0.1 mM CaCl2, 10% glycerol) and snap frozen/stored at -80.0°C. 
Purified monomeric actin (Cytoskeleton Inc) diluted to 0.4 mg/ml in a general actin buffer (5 
mM Tris pH 8.0, 0.2 mM CaCl2, 0.2 mM ATP, 0.5 mM DTT) and polymerized through the 
addition of a 10X actin polymerization buffer (500 mM KCl, 20 mM MgCl2, 10 mM ATP) at 
RT. 
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F-actin co-sedimentation assays 
F-actin co-sedimentation assays performed as previously described 157. Polymerized F-
actin incubated with purified XMAP215 (or deletion construct) protein in injection buffer (10 
mM Tris pH 7.0, 150 mM NaCl, 1 mM ATP, 0.1 mM CaCl2, 2.0 mM MgCl2, 0.2 mM DTT, and 
1.0 mM EGTA) for 15 min at RT. All protein precleared before incubation with F-actin to 
remove aggregates. For non binding-curve experiments, F-actin was added to XMAP215 
purified proteins in excess. For binding curve experiments, XMAP215 (or deletion protein) 
concentration was kept constant, with increasing concentrations of F-actin. Proteins that did not 
show binding at lower concentrations of F-actin were incubated with much higher concentrations 
to determine if any binding possible (XMAP215 C-term). Following incubation, samples were 
centrifuged at 100,000 x g for 20 min at 20 °C using a Beckman TLA100.4 ultracentrifuge. 
Phalloidin used to stabilize F-actin in these experiments (with no apparent effect to F-actin 
binding). Samples were run on SDS-PAGE gels and stained with Coomassie Brilliant Blue G-
250 before imaging. Densitometry of protein bands on SDS-PAGE gels analyzed using ImageJ, 








Embryonic explant cultures were fixed with 0.2% glutaraldehyde and labeled as 
described 40. Growth cones were stained using rat anti-tyrosinated tubulin (1:800, ab6160, 
Abcam), mouse anti-mNeonGreen (1:400, 32F6, Chromotek,) and Phalloidin488 (1:400, 
Molecular Probes). Secondary antibodies used were goat anti-rat AlexaFluor633 (1:500, Life 
Technologies), and goat anti-mouse AlexaFluor556 (1:500, Life Technologies). All antibodies 
used were pre-absorbed to reduce any potential cross-reactions. Blocking and all antibody 
diluent solutions made with 5% goat serum. 
 
Image Acquisition 
Live cell imaging and Structured Illumination imaging setup previously described in 
Slater and Cammarata, 2019. Live cell imaging of cultured spinal cord explants were obtained 
with a CSU-X1M 5000 spinning-disk confocal (Yokogawa, Tokyo, Japan) on a Zeiss Axio 
Observer inverted motorized microscope using a Zeiss 63× Plan Apo 1.4 numerical aperture lens 
and oil based objective (Zeiss, Thornwood, NY). Images acquired with an ORCA R2 charge-
coupled device camera (Hamamatsu, Hamamatsu, Japan) controlled by Zen software. Time-lapse 
images were collected every two seconds for 1 min. For fixed samples using Structured 
Illumination, images were collected on a Zeiss Axio Observer.Z1 microscope with Elyra S.1 




with a PCO-Tech Inc. pco.edge 4.2 sCMOS camera. Images were processed in Zen Black to 
allow Channel alignment and Structured Illumination processing.  
 
Image Analysis 
The following descriptions provide the basis for analysis of microtubules within the 
growth cone. All methodology for image analysis of growth cones has been thoroughly described 
according to Slater and Cammarata, 2019 149. The growth cone was defined as the region 
contained between the growth cone neck and the tip of filopodia for the following imaging 
analysis. To quantify the amount of microtubule penetration into the peripheral domain, 
microtubules were measured from the start of their emergence into the area devoid of F-actin 
mesh to the ends of filopodia. Average penetration of all exploring microtubules were taken per 
growth cone. Measurements were manually taken using the segmented line tool in ImageJ. 
Quantification of number of exploring microtubules and microtubules present in the filopodia 
were all performed manually in ImageJ. The percentage of microtubules that are aligned to F-
actin bundles were quantified by measuring both the distance between microtubule and F-actin 
bundle, and the angle of microtubule and F-actin filament. Microtubule and F-actin were 
considered aligned by the criteria that each filament is within 300 nm from each other and 
separated by a trajectory angle no greater than 15 degrees. 
 
Experimental design and Statistical Analysis 
All graphs and statistical analyses were performed using GraphPad Prism 8. Images of 
growth cones acquired from multiple varied explants per condition. At least three independent 




performed when statistical comparisons between two conditions were being made. One-way 
ANOVA was used to determine that means between multiple conditions were statistically 
different beforehand. All data sets were analyzed using the D'agostino normality test to 
determine normal distribution. The alpha value was set at 0.05 for all statistical tests. The P 
values are represented by: *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001. Values are 
expressed as mean ± standard deviation. 
 
V. Supplemental Data 
 
  
Figure III.S.1. TOG5 requires other domains to stabilize its binding to F-actin directly. A) Purified TOG 
domain proteins utilized in F-actin Sedimentation Assays to determine direct interaction. Purified TOG5, 
TOG5+lattice (TOG5++), TOG4-5, TOG3-5, and TOG1-5 proteins incubated with either 6.0 µM (TOG5 and 
TOG5+lattice), or 2.0 µM F-actin (all others) to determine protein binding to F-actin. TOG1-5 shown as a 
positive control that induced pelleting when incubated with F-actin. B) TOG3-Cterm and TOG5-Cterm proteins 





Chapter 4. Conclusion 
 
I. Contributions to the Literature  
This work establishes several important contributions towards the cell biology, molecular 
biology, and neurodevelopmental fields. Importantly, in this thesis I establish a novel function of 
the plus end tracking protein, XMAP215, known for its role in MT polymerization 94. While this 
protein has been studied for the last three decades 93, no evidence has been shown for how 
XMAP215 plays a part in coordinating not just microtubules, but also the F-actin cytoskeleton as 
well. Especially important in the neuronal cell biology community, while many +TIP proteins 
have been described previously33, increasing attention is being paid on how microtubule and F-
actin cytoskeletons are in coordination with each other 115, and how this coordination can 
regulate axon guidance and outgrowth mechanisms (Chapter 1).  
Early on, I show that XMAP215 possesses a unique ability to regulate axon outgrowth and 
axon guidance through a distinct F-actin related function (Chapter 2). This F-actin related 
function of XMAP215 was hinted at in previous literature 112, although never fully realized until 
now. In the neuronal cell biology community, a vast amount of research is being carried out on 
the signaling mechanisms that can control axon outgrowth and guidance, uncovering how axons 
can make their numerous connections early on in the brain 1,19,115,140. XMAP215, like other +TIP 
proteins, is in a perfect position to regulate signaling of the cytoskeletal systems and cell 
motility, acting as a signaling intermediary downstream of environmental cues and kinase 




role in regulating axon outgrowth and guidance mechanisms through time-lapse imaging of 
growing axons and Ephrin repellent stripe assays.  
 Importantly, I then go on to further narrow down this function towards the N-terminal 
TOG1-5 of XMAP215, highlighting the TOG1-5 involvement in F-actin colocalization, and 
rescue of MT and F-actin alignment defects. Interestingly, this data pointed me towards the 
importance of the region between the TOG4 and TOG5 domain for F-actin and MT interaction, 
however, how XMAP215 was interacting with the microtubule, and just as importantly, F-actin, 
still had to be revealed (questions elucidated further in Chapter 3). Finally, after pointing towards 
a new MT/F-actin mechanism for XMAP215 that could govern the fate of MT guidance in the 
growth cone (and total axon outgrowth), I then set out to determine if this F-actin interaction 
could be a direct mechanism. Utilizing purified proteins and biochemical assays, I showed that 
indeed, XMAP215 does bind directly to F-actin (an ability never been shown before). While 
there are several +TIPs that can interact with F-actin in the cell 33,115, there are very few that 
interact with F-actin directly 115, or have the functional diversity that XMAP215 seems to have 
105,109,112,119,120,158.  
 After establishing that XMAP215 is capable of binding directly to F-actin, I go on to 
demonstrate mechanistically the important domains that are required for this interaction, as well 
as how XMAP215 is interacting with the microtubule while utilizing this F-actin function 
(Chapter 3). In this chapter, I discovered that the TOG5 domain was necessary for binding 
directly to F-actin in vitro, while the C-terminal domain of XMAP215 influenced this interaction 
(possibly through changing conformation or folding in a way to make the TOG5 domain 
accessible). Furthermore, I showed here that XMAP215 (TOG3-Cterm) is capable of rescuing 




microtubule lattice, while the TOG5-Cterm deletion construct did not rescue, as it only bound to 
the MT plus end. In this fashion, XMAP215 may have an internal switch that changes its 
localization from lattice bound to plus-end-oriented, similar to +TIPs, CLASP and APC18,52,53. In 
addition, WT XMAP215 localizes to both plus end and MT lattice localizations in the cell 
normally 109,112. While not shown in this thesis work, I did notice that differences in 
phosphorylation of XMAP215 possessed different strengths in binding to F-actin in vitro (data 
not shown). It is quite possible that further elucidation of this mechanism will reveal 
phosphorylation to be a key component in switching between a lattice-based, and a plus end 
based mechanism, splitting XMAP215’s polymerization role, and its F-actin/MT linking role. 
Therefore, in this thesis work, I offer a critical component of determining the overall mechanism 
of XMAP215, in the context of MT/F-actin interaction, in which the next steps will likely be 
establishing how XMAP215 binds to F-actin structurally, and how phosphorylation, or other 
proteins, affect this capability. 
 Finally, it is quite important that I have established that the novel function that 
XMAP215 possesses is not related to its MT polymerase function (Chapter 3). From the 
beginning, I made sure that the constructs used in this work did not affect MT polymerization at 
all by deleting the TOG1-2 domains responsible for GTP-tubulin binding 94,101,105. However, 
even after deletion of these domains (and confirmation they did not increase growth velocities in 
growth cones), rescue of MT and F-actin alignment phenotypes with these constructs still 
occurred. Thus, our work establishes an important combinatorial role for XMAP215 consisting 
of two main functions, its polymerase activity 94, and its role as a microtubule and F-actin 
cytoskeletal linking protein109. As this novel XMAP215 mechanism is separate from its plus-end 




than just neuronal growth cones 34,105,112, it will be quite interesting to speculate on the reach this 
mechanism plays in other cell contexts, and cellular functions.   
 
II. Future Directions 
Determining the ability of XMAP215 to directly crosslink MTs to F-actin 
 One of the main areas of research that is still being looked into regarding XMAP215 is its 
ability to crosslink MTs and F-actin together. Utilizing a technique that has been employed for a 
few decades in the cytoskeletal field, I have set up a dynamic MT reconstitution assay system in 
our laboratory 159. While I have used this technique in previous work looking at MT/+TIP 
interaction for TACC3 (data not shown), an in vitro reconstitution system will be helpful in 
looking into the MT/F-actin interaction with purified XMAP215. It can then be determined, 
definitively, if XMAP215 is sufficiently acting as a direct MT/F-actin crosslinking protein or 
not. As there are very large +TIP complex networks in the growth cone, XMAP215 may utilize 
an intermediate protein to facilitate its MT/F-actin binding capability 32,36.  
 It will also be worthwhile to determine how phosphorylation is playing a role in localizing 
XMAP215 to the microtubule. Similarly to CLASP and APC, phosphorylation affects these 
+TIP proteins in localizing either along the microtubule lattice, or at the plus end of the 
microtubule 18,51–53. In addition, as stated previously in this thesis, the required F-actin binding 
domain of XMAP215, TOG5, shows high sequence similarity towards the TOGL1 domain of 
CLASP (30-50% in certain stretches of CDS), the proposed F-actin binding domain for that MT 
associated protein 21,51. In this case, there is some basis for further exploration of TOG domains 




XMAP215-FL protein with differential phosphorylation results in an altered strength of binding 
to actin filaments in vitro (data not shown). Therefore, differential phosphorylation states affect 
overall localization to the MT as well as F-actin binding activity in certain TOG domains, which 
may point to the TOG domain as a domain family that possesses dual MT and F-actin filament 
binding based on structural conformation or discrete signaling states in the cell. Thus, in addition 
to the common neuronal culture and microscopy assays, utilizing phospho-mutant XMAP215 
protein in our in vitro reconstitution assays would be extremely beneficial to determine effects on 
localization and signaling. In addition, it would be quite interesting to compare the XMAP215 
TOG and the CLASP TOGL domains to each other, and analyze the functions of each domain 
through a chimeric construct approach in growth cones in the future. By utilizing purified 
XMAP215 proteins along with the techniques described in this thesis, as well as utilizing an in 
vitro MT/F-actin reconstitution method, further uncovering of the overall mechanism of 
XMAP215/MT/F-actin interaction is quite possible.  
 
XMAP215’s role in affecting the Actin cytoskeleton 
 A secondary mechanism +TIPs may employ in growth cones is their ability to stimulate actin 
nucleation 160–162, a function that may be especially relevant in the far reaches of the growth cone 
filopodia and periphery. While significant strides have been made in unraveling how certain 
+TIPs may act on both F-actin and microtubule cytoskeletons 32,35,115, and the ramifications that 
these interactions lend to growth cone behaviors, several chief broad questions remain 
unanswered. In addition, although we know many details about certain +TIPs and how they can 
affect microtubule/actin dynamics, much of this research was not conducted in neurons. There is 




across different cell types 112,163. Thus, it is both valuable and necessary to continue studying the 
functions of +TIPs both in and outside of the neural context.  
 Specifically with XMAP215, I have seen interesting morphological effects in the growth 
cone that cannot be necessarily explained by a transient interaction with F-actin bundles. There 
are changes in growth cone area and total F-actin levels following XMAP215 manipulation, 
which likely indicates changes to the internal signaling state of the growth cone, in which the 
growth cone cannot interpret guidance cues correctly 164 . Although, what this actually means in 
the context of affecting F-actin related protein levels in the cell is unknown. It is interesting to 
point towards the EB1/Drebrin complex, which there is preliminary evidence of its ability to 
inhibit the F-actin severing protein, cofilin 69,76. Although partial XMAP215 KD has shown no 
effect on F-actin treadmilling rates112, XMAP215 may affect other F-actin related protein. Future 
studies of +TIPs, like XMAP215, which have been examined chiefly for their roles in affecting 
microtubules, may reveal that they function in unique roles to affect F-actin in the growth cone. 
 
Expanding the Library of +TIPs controlling MT/F-actin interaction  
 It is also important to note that the known library of +TIPs is still expanding. The more 
recently identified small kinetochore-associated protein, SKAP 165, was also shown to bind to 
EB1 and IQGAP in order to mediate microtubule steering and protrusion in HEK cells 166. 
However, it remains to be seen whether this association with IQGAP may also indicate a role in 
microtubule-F-actin crosslinking events. In addition to SKAP, mitotic interactor and substrate of 
Plk-1 protein, MISP, has been recently demonstrated to interact with EB1 as well as to colocalize 
with the actin cytoskeleton and focal adhesion proteins 167. Although its ability to act as a +TIP 




it could play in mediating microtubule and F-actin interactions. As identification of +TIPs 
increases, we must examine their interactions with F-actin and focal adhesion proteins, with 
signaling cascades, and with one another, in order to fully understand their roles in guidance 
behaviors. 
 While the ability of XMAP215 to affect the F-actin cytoskeleton has now been shown 
through this work, we still do not know all of the proteins that are involved in this specific 
function. As +TIP proteins are usually associated as large complexes32, there is likely many other 
proteins that can facilitate this F-actin function, regardless of XMAP215 being capable of 
interacting with F-actin directly. It has been known for a long time that XMAP215 interacts with 
the TACC family of proteins103,104,129, as well as EB1/SLAIN1/2 complexes96,97,121, and 
genetically interacts with CLASP95. Each of these proteins either shows some level of F-actin 
interaction, or indirectly acts with a protein that can interact with F-actin. In this case, looking 
into the whole network of +TIP proteins that are involved in this function through pull-down 
experiments and mass spectrometry would be beneficial to fully determine the mechanism taking 
place. 
 
III. Closing Remarks 
 The growth cone requires collaborative and dynamic coordination of the F-actin and 
microtubule cytoskeletons in order to properly navigate the extracellular cues presented to it 
within the developing embryo. Coupling and uncoupling mechanisms between the two 
cytoskeletons can alter localization of microtubules, thus promoting their retraction or protrusion 
35,115. Similarly, closely linked microtubules and F-actin can be exposed to the same local 




increasingly demonstrated to act in this capacity, as they can serve as both modulators of plus-
end dynamicity and microtubule-F-actin cross linkers 115, which can be dynamically regulated by 
phosphorylation events downstream of guidance cue signaling pathways. Extracellular signaling 
cues can therefore be translated through actin/microtubule binding into growth cone outgrowth 
and turning events 35.  
 In my thesis work presented here, research into the microtubule polymerase, XMAP215 (ch-
TOG), has revealed a previously unknown mechanism that allows for microtubule and actin 
collaboration in the growth cone. While I have determined through super resolution imaging and 
biochemical techniques that XMAP215 is capable of affecting the F-actin cytoskeleton through a 
microtubule lattice based platform, it is still unknown the extent that this mechanism is employed 
throughout the cell (and other cell types besides neurons). In addition, how XMAP215 
phosphorylation (similar to mechanisms of CLASP and APC) affects the ability of XMAP215 to 
localize to the MT and function as an F-actin interacting +TIP will undoubtedly be necessary to 
explore. 
 Over the last several years, there have been significant advances in the types of techniques 
used to study the cell biological interactions within growth cones. Techniques like live brain 
imaging 168 allow researchers to follow growth cones in living tissue. Also, recent biochemical 
assays employing the protein TIPact, a minimalist molecule containing microtubule and actin 
binding domains, could potentially be used to uncover more information on how these two 
cytoskeletons interact 169. Furthermore, the use of super resolution microscopy techniques has 
also increased, allowing for image resolution that extends beyond the diffraction limit of light 
and confocal microscopes. Specifically, recent experiments on photoactivatable complimentary 




the microtubule plus-ends 170. Employing new techniques in our work may vastly benefit our 
understanding of the inner workings of actin-microtubule interactions. 
 As XMAP215 is a ubiquitous molecule found in most cell types, including being heavily 
upregulated in embryonic and cancerous cells, it would be interesting to speculate about it’s 
potential as a therapeutic target for certain cancer cell types. In addition, there is a diverse 
selection of mutations in microtubule-associated proteins that affect mental disorders and neuro-
related diseases 171. XMAP215 has shown itself to be a functionally diverse molecule, being 
directly involved in cell division, as well as acting as a microtubule polymerase, microtubule 
nucleator, and now a microtubule/F-actin interacting protein. Since we have shown a novel role 
that is functionally separate from its characteristic MT polymerase ability, it may be worthwhile 
to look into how different signaling mechanisms may affect its ability to select between 
microtubule polymerization and MT/F-actin interaction, as its ability to interact with F-actin is 
linked to a MT-lattice based localization, as opposed to a plus end mediated function. In 
conclusion, the work that is presented here in this thesis moves forward the field of cell biology, 
providing a pathway for studying XMAP215 further and uncovering unique mechanisms that 
play a part in cytoskeletal remodeling and neuronal signaling pathways. While I have presented 
data that point towards a novel and uncharacterized function of XMAP215, there is still much 





Chapter 5. Appendix 
__________________________________________________________________ 
Appendix Chapter 1. The microtubule plus-end-tracking protein TACC3 
promotes persistent axon outgrowth and mediates responses to axon guidance 
signals during development 
*My role in facilitating the completion of this chapter was the following: Axon outgrowth and 
KHS drug experiments in Figure 1, MT Dynamics data involved in Figure 3, subcloning of 
constructs and general reagent preparation. However, the full manuscript is included in its 
entirety, adapted from: (Erdogan et. al., 2017 - Neural Development) 
 
Introduction 
Plus-end tracking proteins (+TIPs) selectively bind to the dynamic plus-ends of microtubules 
(MTs), which extend into the distal part of the axon and growth cone 1. This enables + TIPs to 
come into close contact with the cell cortex, where guidance cue receptors reside. These 
receptors transduce asymmetrically-distributed guidance signals down to intracellular effectors, 
which then regulate MT dynamics in a spatially-restricted manner that likely plays a key role in 
growth cone turning events 19,115. Thus, +TIPs deserve attention for their potential function in 
regulating MT dynamics during axon guidance. One of the first + TIPs to be discovered for its 
role in axon guidance was CLASP 17. Genetic studies in Drosophila demonstrated that CLASP is 
a downstream target of Abelson tyrosine kinase (Abl) in the Slit/Robo guidance pathway during 
central nervous system midline crossing 17. Moreover, the + TIP and MT polymerase, msps (fly 




decision in an Abl-dependent manner 95. In addition to its role in Drosophila, XMAP215 has 
been implicated in promoting axon outgrowth in vertebrates 112. We have recently shown that the 
XMAP215-interactor, TACC3, is also a + TIP that regulates MT dynamics in vertebrate growth 
cones and is essential for normal axonal outgrowth 98. However, how TACC3 specifically affects 
axon outgrowth and whether TACC3 plays a role during axon guidance remain to be explored. 
In this study, we examine the role of TACC3 in axon outgrowth and pathfinding in vivo within 
the developing nervous system of Xenopus laevis which is a great model for studying 
cytoskeletal dynamics during axon outgrowth and guidance 172,173. Using time-lapse live 
imaging, we demonstrate that TACC3 is required for persistent axon outgrowth in Xenopus 
laevis, and that both the N- and C- terminal conserved domains of TACC3 are necessary for 
enhanced axon outgrowth. Moreover, TACC3-overexpressing growth cones can mitigate the 
reductive impacts of the MT-depolymerizing agent, Nocodazole, on MT dynamics parameters. 
We also show that TACC3 and XMAP215 can display a synergistic effect and promote axon 
outgrowth ex vivo. Finally, examination of whole mount Xenopus spinal cords shows defects in 
axon guidance in motor neurons when TACC3 levels are depleted, and manipulation of TACC3 
levels impact the growth cone response to the repellent guidance cue Slit2 in cultured Xenopus 
spinal neurons. Together, these investigations provide new insights into the mechanism by which 
TACC3 functions either alone or in combination with other + TIPs, such as XMAP215, to 
regulate MT dynamics during axon outgrowth and guidance. 
 
Results 




We previously showed that normal axonal outgrowth requires TACC3 98. To gain further insight 
into the mechanism by which TACC3 promotes axon outgrowth, we examined the effect of 
TACC3 knockdown (KD) and overexpression (OE) on dynamic axon outgrowth parameters. 
Time-lapse imaging demonstrated that TACC3 KD significantly reduced axon outgrowth 
velocity by 25% relative to control conditions (TACC3 KD, 0.74 ± 0.03, n = 46, versus control, 
1.04 ± 0.03 n = 57, ***p < 0.0001, Figure A.I.1A). In addition to the reduced outgrowth 
velocity, TACC3 reduction dramatically increased axon retraction rates by 5-fold in comparison 
to control axons (TACC3 KD, 5.27 ± 1.22, n = 107, versus control, 1.06 ± 0.35, n = 99, **p = 
0.0015, Figure A.I.1B). Conversely, when TACC3 levels were elevated, the frequency of axon 
Figure A.I.1. TACC3 promotes axon outgrowth velocity and prevents spontaneous axon retractions. a, Axon outgrowth velocity 
is significantly decreased in TACC3-depleted axons by 27% (n = 56) and in TACC3 OE, to a lesser extent, by 11% (n = 106) 
compared to control (GFP only) conditions (n = 58). b, Retraction rate increased 5 fold in TACC3 KD (n = 107) and decreased 0.6 
fold in TACC3 OE (n = 155) in comparison to their corresponding non injected (n = 95) and GFP injected (n = 180) controls 
respectively. c, d, MT growth velocity (DMSO, n = 9, KHS-101, n = 9) (c) and axon outgrowth length (DMSO, n = 8, KHS-101, n = 
12) (d) are significantly reduced by 28 and 26% respectively after acute depletion of TACC3 by the inhibitor KHS101. e, Schematic 
representation of GFP-tagged TACC3 full-length and deletion constructs, along with plus-end tracking ability (denoted by “+”) and 
impact on axon outgrowth length. f, Quantification of axon outgrowth length in cultured neural explants of GFP injected control (n = 
997), full-length GFP-TACC3 (1-931aa) (n = 787), GFP-TACC3-ΔN (133–931) (n = 613), GFP-TACC3- ΔΔN (363–931) (n = 563) 




retraction rates was reduced significantly by 45% compared to controls (TACC3 OE, 0.54 ± 
0.12, n = 155, versus control, 0.99 ± 0.12, n = 180, *p = 0.01, Fig. 1b). Although TACC3 OE led 
to increased axonal length (Figure A.I.1F), TACC3 OE actually reduced axon outgrowth 
velocity by 14% (0.89 ± 0.32, n = 103, versus control, 1.04 ± 0.033, n = 57, *p < 0.0268, Fig. 
1a), suggesting that the increased axonal length may result from reduced axon retraction rather 
than a change in outgrowth velocity. 
To further explore the TACC3 KD phenotype, we examined axon outgrowth of cultured neurons 
in which TACC3 was acutely inhibited by the TACC3 specific inhibitor, KHS-101 174. 
Consistent with the effect seen in TACC3 KD, KHS-101-induced acute inhibition of TACC3 
significantly reduced MT growth velocity by 28% (15.09 ± 0.86 μm/min (before drug treatment); 
10.84 ± 0.75 μm/min (after drug), **p < 0.0019, Figure A.I.1C). Moreover, acute inhibition led 
to an immediate retraction of axon length by 26% compared to vehicle treated controls (KHS-
101, 0.71 ± 0.05, n = 12, versus DMSO, 0.96 ± 0.03, n = 9, ***p = 0.0007, Figure A.I.1C). In 
order to determine which domains of TACC3 are involved in axon outgrowth, we tested various 
truncation mutants of TACC3. We found that, while full- length TACC3 and ΔN (lacking 
conserved N-terminal domain) significantly increased axon outgrowth by 30% (1.30 ± 0.03, n = 
787, ***p < 0.0001) and 18% (1.18 ± 0.31, n = 613, ***p < 0.0001) respectively, expression of 
ΔTACC (lacking the conserved TACC domain, which has been shown to be required for 
centrosome localization and interaction with the MT polymerase, XMAP215) caused a 
significant reduction by 12% in axon length (0.87 ± 0.021, n = 764, ***p = 0.0002) in 
comparison to wild-type neurons (0.99 ± 0.02, n = 997) (Figure A.I.1F). On the other hand, the 
larger N-term deletion (lacking both the conserved N-terminus and the putative SxIP-like motif 




(1.04 ± 0.028, n = 563, p = 0.2012). Additionally, none of the deletion constructs that promoted 
axon outgrowth were as effective as full-length TACC3 OE (Figure A.I.1F). Together, our 
findings suggest that TACC3 is required for proper axon outgrowth by opposing axonal 
retracting forces. Additionally, full-length TACC3 is more efficient in promoting axon 
outgrowth than its truncation mutants, while expression of a version lacking the TACC domain 
results in a mild dominant negative effect. 
 
TACC3 antagonizes nocodazole-induced MT depolymerization but does not affect MT 
lattice stability 
Figure A.I.2. TACC3 antagonizes 
Nocodazole-induced MT 
depolymerization but does not affect 
MT stability.  a-c,  Quantification  of  
the  MT  dynamics shows significant 
reduction in MT growth speed (a), MT 
lifetime (b) and MT growth length (c) 
in control (n = 22) and TACC3 OE (n = 
21) growth       cones in response to 50 
pM  Nocodazole before and 5  min  
after  drug  treatment.  However, the 
effect of Nocodazole on TACC3 OE 
growth cones is dampened compared to 
controls. a’-c’, Although not 
significant, reduction in MT growth 
speed (a’) is more prominent in control 
growth cones compared to TACC3 OE 
growth cones while the  reduction  in  
both  lifetime  (b’)  and  length  (c’)  in  
control  growth  cones  are  
significantly  higher than the TACC3 




Previously, we determined that TACC3 promotes efficient MT polymerization by enhancing MT 
growth velocity within growth cones 98. However, the mechanism by which TACC3 affects MT 
polymerization remains to be elucidated. Thus, we sought to gain further insight by assessing the 
impact of low doses of the MT depolymerizing drug, nocodazole, after TACC3 manipulation. 
We observed that a low dose of nocodazole led to reduction in several parameters of MT 
dynamics, and that TACC3 OE could mitigate these effects. While control growth cones 
exhibited a marked 20% decrease in MT growth speed after treatment with 50 pM nocodazole 
(before, 1.00 ± 0.04, n = 22, after treatment, 0.79 ± 0.03, n = 22, ***p = 0.0001), TACC3 OE 
growth cones showed reduction by only 12% (before, 1.08 ± 0.04, n = 21, after nocodazole, 0.95 
± 0.03, n = 21, *p = 0.0316, Figure A.I.2A). Similar trends were observed with MT growth 
lifetime, in which control growth cones showed a 15% reduction (before, 1.00 ± 0.03 s, n = 22, 
after nocodazole, 0.84 ± 0.03 s, n = 22,***p = 0.0008) versus only a 3% reduction with TACC3 
OE (before, 0.91 ± 0.03, n = 21, after nocodazole, 0.87 ± 0.03, n = 21, p = 0.4305, Figure 
A.I.2B), and for MT growth length, there was a 35% reduction in controls (before, 1.00 ± 0.05, n 
= 22, after nocodazole, 0.65 ± 0.03, n = 22, ***p < 0.0001) versus 14% in TACC3 OE (before, 
1.00 ± 0.04, n = 21, after nocodazole, 0.85 ± 0.04, n = 21, *p = 0.02, Figure A.I.2C). These 
results suggest that TACC3 can mitigate the nocodazole-induced reduction in MT growth 
dynamics parameters. This mitigation can be more clearly visualized when the nocodazole-
induced change is represented as the ratio of after treatment/before treatment. Although the 
relative reduction in MT growth speed when TACC3 is overexpressed is only slightly less 
compared to controls and is not quite statistically significant (0.91 ± 0.06 n = 21 versus control 
0.82 ± 0.04 n = 22, ns p = 0.2, Figure A.I.2A’), for other MT growth parameters, TACC3 OE 




control 0.86 ± 0.03 n = 22, *p = 0.03, Figure A.I.2B’) and length (0.91 ± 0.08 n = 21 versus 
control 0.68 ± 0.04 n = 22, *p = 0.01, Figure A.I.2C’) compared to controls. 
In addition to MT polymerization, MT stabilization is considered an important parameter for 
axon outgrowth and growth cone turning events 40. Hence, we measured the fluorescence 
intensities of tyrosinated and detyrosinated tubulin in the growth cone, and assessed dynamic and 
stable MT lattice profiles in TACC3-manipulated growth cones. We found that the ratio of 
tyrosinated tubulin versus de-tyrosinated tubulin did not statistically differ in TACC3 KD (0.87 ± 
0.07, n = 37, p = 0.2394) nor in TACC3 OE (1.01 ± 0.11, n = 129, p =0.9673) growth cones, 
with respect to control growth cones (1.00 ± 0.09, n = 143, Figure A.I.3A-C). This suggests that 
TACC3 may not specifically regulate MT lattice stability in growth cones. 
Figure A.I.3. Microtubule stability is not affected by modulation of TACC3 levels in the growth cone. Representative growth cone 
images of control, TACC3 KD and TACC3 OE, immunostained for tyrosinated tubulin (red) and detyrosinated tubulin (green) to label 
dynamic versus stable MTs, respectively. e-f, Quantification of the fluorescence intensity of imaging data in G, with TACC3 KD (n = 38) (e) 
and TACC3 OE (n = 129) (f) growth cones showing no significant changes in dynamic/stable MTs compared to corresponding control 
growth cones (n = 37 and n =143, respectively).  *p < 0.05, **p < 0.01, ***p < 0.001. ns not significant.  n = growth cone number. Scale bar, 
2 μm. 




TACC3 and XMAP215 interact to promote axon outgrowth. We previously found that the 
TACC3 interactor and MT polymerase, XMAP215, also promotes axon outgrowth 112, and that 
TACC3 and XMAP215 co-localize at the extreme plus-end of MTs in growth cones in a 
codependent manner 98. However, the consequences of their interaction on axon development 
have not been elucidated. Therefore, we sought to test whether TACC3 and XMAP215 might 
cooperate synergistically to promote axon outgrowth by partially elevating or reducing TACC3 
and XMAP215 levels alone and in combination with each other. While a very mild TACC3 KD 
(approximately 20–30% less) led to 10% reduction in axon out- growth (204.7 ± 4.8 μm, n = 
487, p = 0.3528) and partial XMAP215 KD led to 13% reduction (185.6 ± 6.4 μm, n = 312, *p = 
Figure A.1.4. TACC3 and XMAP215 interacts to 
promote axon outgrowth. a, b, Combinatorial reduction or 
elevation of TACC3 and XMAP215 levels reveals 
synergistic in axon outgrowth. Knocking down both 
TACC3 and XMAP215 (n = 312) showed significant 
reduction in axon length in comparison to control (n = 
219), TACC3 KD (n = 487) and XMAP21 KD alone (n = 
312) (a). Overexpression of both (n = 654) showed 
significant increase in axon length in comparison to control   
(n = 1288) and TACC3 OE (n = 1585), while double 
overexpression had no additive effect in comparison to 
XMAP215 OE (n = 1227) (b).   c, d, Reduced axon 
outgrowth in TACC3 KD (n = 289) (c) or XMAP215 KD 
(n = 299) (d) neurons is rescued by the overexpression of 
XMAP215 (n = 313) or TACC3 (n = 397), respectively. *p 





0.0116), partial knockdown of both reduced axon length significantly by 34% (140.6 ± 3.5 μm, n 
= 552, ***p < 0.0001) compared to control axons (213.6 ± 9.6 μm, n = 219, Figure A.I.4A). 
Conversely, overexpression of both (double OE) increased axon length by 32.7% (237.7 ± 5.4 
μm, n = 654, ***p < 0.0001) while TACC3 OE alone increased by 11% (198.9 ± 3.2, n = 1585, 
***p < 0.0001) and XMAP215 OE increased by 30.9% (234.5 ± 4.3 μm, n = 1227, ***p < 
0.0001) in comparison to controls (179.1 ± 3.2 μm, n = 1288, Figure A.I.4B). Interestingly, 
while double OE significantly increased axon length in comparison to TACC3 OE alone (***p < 
0.0001), it did not show a difference when compared to XMAP215 alone (p = 0.6421) 
suggesting that there may be an upper threshold that is reached with XMAP215 OE by itself. 
We next asked whether overexpression of one + TIP might rescue the reduced axon length in the 
absence of the other. We observed that overexpressing XMAP215 in the stronger TACC3 KD 
background brought axon outgrowth length to control levels (TACC3 KD + XMAP215 OE, 
149.4 ± 5.2 μm, n = 313, **p = 0.005, versus control, 148.8 ± 3.6 μm, n = 558, p = 0.9331) by 
increasing the length 15% in comparison to TACC3 KD (129.7 ± 4.477 μm, n = 289, **p = 
0.0015, Figure A.I.3C). On the other hand, overexpression of TACC3 in the XMAP215 KD 
background increased axon outgrowth length by 30% (XMAP215 KD + TACC3 OE, 262.2 ± 7.8 
μm, n = 397, ***p < 0.0001) in comparison to XMAP215 KD (201.3 ± 7.2 μm, n = 299); 
however, the rescue was not complete when compared to control axons (Control, 304.9 ± 8.5 
μm, n = 463, ***p = 0.003, Figure A.I.4D). These findings suggest that TACC3 and XMAP215 
cooperate during axon outgrowth, with XMAP215 showing more additive effects on TACC3-
mediated axon outgrowth. 
 




The direction that the growth cone acquires during outgrowth is a result of local modulation of 
MT dynamics in response to guidance signals 9,39,40,54. Thus, we wondered whether TACC3 
regulation of MT dynamics could play a role during axon guidance. We first examined 
motor neuron axon outgrowth from the spinal cord in embryos at an early developmental 
stage (st 28), and we discovered that reduction of TACC3 caused significantly impaired 
outgrowth and severely disrupted morphology in all embryos examined (Figure A.I.5A-C).  
Figure A.I.5. TACC3 affects axon guidance in vivo and ex vivo. a, b, confocal images of laterally-viewed whole-mount Xenopus 
spinal cord fluorescently labeled for acetylated tubulin, showing peripheral axon outgrowth in control (a) and TACC3 KD (b) 
embryos at 2 dpf. c, Quantitation of the embryos with motor neuron guidance defects (n = 5 embryos). d, Representative neural tube 
growth cone images of control and TACC3 OE, before and after addition of 400 ng/ml Slit2. e, Quantification of the percentage of 
the growth cone collapse events in control (n = 48) and TACC3 OE (n = 82) growth cones show significant reduction in growth 




To gain greater insight into whether TACC3 manipulation causes this disorganization under 
specific guidance signals, we examined growth cone behavior in response to the guidance 
molecule, Slit2, applied in culture media. Slit2 is a repellent guidance cue which has 
been previously studied with other + TIPs, such as CLASP 17, and the response of 
growth cones of different neuron types isolated from Xenopus embryos at different 
stages has been previously documented 175–177. We monitored the changes in growth 
cone behavior for 10 min prior and for 30 min after addition of Slit2. Growth cones that 
showed persistent growth were analyzed for their behavior after Slit2 addition. Growth 
cones that had reduced lamellaepodial area were considered as collapsed. We found that 
TACC3 OE growth cones had significantly fewer growth cone collapse and axon retraction 
events (TACC3 OE, 21.28 ± 7.24 n = 76 versus control, 54.72 ± 4.26 n = 44, *p = 0.0164) in 
response to Slit2, when compared to wild type growth cones (Figure A.I.5D-E). This suggests 
that overexpressing TACC3 can counteract Slit2-induced growth cone collapse. 
 
Discussion 
Dynamic spatial and temporal regulation of MTs within the growth cone is considered to be of 
key importance during axon outgrowth, guidance decisions and regeneration events 9,14,16,39,40. 
Accordingly, MT plus-end tracking proteins (+TIPs) likely play a critical role during axon 
guidance, as + TIPs dominate the dynamic portion of MTs that reaches the growth cone 
periphery, where guidance cue receptors reside 19. However, few + TIPs have been examined 
within the context of the embryonic growth cone. We previously characterized a MT plus-end 




for proper axonal development 98. Here, we sought to uncover new insights into the mechanism 
underlying axonal regulation by TACC3. 
First, we found that the shorter axons that result from reduced levels of TACC3 were due to 
slower axon outgrowth velocity along with significantly increased retraction rate. Moreover, 
TACC3 overexpression leads to longer axons, not because of fast axon outgrowth velocity (the 
outgrowth rate was actually slower than in controls), but because of reduced axon retraction rate. 
This suggests that TACC3-mediated MT dynamics may be required for opposing the normally 
occurring retractive forces within axons. Another possible explanation is that the reduced axon 
outgrowth velocity and reduced axonal retraction rates after TACC3 OE could be due to stronger 
anchorage to the underlying substrate and adhesion turnover. While there are some + TIPs that 
have been implicated to mediate MT focal adhesion interactions 91, TACC3 has not yet been 
explored in focal adhesion (or point contacts, in the case of growth cones) regulation. However, 
since TACC3 has been identified as an interactor of CLASP 178, and given that CLASP is known 
to function during focal adhesion turnover 179, future studies should examine whether TACC3 
also plays a role at focal adhesions/point contacts. 
+TIPs modulate MT dynamic instability in various ways; for example, XMAP215 promotes MT 
growth by catalyzing addition of tubulin dimers 94, while CLASP and APC rescue MT from 
catastrophe by increasing MT stability 180–182. Here, we showed that TACC3 OE could dampen 
Nocodazole-induced reduction in MT growth speed, length and lifetime. However, this was not 
achieved by increased MT lattice stability, as immunofluorescence analysis of dynamic versus 
stable MTs revealed that TACC3 has no apparent impact on MT stability within the growth cone. 
It is unclear how TACC3 is able to mitigate the reduction in MT growth speed, length and life- 




which enhances XMAP215 localization at MT plus ends 98, may simply promote more efficient 
and processive MT polymerization by XMAP215 to counteract the Nocodazole-induced effects.  
Individual + TIPs comprise a network of proteins at MT plus-ends which can co-localize and 
function together to modulate MT dynamics. We have previously shown such cooperation 
between TACC3 and XMAP215 in growth cones, as we demonstrated that TACC3 and 
XMAP215 co-localize at MT plus-ends in codependent manner 98. Here, we found that TACC3 
and XMAP215 interact to promote axon outgrowth (Figure A.I.4). Partially knocking down both 
TACC3 and XMAP215 resulted in further reduction in axon outgrowth length, which suggests a 
synergistic interaction between the two proteins. However, overexpression of both + TIPs did not 
show further increase in axon length in comparison to XMAP215 OE alone. This might be due to 
an upper threshold that is reached with overexpression of XMAP215 alone. Conversely, rescue 
studies show that XMAP215 can fully restore TACC3 KD-mediated reduced axon length to 
control levels, whereas TACC3 OE fails to show the same impact over XMAP215 KD. As 
XMAP215 is a processive MT polymerase, reduction in XMAP215 levels may exert more 
dramatic effect than the reduction in the levels of TACC3, which may play more of an accessory 
role. Considering that one study suggests that every TACC3 molecule is thought to interact with 
two molecules of XMAP215 103, reduced levels of XMAP215 could be a limiting factor. Even 
though TACC3 OE functions to increase available XMAP215 at MT plus-ends, the reduction in 
overall XMAP215 levels may result in poor axon outgrowth. While knock down approaches 
provide supporting evidence regarding the combinatorial role of TACC3 and XMAP215 during 
axon outgrowth, future studies should utilize mutations that disrupt their interaction 103 in order 




In addition to their role in axon outgrowth, several + TIPs have been implicated in participating 
in growth cone steering decisions in response to extracellular cues. The first of which is 
orbit/MAST, the fly orthologue of mammalian CLASP, that has been identified to cooperate 
with Abelson kinase (Abl) downstream of Slit/Robo guidance pathway 17. In a parallel genetic 
and proteomic screen in fruit flies, minispindles (msps), a fly orthologue of Xenopus XMAP215, 
was identified to function antagonistically against CLASP and Abl during embryonic central 
nervous system development 95, while another genetic interaction study in flies identified dtacc 
as an antagonist of CLASP 130,178, reminiscent of the interaction between CLASP and TACC 
partner, msps. Combining these previous works with our findings on the role of TACC3 in axon 
outgrowth led us to ask whether TACC3 functions during axon guidance.  
As demonstrated in Figure A.I.5, our initial observations revealed that reduction in TACC3 
levels impairs the normal organization of axons exiting the spinal cord in embryos at st 28. 
Stimulation of cultured Xenopus retinal neurons at stage 32 or beyond with bath applied Slit2 
has been shown to cause growth cone collapse 176. Additionally, spinal neurons derived from st 
28 Xenopus embryos have previously shown to be repelled by Slit2 175. Here, we found that 
Slit2-induced neural tube growth cone collapse events can be reduced by 60% in TACC3 
overexpressing growth cones in comparison to control, suggesting an opposing role for TACC3 
in Slit2-induced growth cone collapse. Based on its role in MT polymerization 98, its 
codependent localization at MT plus ends with XMAP215 98,103, and their interaction during 
axon outgrowth (Figure A.I.4), we propose that TACC3 OE will excessively occupy MT plus-
ends, subsequently driving increased recruitment of XMAP215, prompting enhanced MT 




MT modulation, which is the underlying mechanism for growth cone steering events and it 
would result in an aberrant, non-obedient growth cone advance (Figure A.I.6). 
It remains to be determined whether these effects are specific to Slit2 or if TACC3 could exert 
similar opposing effects in response to other repellent signals, and/or if TACC3 mediates 
attractive signals as well. Finally, other TACC members, namely, TACC1 and TACC2, have 
recently been characterized as + TIPs that can promote MT polymerization in Xenopus 
embryonic cells 183,184. Although their expression and MT regulatory function show cell type-
specificity, it would be intriguing to study whether other members of the TACC family also play 
a role in axon outgrowth and guidance decisions. 
Overall, the work here characterizes the mechanism by which TACC3 regulates MT dynamics 
within the embryonic neuronal growth cone and promotes axon outgrowth. Using time-lapse 
Figure A.I.6. Cartoon model for the role of TACC3 at MT plus ends during axon outgrowth and guidance. Microtubule 
(blue) plus-ends decorated by TACC3 (green) promotes axon outgrowth, reduces axon retraction, dampens Nocodazole-induced 





imaging of Xenopus laevis embryonic axons as they grow in culture, we demonstrated that 
TACC3 promotes persistent axon outgrowth not by accelerating axon growth velocity but by 
reducing spontaneous axon retraction events. Moreover, we demonstrate that overexpressing 
TACC3 can mitigate the reduction in MT dynamics parameters that occur after Nocodazole 
application, suggesting that TACC3 may be promoting MT dynamics by dampening MT 
depolymerization. Finally, our data suggests that the + TIP TACC3 mediates axon guidance, as 
reduction in TACC3 levels results in defects in the normal organization of spinal neuron axons 
within the spinal cord. Moreover, bath application of the Slit2 repellent guidance molecule into 
cultured neural tube neurons shows that TACC3 OE reduces the Slit2 induced growth cone 
collapse events, suggesting that TACC3 may involve in generation of response to guidance 




Xenopus embryonic explants 
Egg collection and culturing of Xenopus embryonic explants (from embryos of either sex) were 
performed as described 98,146. All experiments were approved by the Boston College Institutional 
Animal Care and Use Committee and were performed according to national regulatory standards. 
 
Constructs and RNA 
Capped mRNA constructs were transcribed and purified as previously described 98,112. Constructs 




Massachusetts Medical School, Worcester, MA), GFP-TACC3-ΔN, GFP-TACC3-ΔΔN, GFP-
TACC3-ΔTACC (see Fig. 1e for amino acid residues for full length and each deletion construct, 
based on GenBank accession number NP-001081964.1) (all TACC3 constructs were subcloned 
into pSC2+ vector), GFP-MACF43 (a gift from Hoogenraad Lab) in pCS2+, XMAP215-GFP (a 
gift from the Hyman lab, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, 
Germany 101) subcloned into pT7TS. Embryos either at the 2 cell or 4 cell stage received 
injections 4 times total in 0.1× MMR containing 5% Ficoll with the following total mRNA 
amount per embryo; 100 pg of GFP-MACF43 as a control for TACC3 or XMAP215 
overexpression, 2000 pg of GFP-TACC3 full-length and deletion constructs (deletion constructs 
are expressed in wildtype embryos), 3000 pg of XMAP215-GFP. For double overexpression 
studies, 1000 pg of TACC3 and XMAP215 were injected in total. 
 
Morpholinos 
Morpholinos (MOs) were previously described and validated 98,112. In knockdown (KD) 
experiments, TACC3 and control MOs were injected at 80 ng/embryo. For TACC3 and 
XMAP215 double KD analysis, 20.0 ng/embryo for TACC3 and control MOs and 2.0 ng/embryo 
for XMAP215 MO were injected. In rescue experiments, MO (amounts used as in KD, which is 
80 ng/embryo) was injected with mRNA (same amount as in OE, which is 2000 pg/embryo for 
GFP-TACC3 and 3000 pg/embryo for XMAP215-GFP) in the same injection solution. The 







Two-day-old embryos were fixed, as described 112. Primary antibody (diluted  in blocking buffer  
made up by 1% DMSO, 1% Triton, 1% BSA, in PBS) to acetylated tubulin (1:1000, monoclonal, 
clone 6-11B-1, Sigma, St. Louis, MO, USA) and goat anti-mouse Alexa-Fluor 568 conjugate 
secondary antibody (1:1000, polyclonal, A- 1100, Life Technologies) were used. For imaging, 
the spinal cord was exposed by peeling off skin, and somites were kept intact. Embryos were 
transferred in a drop of benzoate:benzyl alcohol (BB:BA) to the imaging chamber (made by 
placing Gene Frame, sticky on both sides, onto a microscope slide). After the tissue was cleared, 
it was covered with a 1.5× coverslip. Image acquisition and quantitation of fixed and labeled 
explants were described previously 112. TACC3 KD-induced change is scored based on the 
percentage of embryos with disorganized axons in each condition. 
 
Immunocytochemistry 
Embryonic explant cultures were fixed and labelled 40 with primary antibodies (1:1000 diluted in 
blocking buffer made up by 1% non-fat dry milk in calcium and magnesium free PBS) to 
tyrosinated tubulin (rat monoclonal, ab6160, Abcam) and detyrosinated tubulin (rabbit poly- 
clonal, AB3201, Millipore), and with the secondary antibodies goat anti-rat Alexa Fluor 568 
(1:1000, ab175476, Abcam) and goat anti-rabbit Alexa Fluor 488 (1:1000, A-11008, Life 
Technologies), respectively. 
 




Recombinant mouse Slit2 protein (R&D Systems) (400 ng/ml) was administered to cultured 
neural tube explants derived from stage 28 Xenopus embryos in 400 μl culture media 
supplemented with 1% Penicillin/Streptomycin and 0.1% BSA. A perfusion chamber was set up 
to exchange media with Slit2-containing culture media. Time-lapse images of growth cones were 
acquired for 10 min with 30 s intervals before and immediately after Slit2 addition for 30 min 
with 30 s intervals, using a Zeiss Axio Observer inverted motorized microscope with a Zeiss 
20×/0.8 Plan Apo phase objective. Frame to frame axon growth was tracked manually and 
retraction or growth cone collapse events were recorded over a movie. Ratio of the number of 
retracting frames over total frames for each axon was scored. Images given in the figures show 
the image of growth cone right before adding Slit2 and the image of the growth cone at collapse. 
 
Nocodazole application 
Nocodazole to final concentration of 50 pM was administered in 400 μl culture media. 
Concentration of Nocodazole was determined after series of titrations and 50 pM was found to 
be the optimum to keep the MTs intact in order to perform MT dynamics analyses. Time-lapse 
images of growth cones were acquired for 1 min with 2 s intervals before and 5 min after 
Nocodazole administration, using a Yokogawa CSU-X1M 5000 spinning disk confocal on a 
Zeiss inverted motorized microscope with a Zeiss 63× Plan Apo 1.4 NA and a Hamamatsu 
ORCA R2 CCD camera. MT dynamics were assessed, as described 98. 
 




MT dynamics were analyzed from GFP-MACF43 movies using plusTipTracker 145,146. Imaging 
conditions and tracking parameters were previously validated and same parameters were used: 
maximum gap length is 8 frames; minimum track length is 3 frames; search radius range 5–12 
pixels; maximum forward angle, 50°, maximum backward angle, 10°; maximum shrinkage 
factor, 0.8; fluctuation radius, 2.5 pixels; time interval, 2 s. MT growth lifetime is the measure of 
persistent outgrowth till MT undergoes catastrophe. MT growth length is the total growth over a 
movie and MT growth velocity is the average of each MT growth event. MT dynamics 
parameters were compiled from multiple individual experiments, and to avoid day-to-day 
fluctuations, the final complied data were normalized to the mean of the control data for each 
experiment. 
 
Image acquisition and analysis 
For axon outgrowth imaging, phase contrast images of axons were collected on a Zeiss Axio 
Observer inverted motorized microscope with a Zeiss 20×/0.5 Plan Apo phase objective and 
analyzed using ImageJ 98. Time-lapse images for axon outgrowth velocity was collected for 4 h 
with 20 min intervals and images were analyzed using plusTipTracker QFSM plugin and 
velocity was measured as the average of instantaneous velocity per axon as described 112. Axon 
retraction events were analyzed from the same data set used to assess axon growth velocity. 
Frame to frame axon growth was tracked manually and retraction events were recorded over a 
movie. Ratio of the number of retracting frames over total frames for each axon was scored. 
Axon outgrowth and MT dynamics data were normalized to controls, to account for day-to-day 
fluctuations in room temperature. Image acquisition and quantitation of fluorescence intensity of 




times to ensure reproducibility. Graphs were made in GraphPad Prism. Statistical differences 
were determined using unpaired two tailed t-tests when comparing two conditions and one-way 






Appendix Chapter 2. Abelson-induced phosphorylation of TACC3 modulates 
its interaction with microtubules and affects its impact on axon outgrowth and 
guidance 
*My role in facilitating the completion of this chapter was the following: Growth cone imaging 
in Figure 1, subcloning, and SDM of TACC3 phospho mutants. However, the full manuscript is 
included in its entirety adapted from: (Erdogan et. al., 2020 - Cytoskeleton) 
 
Introduction 
Regulation of cytoskeletal dynamics within the growth cone is essential for growth cone motility 
and navigation as the axon travels to its target (reviewed in Lowery and Van Vactor, 2009). 
Guidance molecules that the growth cone encounters during its trip can act as repellent or 
attractant depending on the time, location and the signal composition of the environment that the 
growth cone passes. Integration and interpretation of these signals relies on signaling cascades 
that are initiated downstream of guidance cue receptors which will ultimately converge upon 
cytoskeletal elements for their rearrangements and control of growth cone motility. 
Guidance signals are not homogeneously presented to the growth cone in vivo. While the growth 
cone might be exposed to repellent signals on one side, it can be exposed to attractant signals on 
the other side, which necessitates the asymmetric reorganization of the underlying cytoskeleton. 
In order to manage this asymmetric regulation, signals received by guidance cue receptors must 
be processed locally and immediately downstream of the site where the signal is received 
without necessarily leading to a global response. For example, repulsive guidance cues can cause 




collapse on the side that the protein is received, which results in growth cone steering away from 
the source of the signal 16. The interaction between guidance cue receptors and downstream 
targets is required for the growth cone’s directional movement. Microtubule plus-end tracking 
proteins (+TIPs), due to their localization close to the growth cone periphery, are potential 
targets for guidance signals. Their interaction with microtubules at the plus-ends is important for 
regulating microtubule growth dynamics and coordination of signal exchange between the 
growth cone periphery and the central domain, which is critical to the growth cone’s directional 
movement. 
The interaction between +TIPs and microtubules can be modulated by guidance signals and their 
downstream intracellular signaling events. Phosphorylation of +TIPs is one such event that has 
been shown to modulate +TIP affinity for microtubules. For example, the affinity of CLASP for 
microtubules has been shown to be regulated differentially in the growth cone depending on its 
phosphorylation status by GSK3 kinase. Increased microtubule lattice binding activity of 
CLASP, as a result of GSK3 inhibition, results in axon growth inhibition through inhibition of 
microtubule advance into the growth cone periphery. On the other hand, plus-end binding of 
CLASP, as a result of GSK3 activity, promotes axon outgrowth via stabilization of microtubules 
53. In addition to GSK3, CLASP has also been identified as a direct target of Abelson (Abl) 
tyrosine kinase 17,51. Further examination of the interaction between CLASP and Abl in Xenopus 
spinal neurons identified CLASP as a target for Abl phosphorylation and showed that 
phosphorylation can affect CLASP localization in neuronal growth cones 51. 
Similar to CLASP, several +TIPs have been implicated to be involved in regulation of 
microtubule dynamics during directional movement of cells and growth cones 19. However, only 




intracellular signals 19. We have previously characterized a microtubule plus-end tracking 
function for TACC3 in neuronal growth cones and showed that TACC3 overexpression enhances 
microtubule growth dynamics and promotes axon outgrowth 98. Additionally, we have proposed 
a function for TACC3 during axon guidance. Reducing levels of TACC3 resulted in disorganized 
axon elongation of neural tube neurons in Xenopus laevis embryos and its overexpression 
mitigated growth cone collapse induced by bath-applied Slit2 in cultured neural tube explants 142. 
To further investigate the mechanism by which TACC3 overexpression exerts this opposing role 
against Slit2 activity, we became interested in looking at potential phosphorylation events that 
might target TACC3. Our previous studies highlighted a possible genetic interaction network 
between TACC3, its microtubule polymerase interactor XMAP215, and Abelson tyrosine kinase 
(Abl) 95. Thus, we become interested in testing whether TACC3 could be a target for Abl 
phosphorylation downstream of Slit2 and whether its phosphorylation status would alter the 
interaction of TACC3 with microtubules as well as its impact on axon outgrowth and guidance. 
 
Results 
Abelson kinase induces phosphorylation of TACC3 
To investigate whether Abelson tyrosine kinase (Abl) induces phosphorylation of TACC3, we 
co-expressed GFP-TACC3 and Abl in HEK293 cells. Tyrosine phosphorylation of TACC3, 
following GFP immunoprecipitation of GFP-TACC3, was observed with 4G10, an antibody that 
specifically labels phosphorylated tyrosine residues (Figure A.II.1A, lane 4). Phosphorylation of 
TACC3 was only observed when it was co-expressed with Abl (Figure A.II.1A, lane 3 vs lane 
4). Additionally, this phosphorylation specifically happened with the tyrosine kinase Abl, since 




A.II.1A, lane 6). Although we did not determine whether the induced tyrosine phosphorylation 
was a result of direct interaction between Abl and TACC3, our data show that Abl expression 
can induce phosphorylation of tyrosine residues on TACC3. 
To study the role of TACC3 phosphorylation, we next wanted to identify the tyrosine residues 
that are targeted by Abl. Mass-spec analysis of full-length TACC3 identified 4 tyrosine residues: 
two (Y759, Y762) in the conserved TACC domain, the domain that is responsible for 
Figure A.II.1. Abelson kinase induces phosphorylation of TACC3 Abelson kinase induces phosphorylation of TACC3. (A) 
Western blot performed with phospho-tyrosine specific antibody showing Abelson-induced tyrosine phosphorylation of full-
length TACC3 (lane 4). Phosphorylation signal is not present when TACC3 is expressed alone (lane 2) or with another tyrosine 
kinase Fyn (lane 6). (B) Cartoon showing mass-spec-identified tyrosine residues of TACC3 targeted by Abl phosphorylation. (C-
H) Confocal images of growth cones expressing MACF-43 (magenta) and TACC3 (green) with phospho-null mutations at 




microtubule plus-end binding, and two (Y608, Y628) outside of the TACC domain (Figure 
A.II.1B). These phosphorylation events only occurred when Abl was co-expressed with TACC3. 
To assess the importance of these tyrosine residues, we generated single and combinatorial 
phospho-null mutants of TACC3 by substituting tyrosine with alanine or phenylalanine. 
However, neither single nor combinatorial phospho-null mutations caused a reduction in tyrosine 
phosphorylation levels, determined by Western blot analysis (Supplementary Figure 1A-D). 
Moreover, all of the single and combinatorial mutants were still able to track microtubule plus-
ends (Figure A.II.1C-H, Supplemental Movies 1-6). This initial examination suggests that other 
tyrosine residues might also be phosphorylated in TACC3 and thus contribute to the overall 
phospho-tyrosine signal detected by Western blot. 
  
Tyrosine phospho-null mutations impair the localization of the TACC domain at 
microtubule plus-ends in growth cones and mesenchymal cells 
Since none of the TACC3 phospho-null mutants based on mass-spec-identified tyrosine residues 
showed a reduction in phosphorylation signal, and they were all still able to localize to 
microtubules, we decided to examine other tyrosine residues within TACC3. The full-length 
TACC3 possesses a total of 11 tyrosine residues throughout the entire protein. Six of these 
tyrosine residues (Y725, Y759, Y762, Y832, Y846, Y857) are in the TACC domain (aa715- 
aa931), one (Y130) is in the N-terminal domain (aa1-aa133), and four (Y320, Y428, Y608, 
Y628) are in the middle domain (aa134-aa634) (Figure A.II.2A). 
The C-terminal TACC domain of the TACC3 protein shows high sequence similarity among 
vertebrates as well as among other TACC family members 185. Moreover, the TACC domain is 




behavior 98 and also for interacting with the microtubule polymerase XMAP215 103. Therefore, 
we decided to specifically investigate the importance of tyrosine residues within the TACC 
Figure A.II.2. Tyrosine phosphorylation of TACC3 affects its localization in the growth cone. (B-C) Confocal images of 
neuronal growth cones, obtained from time-lapse recordings expressing tubulin (magenta) (B’, C’) and TACC (green) wild type 
(B”) or tyrosine phospho-null mutant (C”). (D-E) Magnified montages of time-lapse sequences of single microtubule. TACC 
wild type (green) localizes to microtubule (magenta) plus-ends (D) while TACC tyrosine phospho-null mutant (green) is absent 
from microtubule (magenta) plus-ends and remains mostly cytoplasmic (E). (F) Fluorescent intensity profile (y-axis) along 
microtubules (x-axis) determined by line- scan analysis showing green fluorescent intensity (TACC wt or TACC p-null mutant) 
relative to background. Line is drawn starting from the beginning of the microtubule plus-end. (G) Plot showing the 
quantification of microtubule plus-end versus cytoplasmic localization of TACC constructs within the growth cones as 
percentage of total growth cones examined. On average, TACC wild-type shows microtubule plus-end binding in 92.5% of the 
growth cones examined while TACC tyrosine p-null mutant showed plus-end localization in 20% of the growth cones and 
remained mostly cytoplasmic in 80% of the growth cones examined. (H) Western blot performed with GFP antibody showing the 




domain to determine whether they might be contributing to the Abl-induced phosphorylation we 
observed earlier. To investigate this, we mutated all six of the tyrosine residues within the TACC 
domain to phenylalanine (Figure A.II.2A) and tested these mutants for their phosphorylation 
status. 
Surprisingly, despite lacking a phosphorylatable tyrosine with the TACC sequence, GFP-TACC 
phospho-null (p-null) mutants showed similar phospho-tyrosine signals compared to the wild-
type TACC domain, as verified with Western blot (Supplementary Figure 2A-B). Since there are 
no tyrosines left in the TACC domain, the only other source that might contribute to the 
observed Western blot signal is GFP. Therefore, we performed a Western blot for the GFP tag 
alone with a phospho-tyrosine specific antibody, and we found that GFP was indeed being 
phosphorylated specifically in the presence of Abl kinase (Supplementary Figure 2C-D). Thus, 
GFP itself was probably contributing to the overall signal that we obtained with the GFP-tagged 
TACC constructs previously. However, while Abl-induced phosphorylation of GFP muddled the 
Western blot results, we still had previously determined that tyrosine residues of TACC3 were 
indeed being phosphorylated as a result of Abl signaling, and we decided to pursue whether 
tyrosine phosphorylation directly affected the ability of the TACC domain to bind microtubules.  
When we examined whether TACC protein with tyrosine phospho-null mutations (TACC 6xYF) 
could still localize to microtubules, we found that both full-length TACC3 (data not shown) and 
TACC domain-only phospho-null mutants showed changes in their microtubule localization 
(Figure A.II.2B-C, Supplemental Movie 7-8). In both neuronal growth cones (and mesenchymal 
cells, data not shown) isolated from Xenopus embryos, TACC phospho-null mutants showed less 
localization along microtubules, determined by line-scan averages of fluorescent intensities 




cytoplasmic in 80% of the growth cones and showed microtubule localization in 20% of the 
growth cones examined, while wild-type TACC localized at microtubule plus-ends in 93% of 
growth cones examined (Figure A.II.2G). We also confirmed protein expression levels by 
Western blot and showed that the GFP-TACC mutant expression was comparable to GFP-TACC 
(Figure A.II.2H). These data suggest that retaining phosphorylatable tyrosines within the TACC 
domain is important for TACC localization along microtubules. 
  
TACC tyrosine phospho-null mutant-expressing axons grow less persistently, thereby 
resulting in shorter axons compared to TACC wild-type-expressing axons 
We have previously shown that TACC3 binding to microtubules is critical for promoting axon 
outgrowth 98. To test whether phosphorylation of the TACC domain is important in regulating 
axon outgrowth parameters, we measured the length of axons in cultured Xenopus laevis neural 
tube explants expressing either TACC wild type (wt) protein or TACC phospho-null mutant 
protein. While expression of TACC wt led to formation of longer axons, expression of the TACC 
phospho-null mutant (0.86 ± 0.04 N=155) was unable to promote increased axon outgrowth, and 
instead, showed a 17% reduction in axon length compared to controls (1.00 ± 0.03 N=277) and a 
34% reduction compared to TACC wt (1.15± 0.06 N=199) (Figure A.II.3A). 
To further assess the difference in axon length between the neurons expressing TACC wt and the 
phospho-null mutant, we measured axon outgrowth velocities. Interestingly, despite the fact that 
phospho-null mutant-expressing axons are not as long as TACC wt-expressing axons, we found 
only minor (insignificant) differences in outgrowth velocity. The average normalized axon 
forward movement velocity was 8% faster in TACC phospho-null mutant conditions (1.10± 0.03 





Figure A.II.3. TACC tyrosine phospho-null mutant expressing axons grow less persistently thereby grow shorter axons 
compared to TACC wt axons. (A) Quantification of axon length in cultured neural tube explants shows TACC phospho-null 
mutant expressing neurons grow axons shorter by 16.8% compared to control and 34% compared to TACC wt, while TACC wt 
expressing explants grow axons longer by 12.8% compared to control. (B) Measurement of axon forward movement velocity 
showing TACC wt increases axon forward movement velocity by 10% compared to control while TACC phospho-null mutant 
increases by 8%. (C) Representative phase contrast image montage of an axon depicting phases of forward movement, retraction 
and pause. (D) Plot showing the percentage of forward movement (green), pause (orange) and retraction (red) of axon growth. 
TACC phospho-null mutant expressing axons spend 18% less time moving forward compared to control and 12% compared to 
TACC wt (green dots). TACC phospho-null mutant axons (20.20 ± 1.150 N=168) spent 42% more time pausing compared to 
control and 27% compared to TACC wt (orange dots). They also tend to retract more frequently; 39% compared to control and 
30% compared to TACC wt. (E) Representative image of an axon growth track depicting displacement and distance traveled 
between t=0 and t=1h 25min (F) Plot showing the directness of axon growth. TACC phospho-null mutant axons grow 12% less 
directly compared to TACC wt) and 17% compared to control axons. TACC wt axons also grow 5% less directly compared to 
control but it was not significant. The asterisk (*) indicates statistical significance with α < 0.05 * P < 0.05, ** P < 0.01, **** P < 
0.0001, ns: not significant, from an ANOVA analysis comparing multiple conditions with Tukey’s post hoc analysis. Values 




 to TACC wt (1.13 ± 0.03 N=217, not significant p=0.3). Average outgrowth velocity in TACC 
wt-expressing axons, on the other hand was 10% faster compared to control axons (Figure 
A.II.3B). Our data suggests that TACC phospho-null mutant-expressing axons grow at similar 
rates to the TACC wt-expressing axons, suggesting that the reduced axon length in the phospho-
null condition could be due to another parameter of axon growth other than outgrowth velocity. 
To further investigate this, we also tracked other growth behaviors of axons and recorded the 
number of frames that they moved forward, paused and/or retracted over the course of 4 hour 
long time-lapse imaging (Figure A.II.3C, Supplemental Movie 9-10, intervals were every 5 
minutes). We found that TACC phospho-null mutant-expressing axons (69.61 ± 1.77 N=168) 
spent 18% less time moving forward compared to controls (82.30 ± 1.5 N=183, ***p<0.0001) 
and 12% less compared to TACC wt (78.20 ± 1.43 N=218, ***p<0.0001) (Figure A.II.3D, 
green dots). Additionally, TACC phospho-null mutant axons (20.20 ± 1.150 N=168) spent 42% 
more time pausing compared to controls (11.67 ± 1.00 N=183, ***p<0.0001) and 27% more 
compared to TACC wt 14.67 ± 0.97 N=218, ***p=0.0003) (Figure A.II.3D, orange dots). They 
also tended to retract more frequently: 39% compared to controls (6.125 ± 0.89 N=183, 
**p=0.0043) and 30% compared to TACC wt (7.098 ± 0.67 N=218, *p=0.0132) (Figure 
A.II.3D, red dots, Supplemental Movie 11). 
In addition to pause and frequency rates, we also examined the directness of axon outgrowth. 
The still images of neural tube explants that were used to measure axon length show the final 
displacement of an axon. However, axons do not necessarily follow a linear trajectory as they 
grow. In fact, they often spend time wandering, which is part of their exploratory behavior. 
Therefore, the directness of outgrowth can be determined by dividing the displacement distance 




expressing- axons (0.5353 ± 0.02 N=179) grow 12% less directly compared to TACC wt-
expressing axons (0.6012 ± 0.02 N=195) and 17% less compared to control axons (0.6313 ± 0.02 
N=192, Figure A.II.3F). These data suggest that while axon outgrowth speed is not affected by 
TACC tyrosine phospho- null mutations, growth persistency, which is determined by pause and 
retraction frequency, as well as growth directionality, both seem to be impaired in TACC 
phospho-null mutant expressing axons. Thus, this could explain the shorter axon length that we 
observed in TACC phospho-null mutant-expressing neural tube explants. 
 
TACC tyrosine phospho-null mutant-expressing growth cones display increased numbers 
of filopodia that contain microtubules 
Axons of neurons expressing the TACC phospho-null mutant tend to stop and retract more 
frequently compared to those expressing wild-type TACC. Additionally, we observe that their 
growth is less directed compared to TACC wt and controls. An inverse correlation between 
growth cone advance rate and growth cone size has been reported previously 186. Therefore, we 
became interested in examining the growth cone size, along with other morphological features, 
to see whether increased pause and retraction rates in TACC phospho- null mutant-expressing 
growth cones might also occur alongside changes in growth cone morphology. 
We initially examined the growth cone area, filopodia length, and filopodia number in cultured 
neural tube explants that are fixed and stained for microtubules (tubulin) and actin (phalloidin), 
followed by high resolution Structured Illumination Microscopy (SIM) imaging. Somewhat 
surprisingly, we found no significant difference in any of the morphological features examined 
(Figure A.II.4A-C). The average growth cone area of TACC phospho-null mutant-expressing 




µm, N=77) and 6% larger than TACC wt (382.5 ± 30.17 µm, N=94, p=0.6) (Figure A.II.4A). 
The average filopodia number did not differ across conditions either (p=0.4). TACC phospho-
null mutant growth cones had an average of 6.9 ± 0.41 N=93 filopodia, which was 10% less than 
control growth cones (7.6 ± 0.45 N=89) while TACC wt had 9% fewer filopodia than control 
(7.0 ± 0.38 N=101) (Figure A.II.4B). The average filopodia length in TACC phospho-null 
mutant growth cones was 17.03 ± 0.84µm, N=113, while it was 16.07 ± 0.77 µm, N=119 in 
control growth cones, and 15.96 ± 0.51 µm, N=126 in TACC wt expressing growth cones 
(Figure A.II.4C). 
However, while average filopodia number was similar among conditions, the number of 
filopodia that contained microtubules was found to be significantly higher in the TACC 
phospho-null mutant-expressing growth cones. Almost 30% of the filopodia had microtubules in 
the TACC phospho-null mutant growth cones (29.13 ± 2.932 percent of total filopodia examined, 
N=82), which is 63% more than control growth cones (10.92 ± 2.011 percent of total filopodia 
examined, N=90, ***p<0.0001), that had only 11% of their filopodia invaded by microtubules. 
TACC wt-expressing growth cones also had a greater number of filopodia with microtubules 
(25.82 ± 2.446 N=92, ***p<0.0001) compared to controls. While not significant, TACC 
phospho-null growth cones had 11% more filopodia with microtubules compared to TACC wt 
(Figure A.II.4F). Thus, it appears that over-expression of the phospho-null TACC domain 
somehow leads to an increased number of microtubules that penetrate into filopodia, which may 






TACC tyrosine phospho-null mutant-expressing axons are more responsive to repellent 
guidance signals 
We previously tested TACC3 function downstream of Slit2 and found that growth cones 
overexpressing TACC3 were more resilient to bath-applied Slit2-induced growth cone collapse 
 
Figure A.II.4. TACC tyrosine phospho-null mutant-expressing growth cones display increased numbers of filopodia that 
contain microtubules. (A-C) The average growth cone area of TACC mutant (406.5 ± 37.17 m, N=88) expressing growth 
cones was 13% smaller than control (432.6 ± 39.62 m, N=77) and 6% larger than TACC wt (382.5 ± 30.17 m, N=94) (A). 
TACC p-null mutant growth cones had an average of 6.9 ± 0.4130 N=93 filopodia which was 10% less than control growth cones 
(7.6 ± 0.4510 N=89) while TACC wt had 9% fewer filopodia than control (7.0 ± 0.3812 N=101) (B). The average filopodia 
length in TACC p-null mutant growth cones was 17.03 ± 0.8448 m, N=113, while it was 16.07 ± 0.7707 m, N=119 in control 
growth cones, and 15.96 ± 0.5079 m, N=126 in TACC wt expressing growth cones (C). Almost 30% of the filopodia had 
microtubules in the TACC p-null mutant growth cones (29.13 ± 2.932 percent of total filopodia examined, N=82, E), which is 
63% more than control growth cones (10.92 ± 2.011 percent of total filopodia examined, N=90, D), that had only 11% of their 
filopodia invaded by microtubules. TACC wt-expressing growth cones also had a greater number of filopodia with microtubules 
(25.82 ± 2.446 N=92) compared to controls. While not significant, TACC p-null growth cones had 11% more filopodia with 




compared to control growth cones 142. While bath application of guidance proteins is useful to 
test how manipulation of protein levels would alter the growth cone’s reaction to an applied 
guidance molecule, it does not convey information regarding the ability of the growth cone to 
make guidance choices such as steering. In order to test that, we utilized an approach where the 
repellent guidance protein Ephrin-A5 is coated on a glass coverslip in zigzag patterns and neural 
tube explants are cultured on top of these cue-coated coverslips. After 12-18 h of culturing, 
explants are fixed and stained for tubulin and actin to examine axon responsiveness to Ephrin-
A5. The responsiveness is scored based on how many of the axons that grow out from the given 
explant preferred to stay on the Ephrin-A5-free (growth permissive) surface versus how many of 
them cross that barrier and grow on the Ephrin-A5 (non-permissive) surface. 
We found that control neural tube explants (Figure A.II.5A), composed of a heterogeneous 
population of neurons, do not show a preference towards a particular surface and grow axons on 
both permissive (Ephrin-A5 free) and non-permissive (Ephrin-A5) surfaces equally (Figure 
A.II.5D; Control - off, 50.01 ± 2.93 N=55; Control- on, 49.99 ± 2.93, respectively, p=0.9). 
However, TACC wt over-expressing neural tube explants (Figure A.II.5B) show a preference 
for the permissive surfaces, as they grow 25% more axons on permissive surfaces (Figure 
A.II.5D; 57.18 ± 2.68 N=62, TACC wt – off, ***p=0.0002) compared to the Ephrin-A5 coated 
surface (TACC wt - on, 42.82 ± 2.68 N=62). TACC phospho-null mutant-expressing axons 
(Figure A.II.5C), on the other hand, show an even stronger preference for the permissive 
surface, as they grow 41.3% more axons on the permissive surface (Figure A.II.5D; TACC mut 
- off, 63.02 ± 3.03 N=42, ***p<0.0001) compared to the Ephrin-A5 coated non-permissive 




TACC domain with the non-phosphorylatable tyrosine residues are less able to grow on the 
Ephrin surface and are thus more responsive to the Ephrin-A5 repellent guidance cue activity. 
 
Discussion 
In this study, we sought to examine the impact of TACC3 tyrosine phosphorylation on its 
interaction with microtubules and regulation of axon outgrowth and guidance. We showed that 
co-expressing TACC3 with Abelson kinase in HEK293 cells induces TACC3 tyrosine 
phosphorylation, as evident by the phospho-tyrosine signal we obtained by Western blot. Our 
Western blot analysis also shows that phosphorylation of TACC3 happens only in the presence 
of Abelson, as we do not observe any phospho-tyrosine signal when TACC3 is expressed alone 
or with Fyn, which is another tyrosine kinase (Figure A.II.1A). 
Figure A.II.5. TACC tyrosine phospho-null 
mutant-expressing axons are more responsive to 
repellent guidance signals. (A-C) 
Immunofluorescence images of control (A). TACC 
wt (B) and TACC p-null mut (C) labelled with 
phalloidin (green) to label growth cones and tubulin 
(red) to label axons showing axon responsiveness to 
Ephrin-A5 coated zigzag surfaces (green). (D) 
Quantification of the number of axons on permissive 
(Ephrin-A5 free) versus non-permissive (Ephrin-A5) 
surfaces. Control neural tube explants does not show 
a preference between permissive versus non-
permissive surfaces and grow axons on both surfaces 
equally (Control - off, 50.01 ± 2.930 N=55; Control- 
on, 49.99 ± 2.930, respectively). TACC wt 
expressing neural tube explants grow 25% more 
axons on permissive surfaces (57.18 ± 2.683 N=62, 
TACC wt - off) compared to Ephrin-A5 coated 
surface (TACC wt - on, 42.82 ± 2.683 N=62). TACC 
p-null mutants grow 41.3% more axons on 
permissive surface (TACC mut - off, 63.02 ± 3.036 
N=42) compared to Ephrin-A5 coated non-
permissive surface (TACC mut - on, 36.98 ± 3.036 




Interestingly, creating single or combinatorial phospho-null mutations at tyrosine residues that 
we identified, as potential targets for Abelson, did not show any changes in phospho-tyrosine 
signal levels observed with Western blot. In an attempt to identify the source of tyrosine 
phosphorylation, we tested other tyrosine residues and focused specifically on the ones in the 
TACC domain positioned at the C-terminal of TACC3 and which is responsible for microtubule 
plus-end tracking and interaction with its well-studied partner, microtubule polymerase 
XMAP215. The TACC domain possesses 6 tyrosine residues with two of them (Y759 and Y762, 
aa location given based on full length protein) identified as Abelson targets from the mass-spec 
analysis and three of them (Y832, Y846 and Y857) predicted as putative targets for Abl via in 
silico analysis. Intriguingly, mutating all these tyrosines into non-phosphorylatable 
phenylalanine did not cause any reduction in the phospho-tyrosine signal level as evident by the 
Western blot (Supplementary Fig. 2A-B). In spite of the lack of any tyrosines in the TACC 
domain, it was intriguing to see that there was still a phospho-tyrosine signal in the Western blot. 
The only possible source of phosphorylatable tyrosine was GFP that is tagged to the TACC 
domain. Tyrosine phosphorylation of GFP has not been reported previously, to our knowledge, 
nor does in silico phosphorylation prediction identify any sites by which kinases might target 
GFP. However, expression of GFP with Abelson clearly showed a strong phospho-tyrosine 
signal (Supplementary Fig. 2C-D) suggesting that GFP might be partially contributing to the 
phospho-tyrosine signal that we have been observing in GFP-TACC. 
The impact of phosphorylation on the interaction between +TIPs and microtubules has been 
studied for several +TIPs, such as CLASP 53,187–189, APC 18, ACF7 190, EB1 64,180,191,192. Here, we 
demonstrated that tyrosine residues within the TACC domain of TACC3 are important for 




tyrosine residues mutated into phenylalanine remains mostly cytoplasmic, while TACC wild-
type localizes to microtubules. It should be noted that the wild-type TACC domain, in contrast to 
full-length TACC3 (which shows primarily plus-end binding), also shows lattice binding in 
addition to plus-end localization. Consistent with our previous observations 98, this suggest that 
N-terminus of TACC3 is important for restricting TACC3 localization to the microtubule plus-
ends. +TIPs track microtubule plus-ends either autonomously, through recognition of the 
growing microtubule structure, or non-autonomously, through an interaction with another plus-
end tracking protein such as end-binding (EB) proteins. Although the mechanism of how TACC3 
tracks plus-ends is not fully resolved, EB-dependent plus-end tracking can be ruled out as 
TACC3 does not contain a SxIP motif (serine- any amino acid- isoleucine-proline) that is 
required for EB binding. It is believed that TACC3 tracks microtubule plus-ends through its 
interaction with XMAP215, which is mediated by the TACC domain 103,185,193. Therefore, it is 
possible that the impaired interaction between microtubules and TACC phospho-null mutant 
could be arising due to a change in TACC3’s ability to interact with XMAP215. 
The TACC domain consists of two coiled-coil domains, which means that the sequence follows 
heptad repeats. Presence of these coiled-coil domains are responsible for TACC3’s 
oligomerization, which is important for TACC3’s function and its interaction with XMAP215 
103,129. Using Multicoil, a coiled-coil prediction program, we looked at whether tyrosine-to-
phenylalanine mutations might have altered coiled-coil formation or dimerization of TACC 
domain. Based on this prediction, it seems as though the TACC phospho-null mutant is still 
likely able to dimerize and form a coiled-coil (Supplementary Figure 3), suggesting that the 
interaction between XMAP215 and TACC phospho-null mutant might be retained. Although in 




phenylalanine does not affect TACC3’s coiled-coil structure, reduced interaction between 
phospho-null TACC mutants and microtubules might be explained by a change in electrostatic 
interactions between the two. While this could be a possibility, negative charges introduced via 
phosphorylation often cause dissociation of proteins from the microtubule 53,194 which is already 
loaded with negative charges due to negatively-charged residues at the C-terminus of tubulin. 
While our findings suggest that the tyrosine residues of TACC domain are important for 
mediating TACC3’s interaction with microtubules, the exact mechanism of how they are 
involved in this interaction remains to be determined. 
Microtubule advance within the growth cone is important for consolidating and driving growth 
cone forward movement 1. Intriguingly, despite increasing microtubule growth speed and length, 
our data shows that TACC phospho-null mutant expressing axons of cultured neural tube 
explants are shorter in spite of slightly higher axon forward velocity rates compared to control. 
When we further examined other axon outgrowth parameters, we found that TACC phospho-null 
mutants tend to pause and retract more frequently compared to TACC wild-type and controls 
(Figure A.II.3D). Additionally, mutant axons tend to grow with less directionality (Figure 
A.II.3F). In an attempt to seek further explanation to axon outgrowth behavior, we examined 
growth cone morphology, since growth cone morphology can often predict the growth behavior 
of axon 186. For example, increased growth cone size is often associated with frequently pausing 
or slow growing axons. Although we did not see a significant difference in growth cone size, 
filopodia length, or number among conditions (Figure A.II.4A-C), there was a significant 
increase in the number of filopodia with microtubules in the TACC phospho-null mutant 




We know that microtubules can play an instructive role in growth cone directional motility. 
Having more filopodia with microtubules might generate more alternative routes for the growth 
cone to extend, which could result in more pausing for decision making and could also cause the 
growth cone to wander more, which would result in less directed movement. Additionally, there 
might be increased microtubule/F-actin coupling, which would enable microtubules to track 
more persistently along F-actin into the filopodia. In fact, increased microtubule/F-actin coupling 
could also explain increased retraction rates. For example, actin filaments in the growth cone are 
subjected to rearward translocation also known as retrograde flow, due to myosin II activity 24. 
The retrograde flow of actin filaments can be attenuated when the F- actin cytoskeleton engages 
with receptors at point contact sites. This interaction acts as a molecular clutch that will restrain 
actin retrograde flow, while continuing actin polymerization will generate the force to allow 
membrane protrusion, thereby growth cone advance. The growth cone retracts when actin 
retrograde flow fails to be attenuated, which is also an indication of poor surface adhesion.  
It is known that dynamic microtubules play an important role in facilitating focal adhesion 
dynamics by transporting molecules that are involved in focal adhesion turnover 91. Several 
microtubule plus-end binding proteins have been studied for their association with adhesion sites 
91,195,196. Therefore, by facilitating microtubule protrusion into the filopodia, the TACC phospho-
null mutant domain might be playing an indirect a role in adhesion dynamics. A potential role in 
point contact regulation can also explain avoidance of EphrinA5-coated repellent substrates. 
Filopodia with microtubules could be more sensitive to cues, due to the microtubule-mediated 
signal trafficking, thereby affecting the interaction with the underlying substrate. Moreover, as 




routes; thus, when the growth cone encounters a non-permissive substrate, it could pick one of 
these alternative routes and steer away from the repellent source. 
In conclusion, we have demonstrated that tyrosine residues within the TACC domain, which is 
the domain important for mediating microtubule plus-end tracking behavior, are critical for 
localizing the protein to microtubules, regulating axon outgrowth parameters and making 
guidance decisions. Given the increased number of microtubules in the filopodia when the 
TACC domain is over-expressed, we hypothesize that the tyrosine residues in the TACC domain 
might be involved in regulating a potential TACC-mediated interaction between microtubules 
and F-actin. Such an interaction has not been proposed for TACC3 before, however, there are 
studies that might offer a potential interaction between TACC3 and the actin cytoskeleton. A 
proteomic screen previously identified an interaction between TACC3 and actin regulator 
proteins Ena/VASP 197. Additionally, the close interactor of TACC3, XMAP215, has recently 
been shown to interact with actin and mediate microtubule/F-actin interaction in growth cones 
149, which makes TACC3 a candidate to be involved in actin cytoskeleton interaction either 
direct or indirectly. 
To our knowledge, TACC3 tyrosine phosphorylation has not been explored extensively before. 
Nelson et. al. identified two tyrosine residues, Y684 and Y753 (corresponding to residues Y725 
and Y832 in X. laevis and conserved across species, Supp. Fig. 4) that showed enhanced 
phosphorylation when it is fused to Fibroblast Growth Factor Receptor 3 (FGFR3) 198. It has 
been indicated that the FGFR3–TACC3 fusion is important for the activation of FGFR3 tyrosine 
kinase activity, and fusion of these proteins increases cell proliferation and tumor formation. 
Moreover, TACC3 in association with ch-TOG has been shown to localize to the mitotic 




spindles and localizes to the spindle poles, causes mitotic defects, which might explain the 
involvement of these proteins in tumor formation 199. From this perspective, it might be 
intriguing to investigate TACC domain tyrosine residues and TACC association with 
microtubules during cell division. Finally, in addition to tyrosine phosphorylation, 
serine/threonine phosphorylation sites within TACC3 would be worthwhile to explore, given that 
there are several S/T kinases that operate under guidance cues, such as GSK3, which is a well-
studied S/T kinase that is already shown to phosphorylate various +TIPs and modulate 
microtubule dynamics. Future work can further explore whether TACC3 is targeted by S/T 
kinases and whether S/T phosphorylation would affect TACC3’s function in a similar way, 
which could shed light on differential and asymmetric regulation of microtubule dynamics under 
various guidance signals. 
 
Materials and Methods  
 
Embryos 
Eggs collected from Xenopus laevis were fertilized in vitro and kept between at 13-22˚C in 0.1X 
Marc’s Modified Ringer’s (MMR). All experiments were approved by the Boston College 
Institutional Animal Care and Use Committee and were performed according to national 
regulatory standards. 
 




Neural tubes of embryos staged according to Nieuwkoop and Faber were dissected at stages 
between 20-21 as described previously 146. Neural tube explants were cultured on MatTek glass 
bottom dishes coated with poly-L-lysine (100 µg/ml) and laminin (20 µg/ml). Culture media 
prepared by mixing L-15 Leibovitz medium and Ringer’s solution supplemented with antibiotics 
NT3 and BDNF to promote neurite outgrowth. 
 
Constructs and RNA 
Capped mRNAs were transcribed and purified as previously described 98,112. TACC3 pET30a 
was a gift from the Richter lab, University of Massachusetts Medical School, Worcester, MA 
and sub-cloned into GFP pCS2+. Tyrosine phospho-null mutations were introduced into wild-
type GFP-TACC3 by using overlapping extension PCR method with appropriate primers 
designed to substitute tyrosine residues with phenylalanine to generate GFP-TACC3 6xYF. Wild 
type and phospho-null mutants of TACC domain were cloned from their full-length counterparts. 
MACF 43 (a gift from Hoogenraad Lab) was sub-cloned into mKate2 pCS2+. Embryos either at 
the 2-cell or 4-cell stage were injected with the following total mRNA amount per embryo; 100 
pg of GFP-MACF43 as a control for GFP-TACC3 and to analyze microtubule dynamics 
parameters. GFP-TACC3 full-length wild type or phospho-null mutant injected at 1000 pg. GFP-
TACC wild type or phospho-null mutant were injected at 400 pg. The human c-Abl construct 
was originally constructed in the Kufe lab (Harvard Medical School) and gifted by Dr. Alan 
Howe (University of Vermont). The Fyn construct in pRK5-Entry 200was acquired from 





Cell Culture and Transfections 
HEK293 cells were maintained at 37 °C and 5% CO2 and cultured in DMEM containing L- 
glutamine, sodium pyruvate and 4.5 g/L glucose (MediaTech/Corning Life Sciences, Tewksbury, 
MA, USA). DMEM was supplemented with 5% fetal bovine serum (Hyclone, Logan, UT, USA), 
5% Cosmic calf serum (Hyclone), 50 units/mL penicillin and 50 μg/mL streptomycin (Penicillin- 
Streptomycin, Invitrogen, Carlsbad, CA, USA). Cells were cultured to 75% of confluence and 
transfected with 3-6 μg GFP-TACC3 full-length (FL) with or without 2 μg c-Abl or 3.5 μg Fyn 
expression plasmids using calcium phosphate precipitation. The following expression constructs 
encoding TACC3 phospho-null and truncation mutants were co-transfected at 3 μg with c-Abl: 
GFP-TACC3 Y2A (Y608A, Y628A); GFP-TACC3 Y3A (Y608A, Y628A, Y759A); GFP-
TACC3 Y4A (Y608A, Y628A, Y759A, Y762A). GFP-TACC domain widtype; GFP-TACC 
domain phospho-null mutant (Y725F, Y759F, Y762F, Y832F, Y846F, Y857F). 
 
Cell Lysis, Immunoprecipitation and Western Blotting 
HEK293 cells were lysed as previously described  in lysis buffer (25 mM Tris pH 7.4, 137 mM 
NaCl, 10% glycerol, 1% NP-40) containing protease inhibitors (5 μg/mL Pepstatin, 10 μg/mL 
Leupeptin, 1 mM PMSF) and phosphatase inhibitors (1 mM NaVO3, 25 mM NaF, 10 mM 
Na2H2P2O7) 201. For cell extract immunoblotting, 20-30 μg total protein extract was denatured 
in protein sample buffer (125 mM Tris pH 6.8, 7.5% glycerol, 2% sodium dodecyl sulfate (SDS), 
5% β-mercaptoethanol, and 0.02% bromophenol blue) at 95 °C for 5 minutes and subjected to 
SDS-PAGE. For immunoprecipitation experiments, 1000 μg of total protein was incubated 
overnight at 4 °C with 2 μg α-GFP (Life Technologies/ThermoFisher Scientific, Carlsbad, CA, 




PA, USA) and Protein G resin (G-Biosciences, St. Louis, MO, USA) prewashed with lysis 
buffer. Immune complexes were washed 3 times with lysis buffer, dried and denatured in protein 
sample buffer at 95 °C for 5 minutes. Denatured cell extract and immunoprecipitation samples 
were subjected to SDS-PAGE separation. For mass spectrometry analysis, the SDS-PAGE gel 
was stained with Coomassie (0.1% Coomassie brilliant blue R-250, 20% glacial acetic acid and 
40% methanol) and subsequently prepared for mass spectrometry as described below. For 
immunoblotting experiments, the following primary antibodies were diluted in 10 mL of 1.5% 
BSA in TBST containing 0.0005% sodium azide and incubated at 4 °C with the membranes 
overnight: α-GFP (1:2000, rabbit pAb, Life Technologies); α-Abl (1:1000, rabbit pAb, Santa 
Cruz Biotechnology, Dallas, TX, USA); α-phosphotyrosine 4G10 (1:1000, mouse mAb, EMD 
Millipore, Billerica, MA, USA). The following secondary antibodies were used: α-mouse- HRP 
(goat IgG, 1:5000; EMD Millipore); α-rabbit-HRP (goat IgG, 1:15,000, EMD Millipore); or for 
immunoprecipitation experiments, α-rabbit-HRP Light Chain Specific (goat IgG, 1:10,000, 
Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Proteins were detected using 
enhanced chemiluminescence (ThermoFisher Scientific, Waltham, MA, USA) and film was 




To identify Abl-induced phosphorylation sites on TACC3, GFP-TACC3 was transfected with or 
without c-Abl. GFP-TACC3 was immunoprecipitated using α-GFP and subjected to SDS-PAGE 
separation and Coomassie staining as described above. The region corresponding to the 




previously described 202. Briefly, gel regions were diced and proteins were subjected to in-gel 
digestion with 6 ng/μL trypsin (Promega, Madison, WI, USA) in 50 mM ammonium bicarbonate 
at 37 °C for 10-12 hours. The tryptic peptides were resuspended in 2.5% acetonitrile, 0.15% 
formic acid and separated via HPLC prior to MS/MS analysis on a linear ion trap-orbitrap (LTQ-
Orbitrap) mass spectrometer (Thermo Electron, Waltham, MA, USA) controlled with Thermo 
Xcalibur 2.1 software. Peptides were eluted and electrosprayed (2.1 kV) into the mass 
spectrometry as previously described 203. The precursor scan (scan range = 360- 1700 m/z, 
resolution = 3.0 x 104) was followed by ten collision-induced dissociation (CID) tandem mass 
spectra. CID spectra were acquired for the top ten ions in the precursor scan. A SEQUEST 
search of the mass spectrometry data was performed using the forward and reverse Xenopus 
TACC3 Uniprot sequence requiring tryptic peptides and permitting phosphorylation of serine, 
threonine and tyrosine (+79.9663 Da), oxidation of methionine (+15.9949 Da), and 
acrylamidation of cysteine (+71.0371Da). Peptides were identified with a false discovery rate of 
less than 1%. 
 
Immunocytochemistry 
Embryonic explant cultures were fixed with 0.2% Glutaraldehyde as described 40 and labelled 
with primary antibody (1:1000 diluted in blocking buffer made up by 1% non-fat dry milk in 
calcium and magnesium free PBS) to tyrosinated tubulin [YL1/2] (rat monoclonal, ab6160, 
Abcam) for 45 min at room temperature which is followed by PBS washes repeated three times 
and 10 min of blocking. Goat anti-rat AlexaFluor568 (1:500, ab175476, Abcam Technologies) 
was used as a secondary to tubulin and Phalloidin 488 (1:500, Molecular Probes) was used to 




temperature followed by PBS washes several times. 90% glycerol stock was used as a mounting 
media for imaging. 
 
Stripe Assay 
The stripe assay is performed as described in Knoll et al 2001 123. 10 ug/ml of Ephrin-A5/Fc 
(chimera human, Sigma, E0628) and 10 ug/ml of Fc are mixed with 2.5 ug/ ml of Anti-human 
IgG (Fc specific) FITC (Sigma, F9512) and Anti-human IgG (Fc specific) respectively in PBS. 
Solutions are incubated at room temperature for 30 min to allow for oligomerization. To coat 
coverslips with Ephrin-A5, a coverslip is attached to a zigzag patterned silicon matrix and 
Ephrin-A5 solution is injected with a micropipette through the channel in the silicon. Injected 
matrices are incubated at 37˚C for 30 min and then rinsed with PBS several times using the same 
injection method. After rinsing, coverslips are detached from the matrix and placed in a culture 
dish and 100 µl of second stripe solution (Fc only) is applied directly on the coverslip and 
incubated at 37˚C for 30 min. After incubation is over coverslips are rinsed with PBS and 20 ug / 
ml of 100ul laminin in PBS is applied on coverslips and incubated for 1 h. After laminin 
incubation, coverslips are rinsed with PBS several times. 400 µl of culture media is applied on 




To assess axon outgrowth parameters, phase contrast images of axons were collected on a Zeiss 




For axon outgrowth length, snap-shots of neural tube explants were taken 12-18h post culturing. 
Time-lapse images were collected for 4 h with 5 min intervals and axon growth was manually 
tracked frame-by-frame using Fiji Manual Tracking plugin. Axon growth velocity information is 
provided by the Manual Tracking plugin but only the forward movement velocity was included 
in the analysis. Axon outgrowth forward movement, pause and retraction frequencies (as a 
percentage of total frames tracked) are scored manually tracking axons frame by frame. High-
resolution images of cultured spinal cord explants were obtained with a CSU-X1M 5000 
spinning-disk confocal (Yokogawa) on a Zeiss Axio Observer inverted motorized microscope 
with a Zeiss Plan-Apochromat 63×/1.40 numerical aperture lens. Images were acquired with an 
ORCA R2 charge-coupled device camera (Hamamatsu) controlled with Zen software. For 
microtubule dynamics and TACC localization experiments, images are time lapse images are 
acquired for 1 min with 2.0 s intervals. Structured illumination super-resolution images were 
collected on a Zeiss Axio Observer.Z1 for super-resolution microscope with Elyra S.1 system, 
utilizing an Objective Plan-Apochromat 63×/1.40 oil (DIC). Images were acquired with a PCO-
Tech Inc.pco.edge 4.2 sCMOS camera. The images were obtained in a chamber at approximately 
28°C and utilizing the immersion oil Immersol 518F 30°.  
 
Image Analysis 
Channel alignment and structured illumination processing were applied to the super-resolution 
images using the Zeiss Black program. Experiments were performed multiple times to ensure 
reproducibility. Graphs were made in GraphPad Prism. Statistical differences were determined 
using unpaired two tailed t-tests when comparing two conditions and one-way analysis of 














Appendix Chapter 3. Characterization of Xenopus laevis Guanine Deaminase 
reveals new insights for its expression and function in the embryonic kidney 
*My role in facilitating the completion of this chapter was the following: Growth cone imaging 
and all MT dynamics data in Figure 2, and subcloning on constructs. However, the full 
manuscript is included in its entirety adapted from: (Slater et. al., 2019 – Dev. Dynamics.) 
 
Introduction 
The proper establishment of neuronal morphology is essential for the correct communication 
between neurons, and the cytoskeleton plays a key role in determining neuronal morphology 
during development. In particular, microtubules (MTs) orchestrate formation of neuronal polarity 
and ensure proper axon and dendrite morphology. MT dynamics are widely regulated by proteins 
that bind to the plus-end of the MT, called plus-end tracking proteins (+TIPs), in addition to 
other types of MT-binding proteins 19,33,36,115,171. While many studies have begun to investigate 
MT plus-end dynamics in the developing nervous system, it is clear that much more information 
is needed to reveal a comprehensive picture for how MT dynamics regulate neural development. 
One important MT regulator in the developing nervous system is the mammalian guanine 
deaminase (GDA), called Cypin (cytosolic PSD-95 interactor) 204. Cypin has been linked to 
autism spectrum disorders and has been described as a risk biomarker for these disorders 205. In 
addition, Cypin levels increase in rat striatal neurons in response to nigro-striatal degeneration, 
which models the degeneration of neurons in Parkinson’s disease 206. Multiple 
neurodevelopmental disorders are associated with defects in axon guidance and dendritogenesis. 




by antagonizing PSD-95 function and increasing dendrite branching 204,207. Cypin contains a 
domain with homology to the collapsin response mediator protein (CRMP), which binds tubulin 
and has a suggested role in regulating MT assembly in the growth cone 208. In addition, Cypin 
can bind tubulin heterodimers and regulate MT assembly in vitro 204. Moreover, the binding 
partner of Cypin, PSD-95, binds to the known +TIP, EB3, in neurons and hence regulates MT 
dynamics 209. However, while Cypin has previously been proposed to regulate MT dynamics, it 
has not yet been determined whether Cypin can actually localize to MT plus-ends or alter MT 
dynamics in living cells. 
Multiple +TIPs have been described and characterized using Xenopus laevis 17,52,98,112,142,183,184. 
Xenopus embryos can be easily manipulated, and their primary embryonic neural cells are facile 
to obtain, culture, and image, as they display large growth cones (diameter of 10 microns or 
more), which are useful for imaging cytoskeletal dynamics 172,173. Live cell imaging is 
particularly important, as some +TIPs only bind to growing MTs and, thus, their localization 
dynamics cannot be visualized using immunohistochemistry of fixed cells 98. 
In this work, we investigated whether human GDA (Cypin) and/or Xenopus laevis GDA (GDA) 
can localize to MT plus ends, perhaps functioning as a +TIP, and tested whether it has a role in 
regulating MT dynamics. Additionally, we examined GDA expression in Xenopus laevis during 
embryonic development, as its expression and function had not been well characterized. We 
visualized exogenously-expressed Cypin and GDA for the first time in living primary embryonic 
neural growth cones using fluorescent confocal microscopy and found that neither of them co-
localize with MT plus-ends, suggesting that GDA does not function as a +TIP. Despite the lack 
of MT binding, we found that expression of Cypin, but not GDA, promotes MT assembly in 




described as important for binding tubulin and regulating MT assembly, is not fully conserved in 
Xenopus. By generating a chimera containing the N-terminal region from GDA plus the Cypin 
domain containing the CRMP homology and PDZ-binding domain, we found that this Cypin 
region is necessary for regulating MT dynamics. Finally, using whole-mount in situ 
hybridization, we observed that GDA is highly expressed in the kidneys and may be important 
for proper kidney function. Our results suggest that the function of GDA to regulate MT 
dynamics is not conserved in Xenopus. 
 
Results 
The CRMP homology domain is not conserved between human and Xenopus GDA 
Figure A.III.1. The CRMP homology domain is not conserved between human and Xenopus GDA. Sequence alignment of X. 
laevis homeologs; X.tropicalis; Danio rerio; Gallus gallus; Homo sapiens; Rattus norvegicus; and Mus musculus GDA. The GDA 
N-terminal, including the Zn2+ binding domain (yellow square), is well conserved among all species, while the CRMP homology 




While a previous phylogeny study reported that the guanine deaminase (GDA) DNA sequence 
has been conserved from prokaryotes to higher eukaryotes 210, this early study did not examine 
the entire amino acid sequence nor did it look specifically at the CRMP domain sequence. X. 
laevis, X. tropicalis, Danio rerio, Gallus gallus, Homo sapiens, Mus musculus and Rattus 
norvegicus form part of the same related clusters of GDA sequences 210. Here, we compared the 
GDA protein sequences of all the aforementioned species. X. laevis is an allotetraploid organism 
and has two GDA homologs, S and L; thus, we considered both homologs for protein sequence 
comparison. We found the following sequence homologies of each organism with human Cypin: 
X. laevis GDA S-homeolog 60%; X. laevis GDA L-homeolog 61%; X. tropicalis 61%; zebrafish 
59%; chicken 72%; rat 91%; and mouse 91% (Figure A.III.1).  
In addition, while all GDAs were previously described to have well-conserved zinc-binding 
domains, the CRMP homology and PDZ-binding domains are not completely conserved. Gallus 
gallus, Homo sapiens, Mus musculus and Rattus norvegicus all have a PDZ-binding domain, 
which is absent from X. laevis, X. tropicalis and Danio rerio (Figure A.III.1). Moreover, even 
though the CRMP homology domain was present in all the organisms, it is not well conserved. 
While chicken, rat, and mouse have strong conservation with human (82%, 91%, 91%, 
respectively), the CRMP homology domains in X. laevis GDA S and L, X. tropicalis, and 
zebrafish are not as similar (60%, 53%, 53%, 58% conservation with human GDA, respectively) 
(Figure A.III.1). Notably, neither the PDZ-binding domain nor the CRMP domains are 
conserved between amniotes and amphibians/fish. 
 




In order to explore the possibility that GDA may function as a +TIP and thereby bind to the plus-
ends of MTs to regulate MT dynamics 1,19, we first examined whether human (Cypin) and/or 
X.laevis (GDA) GDA localize to MT plus-ends or not. We co-injected mRNAs coding for GFP-
tagged N- or C-terminus Cypin and GDA along with mKate2- MACF43, a known marker of 
growing MTs that localizes to the MT plus-ends 64, into X. laevis embryos at the 2-cell stage. We 
prepared spinal cord explants from stages 20–24 Xenopus embryos, and we used live imaging to 
Figure A.III.2. GDAs do not localize to the MT plus-end and only Cypin promotes MT polymerization. A-B. Maximum 
intensity montage of 31 frames from a one-minute time-lapse image series, of Gda and Cypin (green), and mKate2-MACF43 
tracks (magenta), in cultured neuronal growth cones (A) and neural-derived embryonic mesenchymal cells (B), obtained from 
Xenopus embryos at stage 20–24. Scale bars 8.0 μm (A) and 5 μm (B). C. Schematic representation of the GFP-tagged constructs 
used, showing the critical domains. D-F. Quantification of mean values of MT growth velocity (D), growth lifetime (E) and 
growth length (F) in neuronal growth cones upon GFP, Gda, Cypin and Cypin chimera over- expression. (See Supplementary 
Movie 1 for a representative movie of mKate2-MACF43.) Bars on dot plots show mean and SEM. ** P < 0.01; *** P < 0.001; 
**** P < 0.0001; n.s., not significant. A total of 138 control; 107 Gda; 154 Cypin and 83 Cypin chimera growth cones, from 




visualize the exogenously- expressed GDAs. We found that neither Cypin nor GDA localized to 
the MT plus-end in neuronal growth cones (Figure A.III.2A), nor in neural-derived 
mesenchymal cells (Figure A.III.2B), as GDAs did not co-localize with mKate2-MACF43. 
Rather, in all cases, GDA was diffused throughout the cytosol and did not appear to localize to 
MTs at all, consistent with what has been previously described for Cypin localization 204,207,209. 
These data suggest that neither human nor Xenopus GDA accumulate on MTs plus-ends, and 
thus, GDA does not act as a +TIP in Xenopus embryonic cells.  
 
Exogenous expression of Cypin, but not GDA, promotes MT polymerization in living cells 
Considering that some proteins regulate MT dynamics through indirect mechanisms, for 
example, by binding tubulin heterodimers or other proteins that bind to MTs 32,38, we sought to 
determine whether over-expression of Cypin or GDA (Figure A.III.2C) could affect MT 
dynamics indirectly in living cells. We measured MT behavior in cultured primary embryonic 
neuronal growth cones obtained from Xenopus stages 20–24, by quantifying the MT growth 
track velocity, lifetime and length of mKate2- MACF43 comets after GDA over-expression 
(Supplementary Movie 1). We observed that axonal growth cones over-expressing Cypin showed 
an 11% increase in MT growth track velocity and a 17% increase in MT growth track length 
compared to those of control cells, while no change was observed in mKate2-MACF43 comet 
lifetime (Figure A.III.2D-F). Similar results were observed for both N- and C-terminal tagged 
GFP-Cypin (data not shown). However, we observed no changes in MT dynamics in cells over-
expressing GDA compared to control cells (Figure A.III.2D-F). These data show that Cypin 
over-expression increases MT polymerization rate in living Xenopus embryonic cells, and that 




Additionally, considering the differential regulation of MT dynamics by Cypin and GDA, and 
the striking differences between the Cypin and GDA CRMP homology and PDZ-binding 
domain, we decided to evaluate if this Cypin region is responsible for the effect on MT 
dynamics. We generated a chimera GDA containing the N-terminal half from GDA and the 
CRMP homology plus PDZ-binding domain from Cypin (Figure A.III.2C) and examined the 
effect of the chimera GDA on MT dynamics. We found that the chimera GDA was able to 
increase MT growth track velocity and MT growth track length compared to those of control, 
similar to Cypin (Figure A.III.2D-F). Our results suggest that the Cypin region containing both 
CRMP homology and PDZ-binding domains plays an important role in promoting MT 
polymerization. 
 
Xenopus GDA is strongly expressed in the embryonic kidney and thus may play a role in 
kidney function 
Given that our results suggested that Xenopus GDA did not function as a promoter of MT 
polymerization, we wondered if it was still expressed in the developing brain, like Cypin. In 
order to characterize GDA expression during Xenopus embryonic development, we used reverse 
transcription (RT) PCR and whole-mount in situ hybridization at different stages of 
development. First, we performed RT-PCR using cDNA from embryos at various stages 
including 2 cell, blastula, neurula, 3 dpf and 6 dpf, as well as cDNA from the adult brain. We 
found that strong GDA expression was not apparent until 3–6 dpf and persisted, although to a 
lesser extent, through adulthood within the brain (Figure A.III.3A). Whole-mount in situ 
hybridization showed no staining in early stages including 2-cell, blastula, and 1 dpf, confirming 




two bilateral regions behind the embryonic eye became apparent at 3 dpf and remained at a high 
level to 6 dpf (Figure A.III.3B). Following the stages of Xenopus laevis development 144, and 
considering the localization and the tubular structures (Figure A.III.3B), we identified these 
areas to be the developing kidneys. Thus, we used the proximal tubule kidney marker, xSGLT1K 
Figure A.III.3. Xenopus GDA is expressed in the developing kidney. A. RT-PCR showing Gda expression in the different 
developmental stages: two cell, blastula, neurula, 3 dpf, 6 dpf, and adult. ODC1 was used as an internal RT-PCR reference. B. 
Whole- mount in situ hybridization using an antisense probe specific to Gda in different developmental stages. Scale bar: 0.5 mm 
C. Whole-mount in situ hybridization using an antisense probe specific to GDA or the kidney marker xSGLT-1K in 4.5 dpf 





to perform in situ hybridization in 4.5 dpf embryos. Our results showed that both GDA and 
xSGLT1K are expressed in the same location (Figure A.III.3C), confirming the expression of 
GDA in the kidneys. 
 
We were also interested in determining a possible function of GDA in Xenopus. Since our over-
expression analysis suggested that GDA does not play a role in modulating MT dynamics, and 
our expression analysis showed that GDA is not present in most embryonic cells during early 
neural development, we reasoned that GDA could not be playing a role to promote MT 
polymerization in the early nervous system. Given its strong expression in the kidneys beginning 
at 3 dpf, we wondered if GDA might play a role in kidney development or function. However, 
pronephros development in Xenopus begins at stage 12.5, and kidneys become initially 
functional by stage 38, which corresponds to 2 dpf 211,212. Thus, it did not seem likely that GDA 
was required for initial kidney development. Still, we wondered whether GDA might be 
important for kidney function. It has been demonstrated that an altered osmoregulatory function 
of the kidney leads to edema formation due to water retention 212,213 and evaluation of edema has 
been widely used to assess kidney function 213. Thus, we used an antisense oligonucleotide to 
knock down (KD) GDA by 50% (Figure A.III.4A), and at 4 dpf, we analyzed edema formation 
in the chest as a proxy to study kidney function (Figure A.III.4B-C). We observed that GDA 
KD induced edema in 44% of tadpoles, while no edema was observed in the controls (Figure 
A.III.4B-C). This phenotype was rescued by adding back GDA mRNA to the KD condition 
(Figure A.III.4E-D), attributing these effects specifically to GDA. However, as cardiac and 
other developmental anomalies can also lead to edema, we also performed targeted injections at 




With these targeted injections, we did not observe significant edema (not shown), suggesting that 
the edema formation in the GDA knockdown embryos was not necessarily due to defects in 
kidney function alone. We also examined gross morphology of kidney development by 
immunostaining for anti-kidney antibodies, 4A6 and 3G8, at 4 dpf and observed no apparent 
Figure A.III.4. Xenopus GDA knockdown results in edema formation but kidney morphology appears to be normal. A. Schematic 
representation of the MO effect on Gda RNA splicing (above) RT-PCR showing Gda knockdown (KD) when injecting increasing 
concentrations of MO (below). B. Representative images at 4 dpf control and Gda KD tadpoles. Scale bar: 1 mm. C. Schematic 
representation of a tadpole showing the measurements for edema identification. D. Quantification of the ratio: length face-to-chest (a) over 
length of cement gland-to-eye (b). E. Quantification of the percentage of tadpoles showing edema. F. Representative images of 
immunofluorescence using the kidney marker 3G8 in addition to 4A6 at 4 dpf control and Gda KD tadpoles. F. Quantification of the ratio: 
average tubule diameter of the Gda MO- injected side over that of the uninjected side of the same tadpole. Bars on dot plots show mean 





differences with GDA knockdown compared to controls (Figure A.III.4F-G). Thus, these data 
suggest that GDA does not appear to be involved in kidney development, but it may still play a 
role in later kidney function in Xenopus. 
Discussion 
In this study, we first compared the GDA amino acid sequence from different species, which 
were related phylogenetically. We determined that the CRMP homology domain is not present in 
amphibians or fish. Additionally, we visualized fluorescently-tagged Cypin and GDA using live 
imaging for the first time and determined that GDA protein is cytosolic but is not enriched at the 
MT plus-end or the MT lattice in Xenopus embryonic cells. We also showed that over-
expression of Cypin influenced MT dynamics in embryonic cells, and that this effect of GDA is 
not conserved among all vertebrates, since the overexpression of GDA has no effect in Xenopus 
cells. In addition, we showed that the CRMP homology domain and the PDZ-binding domain of 
Cypin are responsible for the effect on MT dynamics, as we could recapitulate the increased MT 
polymerization by expressing a Cypin chimera containing the N-terminal region of GDA 
combined with the Cypin CRMP homology and PDZ-binding domains. Finally, we characterized 
the spatiotemporal expression of GDA throughout Xenopus embryonic development using RT-
PCR and whole-mount in situ hybridization. We show that the highest expression of GDA occurs 
at 3 dpf and that it is strongly expressed in the kidneys, where it may play a role in kidney 
function. Thus, our work provides, for the first time, a characterization of GDA expression 
during embryonic development along with a comparison between human and Xenopus GDA, 
revealing divergence in sequence and function. 
A GDA evolutionary study had determined that the Rattus norvegicus, Xenopus laevis and 




are evolutionarily similar 210. While the GDA enzymatic activity of guanine deamination into 
xanthine and ammonia has been conserved across many species 210, few studies have examined 
GDA function during embryonic development. One of the most prominent studies of GDA 
function has examined the role of the mammalian orthologue, Cypin, during neuronal 
development 204,214,215. Importantly, GDAs contain a PDZ-binding domain that is important for 
interaction and clustering with other proteins 216. The Cypin PDZ-binding domain is necessary 
for binding to PSD-95 protein 207, which has been described to increase dendritic branching 207 
and indirectly affect MT dynamics 209. 
Interestingly, while the enzymatic active site and divalent cation-binding domain are conserved 
among these species, the PDZ-binding domain is not present in either of the Xenopus homologs 
210. Additionally, GDAs also have a CRMP homology domain that is known to bind tubulin 
heterodimers 207,217. The CRMP homology domain is necessary for inducing MT polymerization 
in vitro 204. Our work is the first to evaluate the sequence homology of the CRMP homology 
domain between Cypin and GDA, showing that the CRMP homology domain is not fully 
conserved. These differences in the PDZ-binding and CRMP homology domains between Cypin 
and GDA likely explain the divergence in function between the proteins as it relates to their 
ability to regulate MT dynamics. 
Our results show that exogenous expression of both GFP-tagged Cypin and GDA present a 
cytosolic distribution in living cells, and are not enriched at MT plus-ends, where the majority of 
the proteins that regulate MT plus-end dynamics are localized. Nevertheless, our observations 
are consistent with previous immunocytochemistry studies showing that Cypin has a cytosolic 
localization in rat primary hippocampal neurons 204,207,209,215. Additionally, while GDA is 




other intracellular compartments, where it exists in isoenzymic forms 218,219. Considering this 
evidence, even though GDA localization is not enriched on MTs, we cannot discard a possible 
GDA activity near MT lattice or plus ends, which could still allow Cypin to have an indirect 
effect on MT dynamics. 
Using live imaging, we showed that Cypin over-expression increases the MT growth velocity 
and MT track length in neuronal growth cones. These results are in accordance with previous 
studies showing that rat Cypin promotes MT assembly and polymerization using in vitro assays 
204. Additionally, it is well known that Cypin increases dendritic arbor length 204 and that it 
interacts with PSD-95 207. Cypin interaction with PSD-95 leads to decreased dendrite branching, 
potentially caused by the disruption of the MT cytoskeleton 220. Interestingly, PSD-95 was found 
to bind and reduce the MT binding of the known +TIP EB3, as well as reduce EB3 comet 
lifetime and velocity 209. Thus, given that Cypin has been shown to oppose PSD-95 function, and 
that PSD-95 reduces MT polymerization, it is possible that Cypin expression in our study 
perturbs the ability of PSD-95 to inhibit MT polymerization. 
However, we observed that expression of mammalian Cypin, but not Xenopus GDA, promotes 
MT polymerization. This result is consistent with the fact that the CRMP homology domain, 
which has been shown to bind tubulin and regulate MT assembly 208, is not fully conserved 
between Cypin and GDA. Additionally, the Cypin PDZ-binding domain that has been described 
to bind PSD-95 and is responsible for regulating MT dynamics 209 is absent from GDA. Finally, 
we found that by adding the Cypin CRMP homology and PDZ-binding domains to the N 
terminal region of Xenopus GDA, we observed MT dynamics regulation similar to that of Cypin. 





We found that GDA is highly expressed at 3 dpf, which corresponds to stages 41–44, a relatively 
late time point in Xenopus embryonic development. By this point, significant dendrite branching 
and elongation in Xenopus retinal ganglion cells has already occurred (stages 32–34) and the 
specialization into various dendritic subtypes is in process (stages 34–46) 221. While we cannot 
overlook the possibility of GDA being involved in this second phase of dendrite branching and 
differentiation, this hypothesis is unlikely due to the fact that whole-mount in situ hybridization 
showed minimal GDA expression in the brain or neural tube in Xenopus. While the lack of GDA 
staining in the neural tube is unsurprising given that Cypin is absent from the mammalian spinal 
cord 207, the lack of GDA expression in the brain is striking, as Cypin is highly expressed in the 
developing brain in mammals. This suggests that Cypin may have evolved to serve a different 
function in mammals than that observed in Xenopus. In the present work, we demonstrated by in 
situ hybridization that GDA is expressed primarily in the kidney. This expression pattern is more 
restricted than that observed for Cypin, which is expressed in the human nervous system, 
placenta, liver, and kidney, and absent from the heart, lung, muscle, and pancreas 207. Moreover, 
Cypin protein is expressed in rat kidney, liver, lung, brain, and spleen 207. Thus, rat Cypin 
expression pattern contrasts with that of human Cypin, which is not expressed in the lung, 
suggesting that even within mammals, Cypin has a slightly different expression pattern.  
To date, most studies relating to GDA function have focused on its role in maintenance of 
homeostasis of triphosphate nucleotides, its role as a nitrogen source, its signal transduction 
pathway, and, lately, on its role in neuronal development. In the present work, we showed that 
the peak GDA expression is at 3 dpf, which is temporally coincident with a fully functional 
primitive kidney. Thus, a GDA effect on kidney functioning or maturation to mesonephroi might 




been shown to be indicative of kidney malfunction 212,213. Nevertheless, at the Xenopus 
developmental time point that we performed our studies, the pronephroi has still not matured to 
mesonephroi, thus, it remains to be determined if GDA has an effect on kidney maturation to 
mesonephroi, or if the effect is restricted to kidney function. Additionally, given that edema also 
results from cardiac and other developmental issues, it is also possible that other organ systems 
are affected by reduced GDA function. 
The present study shows that human Cypin and Xenopus GDA have different protein sequences 
and functions. In addition, our MT dynamics analysis suggests that the role of GDA in regulating 
MT dynamics is not conserved among species. Furthermore, GDA is expressed with high 
specificity in the kidneys during Xenopus development. Thus, our study suggests a novel 
function for GDA and warrants further study of its potential role in kidney maturation and 
function. 
 
Materials and Methods 
 
Culture of Xenopus embryonic explants 
Eggs obtained from female X. laevis frogs (NASCO, Fort Atkinson, WI) were fertilized in vitro, 
dejellied, and cultured following standard methods 156. Embryos were staged according to 
Nieuwkoop and Faber 144, and embryonic explants were dissected at stage 22–24 and cultured as 
described 146. All experiments were approved by the Boston College Institutional Animal Care 





Guanine deaminase constructs and sequence alignment 
The X. laevis GDA L homeolog (GDA) sequence was designed based on the GDA annotated 
sequence from the laevis genome, version 9.1 (www.xenbase.org) using the transcript model of 
chr1L:128,874,669..128,903,678 (+ strand), which was predicted to contain the X. laevis GDA 
genomic sequence. The GDA sequence was acquired from Biomatik (Biomatik, Atlanta, GA, 
USA) in pBluescript, and then subcloned into the GFP-pCS2+ vector to add a GFP tag to the N-
terminus of GDA. The human Cypin sequence, based on NCBI reference sequence 
NM_004293.4, was obtained from Origen (Origen, Rockville, MD, USA) and subcloned into a 
GFP-pCS2+ to generate GFP-Cypin and Cypin-GFP. The Cypin-chimera was obtained by 
removing the GDA region, beginning with the CRMP domain, and replacing it with the human 
Cypin CRMP homology and PDZ-binding domain. The NCBI Reference Sequences for the 
GDA protein sequence comparison were the following: Xenopus laevis S homeolog 
(XP_018099342.1); Xenopus laevis L homeolog (NP_001083074.1); Homo sapiens 
(NP_001229434.1); Xenopus tropicalis (XP_004910825.1); Danio rerio (NP_001018510.1); 
Rattus norvegicus (NP_113964.2); Mus musculus (NP_034396.1); Gallus gallus (XP_424835.3). 
The GDA protein sequences were compared using Clustal Omega 
(www.ebi.ac.uk/Tools/msa/clustalo/; RRID: SCR_001591). 
 
RNA and Morpholino 
Capped mRNA was transcribed in vitro using the SP6 mMessage mMachine Kit (Thermo Fisher 
Scientific, Waltham, MA, USA). RNA was purified with LiCl precipitation and re- suspended in 
nuclease-free water. Constructs coding for GFP, GFP-GDA, GFP-Cypin and Cypin-GFP, Cypin-




as templates for in vitro transcription. Embryos were injected at the two-to-four-cell stage in 
each dorsal blastomere (in 0.1× MMR containing 5% Ficoll) with total mRNA amount per 
embryo of 1000 pg of Cypin, GDA and 200 pg of mKate2-MACF43. 
A morpholino (MO) was designed specific to the Xenopus GDA L homeolog with the sequence 
5’ TCCCCAAACCAAAGTCCTTACCACA 3’ and targeted to the exon 3 – intron 3 splice 
junction (Fig. 4C) (Gene Tools, LLC, Philomath OR, USA). A standard control MO (5’-
cctcttacctcagttacaatttata-3’) (Gene Tools, LLC, Philomath OR, USA) was used as control MO. 
The GDA MO was injected at concentrations of 10, 20, and 50 ng per embryo in order to assess 
knock down of GDA (Fig. 4C). The GDA transcript levels were measured by reverse-
transcription PCR, and the PCR product was sent for sequencing to ensure the introduction of a 
stop codon. A 50% KD was obtained when injecting 20 ng of the MO (Fig. 4A), which was used 
for the rest of the experiments in order to generate a partial KD phenotype. 
 
Reverse-transcription PCR 
Whole RNA was extracted from embryos at various stages and adult Xenopus brain using Trizol 
reagent (Invitrogen, LifeTechnologies) and reverse transcribed using SuperScript IV reverse 
transcriptase (Invitrogen, LifeTechnologies). PCR was then performed with HotStarTaq Plus 
DNA Polymerase (Qiagen, Hilden, Germany) and primers specific to Xenopus GDA: forward 5’ 
CCCTTGTGCTGGCCGATATTAC 3’ and reverse 5’ GTAGCAGCCATGAGCCATCAC 3’ 
PCR was performed on the same samples of cDNA, also using primers specific to the 
housekeeping gene ODC1: forward 5’GCCATTGTGAAGACTCTCTCCATTC 3’ and reverse 






Live images of cultured cells were obtained with a CSU-X1M 5000 spinning-disk confocal 
(Yokogawa, Tokyo, Japan) on a Zeiss Axio Observer inverted motorized microscope with a 
Zeiss 63× Plan Apo 1.4 numerical aperture lens (Zeiss, Thornwood, NY). Images were acquired 
with an ORCA R2 charge-coupled device camera (Hamamatsu, Hamamatsu, Japan) controlled 
with Zen software. For time-lapse, images were collected every 2 sec for 1 min. For two-color 
images, the red and green channels were imaged sequentially. The images were deconvolved 
using the “Iterative Deconvolve 3D” plugin within ImageJ. Lateral images of embryos at 4 days 
post-fertilization (dpf), for quantification of edema formation, in addition to in situ hybridization 
images, were obtained with a SteREO Discovery.V8 microscope using a Zeiss 1X objective for 
edema formation experiments and 5X or 8X objectives for in situ hybridization, and Axiocam 
512 color camera (Zeiss, Thornwood, NY). Images of immunostained fluorescent kidneys at 4 
dpf were obtained with a Leica TCS SP5 scanning confocal inverted microscope (Leica, Buffalo 
Grove, IL) using a 10X objective. Lateral images of embryos were obtained in a BABB solution 
on a MatTek glass bottom dish. 
 
plusTipTracker software analysis 
MT dynamics were analyzed from mKate2-MACF43 movies from embryonic mesenchymal 
cells using plusTipTracker, as previously described 112,145. The same parameters were used for all 
movies: maximum gap length, eight frames; minimum track length, three frames; search radius 




shrinkage factor, 0.8; fluctuation radius, 2.5 pixels; and time interval 2 sec. Only cells with a 
minimum number of 10 MT tracks in a 1-min time lapse were included for analysis. All raw data 
of automated tracking of mKate2-MACF43 comets were normalized to the same-day control 
means. Dot plots were made using GraphPad Prism (GraphPad Software, La Jolla, CA). To 
determine statistical differences, unpaired two-tailed t tests were used for comparing two 
conditions, after confirming normalized data distribution (GraphPad). A total of 83–154 growth 
cones were analyzed for each condition, from three independent experiments. 
 
Whole-mount in situ hybridization 
Embryos at various developmental stages from two-cell to 6 dpf were fixed overnight at 4°C in a 
solution of 4% paraformaldehyde in phosphate-buffered saline (PBS), gradually dehydrated 
using ascending concentrations of methanol in PBS, and stored in methanol at −20°C before in 
situ hybridization, which was performed as previously described 143. Embryos were treated with 
proteinase K for: 1–2 min in the case of 1 dpf embryos and 3–5 min for 3–6 dpf embryos, and 
then bleached under a fluorescent light in 1.8× saline–sodium citrate, 1.5% H2O2, and 5% 
(vol/vol) formamide for 45 min before prehybridization. Probes for both GDA and the proximal 
tubule kidney marker, xSGLT1K (sodium glucose transporter), were used at a concentration of 
0.5 μg/ml and hybridized overnight. Sglt1K construct pCMV-SPORT6, SalI/T7 was a gift from 
the Wessely Lab (Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA). The full-
length antisense digoxigenin-labeled hybridization RNA probes were transcribed in vitro using 
the T7 MAXIscript kit (Thermo Fisher Scientific, Waltham, MA, USA). The probes were 





Quantification of the edema formation 
Embryos were injected with 20 ng of the control MO, Xenopus GDA MO or Xenopus GDA MO 
plus 1000 pg GDA mRNA, for rescue experiments. From lateral images of 4 dpf injected 
tadpoles, the formation of edema was analyzed by measuring the length from the top of the face 
to the bottom of the chest (face-chest), and as the size of the head can vary from tadpole to 
tadpole, the length from the middle of the cement gland to the middle of the eye (cement gland-
eye) was used as an internal reference (Figure A.III.4C). The ratios of the former over the latter 
measurement were compared among the different conditions, to normalize the data for 
differences in tadpole size. The presence of edema in the embryo was defined as when the above 
ratio was 2×greater than standard deviation of ratios from the control MO injected embryos. Dot 
plots were produced using GraphPad Prism (GraphPad Software, La Jolla, CA). 
 
Whole-mount immunostaining 
Embryos were injected at the 4-cell stage in the left ventral blastomere to target the developing 
kidney on the left side of the embryo, leaving the right side as an uninjected internal control. 
Embryos were injected with 20 ng of control MO with 300 pg of GFP mRNA or 20 ng of 
Xenopus GDA MO with 300 pg of GFP mRNA. At 4 dpf, the embryos were fixed overnight at 
4° C in a solution of 4% paraformaldehyde in phosphate-buffered saline (PBS). After 24 hours, 
the 4% paraformaldehyde solution was removed and embryos were dehydrated in multiple 
methanol washes, and subsequently rehydrated in a methanol/PBS series. The eyes and 
surrounding cartilage were removed from each embryo for ease of mounting when imaging. 
Embryos were bleached under a fluorescent lamp in a 1.8X saline-sodium citrate, 1.5% H2O2, 




solution (3% bovine serum albumin, 1% Triton X-100 in PBS) for two hours, embryos were 
incubated overnight at 4° in 2% 4A6 and 2% 3G8 monoclonal antibodies (European Xenopus 
Resource Center) in blocking solution. After multiple rinses, embryos were incubated with 0.1% 
anti-mouse Alexa 488 overnight at 4° C. Embryos were then cleared overnight in BABB solution 
(33% benzyl alcohol, 66% benzyl benzoate). 
 
Quantification of pronephric tubule diameter 
The embryonic kidneys were immunostained using both 3G8 and 4A6 antibodies, specific 
markers of pronephric tubules and nephrostomes, respectively, in order to obtain a full picture of 
the kidney. The diameter of each tubule at its widest point was measured at 4 layers through the 
immunostained embryonic kidney: 35%, 45%, 55%, and 65% through the sample. The average 
of the widest diameter was obtained for each sample, then a ratio was calculated between the 
average tubule diameter of the injected and uninjected sides. The Xenopus GDA knockdown 
condition was compared with the control MO condition, and the results were presented with a 
dot plot produced with GraphPad Prism (GraphPad Software, La Jolla, CA). 
 
Statistical Analysis 
Statistical analyses were performed using GraphPad Prism (GraphPad Software Inc). The 
D’Agostino and Pearson normality test was used to determine if the data was distributed 
normally. For MT dynamics analyses, the unpaired Student’s t-test was performed when 
comparing two conditions. To assess statistical significance when quantifying the edema 




test. At least 3 independent experiments were carried out for each condition. The alpha value was 
set at 0.05 for all statistical tests, and the P values are represented as follows: *P<0.05, 
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